<SEC-DOCUMENT>0001493152-22-001058.txt : 20220112
<SEC-HEADER>0001493152-22-001058.hdr.sgml : 20220112
<ACCEPTANCE-DATETIME>20220112165657
ACCESSION NUMBER:		0001493152-22-001058
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20220111
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220112
DATE AS OF CHANGE:		20220112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LifeMD, Inc.
		CENTRAL INDEX KEY:			0000948320
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
		IRS NUMBER:				760238453
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39785
		FILM NUMBER:		22527090

	BUSINESS ADDRESS:	
		STREET 1:		800 THIRD AVENUE, SUITE 2800
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		(866) 351-5907

	MAIL ADDRESS:	
		STREET 1:		800 THIRD AVENUE, SUITE 2800
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CONVERSION LABS, INC.
		DATE OF NAME CHANGE:	20180622

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Immudyne, Inc.
		DATE OF NAME CHANGE:	20120514

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IMMUDYNE INC
		DATE OF NAME CHANGE:	19950720
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:LFMD="http://lifemd.com/20220111">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_032_LFMD_lifemd.com_20220111 -->
<!-- Field: Set; Name: xdx; ID: xdx_045_20220111_20220111 -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0000948320 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-01-11to2022-01-11" name="dei:EntityCentralIndexKey">0000948320</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-11to2022-01-11" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="lfmd-20220111.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-01-11to2022-01-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-11</xbrli:startDate>
        <xbrli:endDate>2022-01-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-112022-01-11_custom_CommonStockParValue0.01PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFMD:CommonStockParValue0.01PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-11</xbrli:startDate>
        <xbrli:endDate>2022-01-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-112022-01-11_custom_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFMD:SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-11</xbrli:startDate>
        <xbrli:endDate>2022-01-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_906_edei--DocumentType_c20220111__20220111_ziswgFKXSS3c"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT
REPORT</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the Securities and Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (Date of earliest event reported): <span id="xdx_909_edei--DocumentPeriodEndDate_c20220111__20220111_zp0PmRfG6q7f"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">January 11, 2022</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline"><span id="xdx_900_edei--EntityRegistrantName_c20220111__20220111_zikQAwTQjTx3"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" name="dei:EntityRegistrantName">LIFEMD,
INC.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of Registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20220111__20220111_zTI2AW6ZMlHl"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityFileNumber_c20220111__20220111_zHA6bUQT9ao1"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" name="dei:EntityFileNumber">001-39785</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20220111__20220111_zouRs8Hx3xM1"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" name="dei:EntityTaxIdentificationNumber">76-0238453</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
    or other jurisdiction</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
    incorporation)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Commission</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>File
    Number)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(IRS
    Employer</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
    No.)</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_903_edei--EntityAddressAddressLine1_c20220111__20220111_z52nfdy1MNbl"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" name="dei:EntityAddressAddressLine1">800
Third Avenue</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressAddressLine2_c20220111__20220111_ztnZlff8sv8c"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" name="dei:EntityAddressAddressLine2">Suite 2800</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_900_edei--EntityAddressCityOrTown_c20220111__20220111_zFJ0H2QZzzvj"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" name="dei:EntityAddressCityOrTown">New
York</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20220111__20220111_z2949u0Cd6bi"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" name="dei:EntityAddressStateOrProvince">NY</ix:nonNumeric></span> <span id="xdx_903_edei--EntityAddressPostalZipCode_c20220111__20220111_zATlpICiJeO1"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" name="dei:EntityAddressPostalZipCode">10022</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address
of principal executive offices, including zip code)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_90D_edei--CityAreaCode_c20220111__20220111_zziJDFyeq87k"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" name="dei:CityAreaCode">(866)</ix:nonNumeric></span>
<span id="xdx_904_edei--LocalPhoneNumber_c20220111__20220111_zW5rBP3ImCX1"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" name="dei:LocalPhoneNumber">351-5907</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Registrant&#8217;s
telephone number, including area code)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any
of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--WrittenCommunications_c20220111__20220111_zYDtNvRAxZb1"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communication
    pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--SolicitingMaterial_c20220111__20220111_zotmBPmwoKIf"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant
    to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--PreCommencementTenderOffer_c20220111__20220111_zBvthyxEXfgb"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20220111__20220111_z2Woz9Q0v4Ae"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 36%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--Security12bTitle_c20220111__20220111__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.01PerShareMember_zE6sbsCZxmuh"><ix:nonNumeric contextRef="From2022-01-112022-01-11_custom_CommonStockParValue0.01PerShareMember" name="dei:Security12bTitle">Common Stock, par value
                                                                             $0.01 per share</ix:nonNumeric></span></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--TradingSymbol_c20220111__20220111__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.01PerShareMember_zhpE3sHRrtv1"><ix:nonNumeric contextRef="From2022-01-112022-01-11_custom_CommonStockParValue0.01PerShareMember" name="dei:TradingSymbol">LFMD</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--SecurityExchangeName_c20220111__20220111__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.01PerShareMember_zCt16lsh2Fh"><ix:nonNumeric contextRef="From2022-01-112022-01-11_custom_CommonStockParValue0.01PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Global Market</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--Security12bTitle_c20220111__20220111__us-gaap--StatementClassOfStockAxis__custom--SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember_z2zY4bArKJF9"><ix:nonNumeric contextRef="From2022-01-112022-01-11_custom_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember" name="dei:Security12bTitle">Series A Cumulative Perpetual
    Preferred Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--TradingSymbol_c20220111__20220111__us-gaap--StatementClassOfStockAxis__custom--SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember_zjpoaXRyENbe"><ix:nonNumeric contextRef="From2022-01-112022-01-11_custom_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember" name="dei:TradingSymbol">LFMDP</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--SecurityExchangeName_c20220111__20220111__us-gaap--StatementClassOfStockAxis__custom--SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember_zkIZxL1R4RI5"><ix:nonNumeric contextRef="From2022-01-112022-01-11_custom_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Global Market</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_900_edei--EntityEmergingGrowthCompany_c20220111__20220111_zNQgpJvanLql"><ix:nonNumeric contextRef="From2022-01-11to2022-01-11" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="text-align: center; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; text-align: center; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry into a Material Definitive Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 11, 2022, LifeMD, Inc., a Delaware corporation (the &#8220;Company&#8221;), entered into a Stock Purchase Agreement (the &#8220;Purchase
Agreement&#8221;), by and among the Company, Cleared Technologies, PBC, a Delaware public benefit corporation (&#8220;Cleared&#8221;)
and the stockholders of Cleared identified in the Purchase Agreement (the &#8220;Sellers&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Purchase Agreement, the Company agreed to acquire all of the issued and outstanding equity securities of Cleared (the &#8220;Acquisition&#8221;)
in exchange for (i) a payment equal to $460,000 to be paid at the closing of the Acquisition, (ii) a payment equal to $1,730,000 to be
paid on or before the one year anniversary of the closing of the Acquisition, and (iii) a payment equal to $1,730,000 to be paid on or
before the two year anniversary following the closing of the Acquisition (all payments, the &#8220;Acquisition Consideration&#8221;).
In addition, pursuant to the Purchase Agreement, the Company agreed to pay to the Sellers certain &#8220;earn-out&#8221; payments, contingent
upon the achievement of certain milestones through December 31, 2025 if and when Cleared produces specified amounts of revenue (the &#8220;Earn
Out Consideration&#8221;). The maximum amount of Earn Out Consideration that Cleared can earn under the Purchase Agreement is $72,800,000
upon producing $150,000,000 of revenue within a trailing period of twelve consecutive months. The Acquisition Consideration and Earn
Out Consideration is payable, as determined by the Company in its sole discretion, by (i) cash, (ii) common stock of the Company based
upon the volume weighted average price of the common stock of the Company on the Nasdaq Capital Market (or another stock exchange, if
the common stock of the Company is no longer listed on the Nasdaq Capital Market) for the 20 trading days immediately preceding the fifth
day before the date of payment, or (iii) any combination of cash and common stock of the Company (valued in accordance with (ii) above).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cleared
is a privately held, telehealth company that provides personalized treatments for allergy, asthma, and immunology to patients across
the United States. Cleared is based in New York City, New York.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement contains customary representations, warranties and covenants by each of the parties, and contains indemnification
provisions under which the parties have agreed, subject to certain limitations, to indemnify each other against certain liabilities.
On the closing date of the Acquisition, the Company will deposit a portion of the Acquisition Consideration with an escrow agent to be
held in escrow. The escrow amount may be used to account for indemnification claims and any post-closing adjustment of the Acquisition
Consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the Acquisition is subject to customary conditions, including, among others, (i) the absence of any governmental order that
restrains, prevents or materially alters the transactions contemplated by the Purchase Agreement, (ii) the accuracy of the parties&#8217;
representations and warranties contained in the Purchase Agreement (subject to certain qualifications), (iii) the parties&#8217; material
compliance with the covenants and agreements in the Purchase Agreement, and (iv) the absence of a material adverse effect on the Company
or Cleared. The Company expects the Acquisition to close in the first quarter of 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement also contains customary pre-closing covenants, including the obligation of Cleared to conduct its business in all
material respects in the ordinary course and to refrain from taking certain specified actions without the consent of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement is terminable at any time prior to closing by mutual consent of the parties and in the following limited circumstances:
(i) by the Company if there is an uncured (within 10 days of written notice) breach by Sellers that would result in the failure of a
closing condition; (ii) by Sellers if there is an uncured (within 10 days of written notice) material breach by the Company that would
result in the failure of a closing condition; (iii) by the Company, if the Sellers or Cleared have not satisfied their respective closing
conditions as of January 31, 2022 or if satisfaction of such a condition becomes impossible and the Company has not waived such condition
on or before such date; or (iv) by Sellers, if the Company has not satisfied its closing conditions as of January 31, 2022 or if satisfaction
of such a condition becomes impossible and Sellers or Cleared has not waived such condition on or before such date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Purchase Agreement and the transactions contemplated therein does not purport to be complete and is qualified
in its entirety by reference to the complete text of the Purchase Agreement, which is filed as Exhibit 2.1 to this Current Report on
Form 8-K and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02 Unregistered Sales of Equity Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information provided in response to Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may issue shares of its common stock in lieu of cash as the Acquisition Consideration and Earn Out Consideration, if applicable,
to persons who are &#8220;accredited investors&#8221; as defined in Rule 501 of Regulation D promulgated under the Securities Act of
1933, as amended (the &#8220;Securities Act&#8221;). The issuance of shares of common stock in lieu of cash as the Acquisition Consideration
and Earn Out Consideration in the Acquisition will be made in reliance on the exemption from registration afforded under Section 4(a)(2)
of the Securities Act and/or Rule 506 of Regulation D under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
7.01 Regulation FD Disclosure</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 11, 2022, the Company issued a press release announcing its entry into the Purchase Agreement. A copy of the Company&#8217;s
press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not intend for this Item 7.01, Exhibit 99.1 to be treated as &#8220;filed&#8221; for purposes of the Securities Exchange
Act of 1934, as amended, or incorporated by reference into its filings under the Securities Act of 1933, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cautionary
Statements Regarding Forward-Looking Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
statements contained in this report that are not statements of historical fact constitute forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, certain plans, expectations,
goals, projections and benefits relating to the Acquisition, which are subject to numerous assumptions, risks and uncertainties. Words
such as &#8216;&#8216;believes,&#8217;&#8217; &#8216;&#8216;anticipates,&#8217;&#8217; &#8220;likely,&#8221; &#8220;expected,&#8221;
&#8220;estimated,&#8221; &#8216;&#8216;intends&#8217;&#8217; and other similar expressions are intended to identify forward-looking statements
but are not the exclusive means of identifying such statements. Please refer to the Company&#8217;s Report on Form 10-K for the year
ended December 31, 2020, as well as its other filings with the SEC, for a more detailed discussion of risks, uncertainties and factors
that could cause actual results to differ from those discussed in the forward-looking statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements are not historical facts but instead express only management&#8217;s beliefs regarding future results or events, many of which,
by their nature, are inherently uncertain and outside of the management&#8217;s control. It is possible that actual results and outcomes
will differ, possibly materially, from the anticipated results or outcomes indicated in these forward-looking statements. In addition
to factors previously disclosed in reports filed by the Company with the SEC, risks and uncertainties for the Company include, but are
not limited to, the failure to satisfy conditions to completion of the Acquisition, including receipt of required regulatory and other
approvals and the failure of the Acquisition to close for any other reason. All forward-looking statements included in this filing are
made as of the date hereof and are based on information available at the time of the filing. Except as required by law, the Company does
not assume any obligation to update any forward-looking statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    </b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No.</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex2-1.htm">Stock Purchase Agreement, dated as of January 11, 2022</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release, dated January 12, 2022</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">104</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Schedules
and exhibits to the Stock Purchase Agreement have been omitted. A copy of any omitted schedule or exhibit will be furnished supplementally
to the SEC upon its request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LIFEMD, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 12, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Eric Yecies</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric Yecies</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General Counsel and Chief Compliance Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJyNkNFKAzEQRb+g/zAsPpY2WezLvtVFi9jK0pbia+xONXSTLJPsaj/Jv3Q2qy1ii4ZACHPn3DuTJMNk5u50hQRPN8s5rNHUlQoIS9whod0iK/L7hwz4XeKL9oGUDfH73Zg77kHumYykVFyI0lZ7LDMQcizTcZqCuM4mKRSLZNDVc2d3ukQbtKpA2RIKcjVpDIoOPWGt3p115hCtNkheO5uBHIm+/AGpkCk8ula9Odp7mM/zZDCMZ5DMyDV1Z9P44AzcVmjYy/etpxujbKMmWyHb+7wxDc+vWyyQagyNqgrqVkFYroLb7gtFG1U1KEZCCMmi1asiXKB5RmKYFCnnmn6F7JkwhRMWjlw4giGSh1ArgraDw1WPh5rX6zuDM4F57cbZH6EuxOiVv1z+x+Qkf415gR+nODPDJ7Erv2M= -->

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>ex2-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
2.1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STOCK
PURCHASE AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">between</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIFEMD,
INC.,</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLEARED
TECHNOLOGIES, PBC,</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sellers listed on Schedule 1 attached</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dated
as of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
11, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TABLE
OF CONTENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ARTICLE
    I DEFINITIONS</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ARTICLE
    II PURCHASE AND SALE</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 2.01 Purchase and Sale.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 2.02 Purchase Price.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 2.03 Transactions to be Effected at the
    Closing.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 2.04 Purchase Price Adjustment.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 2.05 Closing.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 2.06 Withholding Tax.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 2.07 Post-Closing Fixed Payments.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 2.08 Earn-Out.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 2.09 Satisfaction of Purchase Price.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 2.10 NASDAQ Limitations.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ARTICLE
    III REPRESENTATIONS AND WARRANTIES OF SELLER</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 3.01 Organization and Authority of Seller.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 3.02 Organization, Authority and Qualification
    of the Company.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 3.03 Capitalization.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 3.04 No Subsidiaries.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 3.05 No Conflicts; Consents.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 3.06 Financial Statements.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 3.07 Undisclosed Liabilities.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 3.08 Absence of Certain Changes, Events
    and Conditions.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 3.09 Material Contracts.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 3.10 Title to Assets; Real Property.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 3.11 Condition and Sufficiency of Assets.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 3.12 Intellectual Property.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 3.13 Inventory.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 3.14 Accounts Receivable.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section 3.15 Customers and Suppliers.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    3.16 Insurance.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    3.17 Legal Proceedings; Governmental Orders.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    3.18 Compliance With Laws.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    3.19 Environmental Matters.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    3.20 Employee Benefit Matters.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    3.21 Employment Matters.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    3.22 Taxes.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    3.23 Books and Records.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    3.24 Brokers.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    3.25 Health Care Regulations.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    3.26 Permits.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    3.27 Affiliated Practices.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    3.28 Full Disclosure.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ARTICLE
    IV REPRESENTATIONS AND WARRANTIES OF BUYER</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    4.01 Organization and Authority of Buyer.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    4.02 No Conflicts; Consents.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    4.03 Investment Purpose.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    4.04 Brokers.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    4.05 Legal Proceedings.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ARTICLE
    V COVENANTS</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    5.01 Conduct of Business Prior to the Closing.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    5.02 Access to Information.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    5.03 No Solicitation of Other Bids.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    5.04 Notice of Certain Events.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    5.05 Resignations.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    5.06 Confidentiality.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    5.08 Governmental Approvals and Consents.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    5.09 Books and Records.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    5.10 Closing Conditions</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    5.11 Public Announcements.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    5.12 Release of Claims.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    5.13 Further Assurances.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ARTICLE
    VI TAX MATTERS</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    6.01 Tax Covenants.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    6.02 Termination of Existing Tax Sharing Agreements.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    6.03 Tax Indemnification.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    6.04 Straddle Period.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    6.05 Contests.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    6.06 Cooperation and Exchange of Information.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    6.07 Tax Treatment of Indemnification Payments.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    6.08 Payments to Buyer.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    6.09 Survival.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    6.10 Overlap.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ARTICLE
    VII CONDITIONS TO CLOSING</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    7.01 Conditions to Obligations of All Parties.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    7.02 Conditions to Obligations of Buyer.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    7.03 Conditions to Obligations of Seller.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ARTICLE
    VIII INDEMNIFICATION</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    8.01 Survival.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    8.02 Indemnification By Seller.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    8.03 Indemnification By Buyer.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    8.04 Certain Limitations.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    8.05 Indemnification Procedures.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    8.06 Payments; Indemnification Escrow Fund.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">82</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    8.07 Tax Treatment of Indemnification Payments.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">82</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    8.08 Effect of Investigation.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">82</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    8.09 Exclusive Remedies.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">82</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ARTICLE
    IX TERMINATION</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    9.01 Termination.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    9.02 Effect of Termination.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">84</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ARTICLE
    X MISCELLANEOUS</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">84</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    10.01 Seller Representative.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">84</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    10.02 Expenses.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    10.03 Notices.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    10.04 Interpretation.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    10.05 Headings.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    10.06 Severability.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    10.07 Entire Agreement.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    10.08 Successors and Assigns.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    10.09 No Third-party Beneficiaries.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    10.10 Amendment and Modification; Waiver.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    10.11 Governing Law; Submission to Jurisdiction; Waiver of Jury Trial.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    10.12 Specific Performance.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    10.13 Counterparts.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STOCK
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Stock Purchase Agreement (this &ldquo;<B>Agreement</B>&rdquo;), dated as of January 11, 2022, is entered into between the holders of
the shares of common stock of the Company (as defined below) identified on Schedule 1 attached hereto (the &ldquo;<B>Sellers</B>&rdquo;)
and LifeMD, Inc., a Delaware corporation (&ldquo;<B>Buyer</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
Sellers own all of the issued and outstanding shares of common stock, par value $0.0001 per share (the &ldquo;<B>Shares</B>&rdquo;),
of Cleared Technologies, PBC, a Delaware public benefit corporation (the &ldquo;<B>Company</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
Sellers wish to sell to Buyer, and Buyer wishes to purchase from Sellers, the Shares, subject to the terms and conditions set forth herein;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
a portion of the purchase price payable by Buyer to Sellers shall be placed in escrow by Buyer, the release of which shall be contingent
upon certain events and conditions, all as set forth in this Agreement and the Escrow Agreement (as defined herein);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I<FONT STYLE="text-transform: uppercase"><BR>
Definitions</FONT></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following terms have the meanings specified or referred to in this ARTICLE I:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Acquisition
Proposal</B>&rdquo; has the meaning set forth in Section 5.03(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Action</B>&rdquo;
means any claim, action, cause of action, demand, lawsuit, arbitration, inquiry, audit, notice of violation, proceeding, litigation,
citation, summons, subpoena or investigation of any nature, civil, criminal, administrative, regulatory or otherwise, whether at law
or in equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is
under common control with, such Person. The term &ldquo;control&rdquo; (including the terms &ldquo;controlled by&rdquo; and &ldquo;under
common control with&rdquo;) means the possession, directly or indirectly, of the power to direct or cause the direction of the management
and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliated
Practices</B>&rdquo; means all of the professional medical companies, corporations, associations and entities to which the Company provides
administrative and business support services, and including any limited liability company, corporation, association or other entity owned
by the same.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliated
Practices Agreements</B>&rdquo; is defined in Section 3.27(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliated
Practices Capital Stock</B>&rdquo; means shares of stock of each of the Affiliated Practices that are issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliated
Practices Employment Agreements</B>&rdquo; is defined in Section 3.27(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliated
Practices Personnel</B>&rdquo; means any former or current director, officer, employee, independent contractor or consultant of any Affiliated
Practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Affiliated
Practices Shareholder</B>&rdquo; means a holder of Affiliated Practices Capital Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Allocation
Schedule</B>&rdquo; has the meaning set forth in Section 6.05(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Ancillary
Documents</B>&rdquo; means the Escrow Agreement and any other agreement required to be delivered under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Financial
Statements</B>&rdquo; has the meaning set forth in Section 3.06.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Balance
Sheet</B>&rdquo; has the meaning set forth in Section 3.06.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Balance
Sheet Date</B>&rdquo; has the meaning set forth in Section 3.06.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Benefit
Plan</B>&rdquo; has the meaning set forth in Section 3.20(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Business
Day</B>&rdquo; means any day except Saturday, Sunday or any other day on which commercial banks located in New York are authorized or
required by Law to be closed for business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Buyer</B>&rdquo;
has the meaning set forth in the preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Buyer
Change of Control</B>&rdquo; means the occurrence of a single transaction or series of related transactions pursuant to which (i) any
&ldquo;person&rdquo; or &ldquo;group&rdquo; (within the meaning of Section 13(d) and 14(d) of the Exchange Act), becomes the &ldquo;beneficial
owner&rdquo; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of more than 50% of the (a) aggregate ownership
by value or (b) outstanding voting securities of the Buyer having the right to vote for the election of members of the board of directors
of Buyer, (ii) any reorganization, merger or consolidation of the Buyer, other than a transaction or series of related transactions in
which the holders of the voting securities of the Buyer outstanding immediately prior to such transaction or series of related transactions
retain, immediately after such transaction or series of related transactions, at least a majority of the (a) aggregate ownership of Buyer
by value and (b) total voting power represented by the outstanding voting securities of the Buyer or such other surviving or resulting
entity or (iii) a sale, lease or other disposition or exclusive license of all or substantially all of the assets of the Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Buyer
Indemnitees</B>&rdquo; has the meaning set forth in Section 8.02.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Buyer
Shares</B>&rdquo; has the meaning set forth in Section 2.08(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Buyer&rsquo;s
Accountants</B>&rdquo; means Friedman LLP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Cap</B>&rdquo;
has the meaning set forth in Section 8.04(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>CARES
Act</B>&rdquo; means the Coronavirus Aid, Relief and Economic Security Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>CERCLA</B>&rdquo;
means the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended by the Superfund Amendments and Reauthorization
Act of 1986, 42 U.S.C. &sect;&sect; 9601 et seq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Closing</B>&rdquo;
has the meaning set forth in Section 2.05.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Closing
Date</B>&rdquo; has the meaning set forth in Section 2.05.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Closing
Date Payment</B>&rdquo; has the meaning set forth in Section 2.04(a)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Closing
Payables</B>&rdquo; means: the Current Liabilities of the Company, determined as of the open of business on the Closing Date, and as
may be adjusted pursuant to Schedule 2 attached hereto and Section 3.07(2) of the Disclosure Schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Closing
Working Capital Statement</B>&rdquo; has the meaning set forth in Section 2.04(b)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Code</B>&rdquo;
means the Internal Revenue Code of 1986, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company</B>&rdquo;
has the meaning set forth in the recitals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
Claims</B>&rdquo; has the meaning set forth in Section 5.13.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
Intellectual Property</B>&rdquo; means all Intellectual Property that is owned by the Company, any Subsidiary, or any Affiliated Practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
IP Agreements</B>&rdquo; means all licenses, sublicenses, consent to use agreements, settlements, coexistence agreements, covenants not
to sue, waivers, releases, permissions and other Contracts, whether written or oral, relating to Intellectual Property to which the Company,
any Subsidiary, or any Affiliated Practice is a party, beneficiary or otherwise bound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
IP Registrations</B>&rdquo; means all Company Intellectual Property that is subject to any issuance, registration or application by or
with any Governmental Authority or authorized private registrar in any jurisdiction, including issued patents, registered trademarks,
domain names and copyrights, and pending applications for any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Company
IT Systems&rdquo;</B> means all Software, computer hardware, servers, networks, platforms, peripherals, and similar or related items
of automated, computerized, or other information technology (IT) networks and systems (including telecommunications networks and systems
for voice, data and video) owned, leased, licensed, or used (including through cloud-based or other third-party service providers) by
the Company, and Subsidiary, or any Affiliated Practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Contracts</B>&rdquo;
means all contracts, leases, deeds, mortgages, licenses, instruments, notes, commitments, undertakings, indentures, joint ventures and
all other agreements, commitments and legally binding arrangements, whether written or oral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Current
Assets</B>&rdquo; means cash and cash equivalents, accounts receivable, inventory and prepaid expenses, but excluding (a) the portion
of any prepaid expense of which Buyer will not receive the benefit following the Closing, (b) deferred Tax assets, and (c) receivables
from any of the Company&rsquo;s Affiliates, directors, employees, officers or stockholders and any of their respective Affiliates, determined
in accordance with GAAP applied using the same accounting methods, practices, principles, policies and procedures, with consistent classifications,
judgments and valuation and estimation methodologies that were used in the preparation of the Financial Statements for the most recent
fiscal year end as if such accounts were being prepared and audited as of a fiscal year end.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Current
Liabilities</B>&rdquo; means accounts payable, accrued Taxes and accrued expenses, but excluding payables to any of the Company&rsquo;s
Affiliates, directors, employees, officers or stockholders and any of their respective Affiliates, deferred Tax liabilities, Transaction
Expenses and the current portion of any Indebtedness of the Company, determined in accordance with GAAP applied using the same accounting
methods, practices, principles, policies and procedures, with consistent classifications, judgments and valuation and estimation methodologies
that were used in the preparation of the Financial Statements for the most recent fiscal year end as if such accounts were being prepared
and audited as of a fiscal year end.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>De
Minimus Amount</B>&rdquo; has the meaning set forth in Section 8.04(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Direct
Claim</B>&rdquo; has the meaning set forth in Section 8.05(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Disclosure
Schedules</B>&rdquo; means the Disclosure Schedules delivered by Sellers and Buyer concurrently with the execution and delivery of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Disputed
Amounts</B>&rdquo; has the meaning set forth in Section 2.04(c)(iii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Dollars
or $</B>&rdquo; means the lawful currency of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Earn-Out
Event</B>&rdquo; has the meaning set forth in Section 2.08(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Earn-Out
Payment</B>&rdquo; has the meaning set forth in Section 2.08(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Earn-Out
Period</B>&rdquo; has the meaning set forth in Section 2.08(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Earn-Out
Products</B>&rdquo; means ear, nose, throat, allergy, and asthma categories of care products and services (including diagnostic tests)
(the &ldquo;<B>Categories</B>&rdquo;) provided by either Buyer or Seller (but excluding Buyer primary care patients) which are obtained
or scheduled through the Company brand names of &ldquo;Cleared&rdquo; or any other brand name under which products or services in the
Categories are sold, which products, services, or brand name is derived predominantly or in full from the intellectual property of the
Company (the &ldquo;<B>Brand</B>&rdquo;). &ldquo;Earn-Out Products&rdquo; shall include but not be limited to any form of online or offline
business sales activity or revenue received from sales of products or services under the Brand, including sales activity and revenue
associated with patients, organizations, insurance providers, and clients from products or services under the Brands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Encumbrance</B>&rdquo;
means any charge, claim, community property interest, pledge, condition, equitable interest, lien (statutory or other), option, security
interest, mortgage, easement, encroachment, right of way, right of first refusal, or restriction of any kind, including any restriction
on use, voting, transfer, receipt of income or exercise of any other attribute of ownership.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Environmental
Attributes</B>&rdquo; means any emissions and renewable energy credits, energy conservation credits, benefits, offsets and allowances,
emission reduction credits or words of similar import or regulatory effect (including emissions reduction credits or allowances under
all applicable emission trading, compliance or budget programs, or any other federal, state or regional emission, renewable energy or
energy conservation trading or budget program) that have been held, allocated to or acquired for the development, construction, ownership,
lease, operation, use or maintenance of the Company as of: (i) the date of this Agreement; and (ii) future years for which allocations
have been established and are in effect as of the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Environmental
Claim</B>&rdquo; means any Action, Governmental Order, lien, fine, penalty, or, as to each, any settlement or judgment arising therefrom,
by or from any Person alleging liability of whatever kind or nature (including liability or responsibility for the costs of enforcement
proceedings, investigations, cleanup, governmental response, removal or remediation, natural resources damages, property damages, personal
injuries, medical monitoring, penalties, contribution, indemnification and injunctive relief) arising out of, based on or resulting from:
(a) the presence, Release of, or exposure to, any Hazardous Materials; or (b) any actual or alleged non-compliance with any Environmental
Law or term or condition of any Environmental Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Environmental
Law</B>&rdquo; means any applicable Law, and any Governmental Order or binding agreement with any Governmental Authority: (a) relating
to pollution (or the cleanup thereof) or the protection of natural resources, endangered or threatened species, human health or safety,
or the environment (including ambient air, soil, surface water or groundwater, or subsurface strata); or (b) concerning the presence
of, exposure to, or the management, manufacture, use, containment, storage, recycling, reclamation, reuse, treatment, generation, discharge,
transportation, processing, production, disposal or remediation of any Hazardous Materials. The term &ldquo;Environmental Law&rdquo;
includes, without limitation, the following (including their implementing regulations and any state analogs): the Comprehensive Environmental
Response, Compensation, and Liability Act of 1980, as amended by the Superfund Amendments and Reauthorization Act of 1986, 42 U.S.C.
&sect;&sect; 9601 et seq.; the Solid Waste Disposal Act, as amended by the Resource Conservation and Recovery Act of 1976, as amended
by the Hazardous and Solid Waste Amendments of 1984, 42 U.S.C. &sect;&sect; 6901 et seq.; the Federal Water Pollution Control Act of
1972, as amended by the Clean Water Act of 1977, 33 U.S.C. &sect;&sect; 1251 et seq.; the Toxic Substances Control Act of 1976, as amended,
15 U.S.C. &sect;&sect; 2601 et seq.; the Emergency Planning and Community Right-to-Know Act of 1986, 42 U.S.C. &sect;&sect; 11001 et
seq.; the Clean Air Act of 1966, as amended by the Clean Air Act Amendments of 1990, 42 U.S.C. &sect;&sect; 7401 et seq.; and the Occupational
Safety and Health Act of 1970, as amended, 29 U.S.C. &sect;&sect; 651 et seq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Environmental
Notice</B>&rdquo; means any written directive, notice of violation or infraction, or notice respecting any Environmental Claim relating
to actual or alleged non-compliance with any Environmental Law or any term or condition of any Environmental Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Environmental
Permit</B>&rdquo; means any Permit, letter, clearance, consent, waiver, closure, exemption, decision or other action required under or
issued, granted, given, authorized by or made pursuant to Environmental Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Equity
Consideration</B>&rdquo; has the meaning set forth in Section 2.09(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>ERISA</B>&rdquo;
means the Employee Retirement Income Security Act of 1974, as amended, and the regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>ERISA
Affiliate</B>&rdquo; means all employers (whether or not incorporated) that would be treated together with the Company or any of its
Affiliates as a &ldquo;single employer&rdquo; within the meaning of Section 414 of the Code or Section 4001 of ERISA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Escrow
Agent</B>&rdquo; means Lucosky Brookman LLP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Escrow
Agreement</B>&rdquo; means the Escrow Agreement to be entered into by Buyer, Sellers and Escrow Agent at the Closing, substantially in
the form of Exhibit A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Estimated
Closing Payables</B>&rdquo; has the meaning set forth in Section 2.04(a)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Estimated
Closing Working Capital Statement</B>&rdquo; has the meaning set forth in Section 2.04(a)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Financial
Statements</B>&rdquo; has the meaning set forth in Section 3.06.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Federal
Health Care Program</B>&rdquo; means all health benefit programs that are sponsored by a Governmental Authority, including &ldquo;Federal
health care programs&rdquo; as defined by 42 U.S.C. &sect;1320a-7b(f), Medicaid, Medicare, Medicare Advantage and TRICARE.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Four-Year
Earn-Out Period</B>&rdquo; has the meaning set forth in Section 2.08(a)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>GAAP</B>&rdquo;
means United States generally accepted accounting principles in effect from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Government
Contracts</B>&rdquo; has the meaning set forth in Section 3.09(a)(viii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Governmental
Authority</B>&rdquo; means any federal, state, local or foreign government or political subdivision thereof, or any agency or instrumentality
of such government or political subdivision, or any self-regulated organization or other non-governmental regulatory authority or quasi-governmental
authority (to the extent that the rules, regulations or orders of such organization or authority have the force of Law), or any arbitrator,
court or tribunal of competent jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Governmental
Order</B>&rdquo; means any order, writ, judgment, injunction, decree, stipulation, determination or award entered by or with any Governmental
Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Gross
Revenue</B>&rdquo; has the meaning set forth in Section 2.07(c)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Hazardous
Materials</B>&rdquo; means: (a) any material, substance, chemical, waste, product, derivative, compound, mixture, solid, liquid, mineral
or gas, in each case, whether naturally occurring or manmade, that is hazardous, acutely hazardous, toxic, or words of similar import
or regulatory effect under Environmental Laws; and (b) any petroleum or petroleum-derived products, radon, radioactive materials or wastes,
asbestos in any form, lead or lead-containing materials, urea formaldehyde foam insulation, and polychlorinated biphenyls.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Health
Care Laws </B>&ldquo; means any and all applicable Laws, one purpose of which is the regulation of health care, applicable to the Company
or the Affiliated Practices, including: (i) the federal Anti-Kickback Statute (42 U.S.C. &sect; 1320a-7b(b) (including applicable statutory
exceptions and safe harbor regulations)), (ii) the Exclusion Law (42 U.S.C. &sect; 1320a-7), (iii) the Civil Monetary Penalties Law (42
U.S.C. &sect;&sect; 1320a-7a and 1320a-7b), (iv) the &ldquo;Stark Law&rdquo; (42 U.S.C. &sect; 1395nn), including the statutory exceptions
and regulatory exceptions (42 C.F.R. &sect; 411.350 et seq.), (v) the federal False Claims Act (42 C.F.R. &sect; 3729 et seq.), (vi)
the Program Fraud Civil Remedies Act (31 U.S.C. &sect; 3801 et seq.) and the Federal Health Care Fraud Law (18 U.S.C. &sect; 1347), (vii)
the Medicaid statute (Title XIX of the Social Security Act, 42 U.S.C. &sect; 1396 et seq.), (viii) the Consolidated Omnibus Budget Reconciliation
Act of 1985, (ix) TRICARE, 10 U.S.C. &sect;1071 et seq., (x) all Information Laws as defined herein, (xi) any Laws concerning the billing,
coding or submission of claims or collection of accounts receivable or refund of overpayments; (xii) any Laws concerning the corporate
practice of medicine and the provision of management or administrative services to medical practices; (xiii) any Laws related to the
provision of telemedicine, telehealth, or remote telemetry services; and (xiv) any other Law or regulation of any domestic Governmental
Authority which regulates kickbacks, fraud and abuse, Federal Health Care Programs, claims processing, medical record documentation requirements,
the hiring of employees or acquisition of services or products from those who have been excluded from Federal Health Care Programs, licensure
or any other aspect of providing health care.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>HIPAA</B>&rdquo;
means the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and
Clinical Health Act provisions of the American Recovery and Reinvestment Act of 2009, and as otherwise may be amended from time to time,
and any and all implementing regulations, as in effect from time to time, including, the Privacy Standards (45 C.F.R. Parts 160 and 164),
the Electronic Transactions Standards (45 C.F.R. Parts 160 and 162), and the Security Standards (45 C.F.R. Parts 160, 162 and 164) promulgated
under the Administrative Simplifications subtitle of the Health Insurance Portability and Accountability Act of 1996, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>HSR
Act</B>&rdquo; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Indebtedness</B>&rdquo;
means, without duplication and with respect to the Company, all (a) indebtedness for borrowed money; (b) obligations for the deferred
purchase price of property or services (other than Current Liabilities taken into account in the calculation of Closing Payables), (c)
long or short-term obligations evidenced by notes, bonds, debentures or other similar instruments; (d) obligations under any interest
rate, currency swap or other hedging agreement or arrangement; (e) capital lease obligations; (f) reimbursement obligations under any
letter of credit, banker&rsquo;s acceptance or similar credit transactions; (g) all accrued but unpaid Taxes attributable to a Pre-Closing
Tax Period; (h) all Taxes deferred pursuant to the CARES Act or the Payroll Tax Executive Order; (i) guarantees made by the Company on
behalf of any third party in respect of obligations of the kind referred to in the foregoing clauses (a) through (h); and (j) any unpaid
interest, prepayment penalties, premiums, costs and fees that would arise or become due as a result of the prepayment of any of the obligations
referred to in the foregoing clauses (a) through (i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Indemnification
Escrow Amount</B>&rdquo; means $250,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Indemnification
Escrow Fund</B>&rdquo; has the meaning set forth in Section 2.03(a)(iii)(B).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Indemnified
Liabilities</B>&rdquo; means (a) any and all Indemnified Taxes, (b) all Liabilities of the Company relating to the business of the Company
or otherwise arising out of events, transactions, facts, circumstances, acts, or omissions which occurred prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Indemnified
Party</B>&rdquo; has the meaning set forth in Section 8.05.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Indemnified
Taxes</B>&rdquo; means: (a) any and all Taxes attributable to any breach of or inaccuracy in any representation or warranty made in Section
3.22 (Taxes); (b) any and all Taxes attributable to any breach or violation of, or failure to fully perform, any covenant, agreement,
undertaking or obligation in this Article VII (Tax Matters); (c) any and all Taxes of Seller; (d) any and all Taxes of the Company for
all Pre-Closing Tax Periods; (e) any and all Taxes of any member of an affiliated, consolidated, combined or unitary group of which the
Company (or any predecessor of the Company) is or was a member on or prior to the Closing Date by reason of a Liability under Treasury
Regulations Section 1.1502-6 or any comparable provisions of foreign, state or local Law; (f) any and all Taxes of any Person imposed
on the Company arising under the principles of transferee or successor liability or by contract, or otherwise, relating to an event or
transaction occurring before the Closing Date; (g) Transfer Taxes; (h) any and all Taxes deferred pursuant to the CARES Act, the Payroll
Tax Executive Order, or any similar applicable federal, state or local Law; and (i) any out-of-pocket fees and expenses (including attorneys&rsquo;
and accountants&rsquo; fees) incurred in connection with any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Indemnifying
Party</B>&rdquo; has the meaning set forth in Section 8.05.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Independent
Accountant</B>&rdquo; has the meaning set forth in Section 2.04(c)(iii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Initial
Payment</B>&rdquo; has the meaning set forth in Section 2.02.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Insurance
Policies</B>&rdquo; has the meaning set forth in Section 3.16.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Intellectual
Property</B>&rdquo; means any and all rights in, arising out of, or associated with any of the following in any jurisdiction throughout
the world: (a) issued patents and patent applications (whether provisional or non-provisional), including divisionals, continuations,
continuations-in-part, substitutions, reissues, reexaminations, extensions, or restorations of any of the foregoing, and other Governmental
Authority-issued indicia of invention ownership (including certificates of invention, petty patents, and patent utility models) (&ldquo;<B>Patents</B>&rdquo;);
(b) trademarks, service marks, brands, certification marks, logos, trade dress, trade names, and other similar indicia of source or origin,
together with the goodwill connected with the use of and symbolized by, and all registrations, applications for registration, and renewals
of, any of the foregoing (&ldquo;<B>Trademarks</B>&rdquo;); (c) copyrights and works of authorship, whether or not copyrightable, and
all registrations, applications for registration, and renewals of any of the foregoing (&ldquo;<B>Copyrights</B>&rdquo;); (d) internet
domain names and social media account or user names (including &ldquo;handles&rdquo;), whether or not Trademarks, all associated web
addresses, URLs, websites and web pages, social media sites and pages, and all content and data thereon or relating thereto, whether
or not Copyrights; (e) mask works, and all registrations, applications for registration, and renewals thereof; (f) industrial designs,
and all Patents, registrations, applications for registration, and renewals thereof; (g) trade secrets, know-how, inventions (whether
or not patentable), discoveries, improvements, technology, business and technical information, databases, data compilations and collections,
tools, methods, processes, techniques, and other confidential and proprietary information and all rights therein (&ldquo;<B>Trade Secrets</B>&rdquo;);
(h) computer programs, operating systems, applications, firmware, and other code, including all source code, object code, application
programming interfaces, data files, databases, protocols, specifications, and other documentation thereof; (i) rights of publicity; and
(j) all other intellectual or industrial property and proprietary rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Interim
Balance Sheet</B>&rdquo; has the meaning set forth in Section 3.06.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Interim
Balance Sheet Date</B>&rdquo; has the meaning set forth in Section 3.06.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Interim
Financial Statements</B>&rdquo; has the meaning set forth in Section 3.06.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Investor
Representation Letter</B>&rdquo; means a letter to be delivered by each Seller, substantially in the form attached as Exhibit B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Key
Employees</B>&rdquo; mean Ryan Rockefeller and Payel Gupta.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Key
Employee Agreement</B>&rdquo; means an employment agreement between the Buyer and a Key Employee, in substantially the form attached
as Exhibit C.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Knowledge
of Seller or Seller&rsquo;s Knowledge</B>&rdquo; or any other similar knowledge qualification, means the actual or constructive knowledge
of any director or officer of any Seller or the Company, after due inquiry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Law</B>&rdquo;
means any statute, law, ordinance, regulation, rule, code, order, constitution, treaty, common law, judgment, decree, other requirement
or rule of law of any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Liabilities</B>&rdquo;
has the meaning set forth in Section 3.07.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Licensed
Intellectual Property&rdquo;</B> means all Intellectual Property in which the Company, any Subsidiary, or any Affiliated Practice holds
any rights or interests granted by other Persons, including Sellers or any of their Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Losses</B>&rdquo;
means losses, damages, liabilities, deficiencies, Actions, judgments, interest, awards, penalties, fines, costs or expenses of whatever
kind, including reasonable attorneys&rsquo; fees and the cost of enforcing any right to indemnification hereunder and the cost of pursuing
any insurance providers; <I>provided, however,</I> that &ldquo;<B>Losses</B>&rdquo; shall not include punitive damages, except to the
extent actually awarded to a Governmental Authority or other third party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Material
Adverse Effect</B>&rdquo; means any event, occurrence, fact, condition or change that is, or could reasonably be expected to become,
individually or in the aggregate, materially adverse to (a) the business, results of operations, condition (financial or otherwise) or
assets of the Company, any Subsidiary, or any Affiliated Practice or (b) the ability of any Seller to consummate the transactions contemplated
hereby on a timely basis; <I>provided, however,</I> that &ldquo;Material Adverse Effect&rdquo; shall not include any event, occurrence,
fact, condition or change, directly or indirectly, arising out of or attributable to: (i) general economic or political conditions; (ii)
conditions generally affecting the industries in which the Company operates; (iii) any changes in financial or securities markets in
general; (iv) acts of war (whether or not declared), armed hostilities or terrorism, or the escalation or worsening thereof; (v) any
action required or permitted by this Agreement, except pursuant to Section 3.05 and Section 5.09; (vi) any changes in applicable Laws
or accounting rules, including GAAP; or (vii) the public announcement, pendency or completion of the transactions contemplated by this
Agreement; <I>provided further, however,</I> that any event, occurrence, fact, condition or change referred to in clauses (i) through
(iv) immediately above shall be taken into account in determining whether a Material Adverse Effect has occurred or could reasonably
be expected to occur to the extent that such event, occurrence, fact, condition or change has a disproportionate effect on the Company,
any Subsidiary, or any Affiliated Practice compared to other participants in the industries in which the Company, any Subsidiary, or
any Affiliated Practice conducts its businesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Material
Contracts</B>&rdquo; has the meaning set forth in Section 3.09(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Material
Customers</B>&rdquo; has the meaning set forth in Section 3.15(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Material
Suppliers</B>&rdquo; has the meaning set forth in <FONT>Section 3.15(b)</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Multiemployer
Plan</B>&rdquo; has the meaning set forth in Section 3.20(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>One
Year Fixed Payment</B>&rdquo; has the meaning set forth in Section 2.02(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Paycheck
Protection Program</B>&rdquo; means a loan originated or received pursuant to or in accordance with the CARES Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Payroll
Tax Executive Order</B>&rdquo; means the Presidential Memorandum on Deferring Payroll Tax Obligations in Light of the Ongoing COVID-19
Disaster, as issued on August 8, 2020, and including any administrative or other guidance published with respect thereto by any Governmental
Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Permits</B>&rdquo;
means all permits, licenses, franchises, approvals, authorizations, registrations, certificates, variances and similar rights obtained,
or required to be obtained, from Governmental Authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Permitted
Encumbrances</B>&rdquo; has the meaning set forth in Section 3.10(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
means an individual, corporation, partnership, joint venture, limited liability company, Governmental Authority, unincorporated organization,
trust, association or other entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Platform
Agreements</B>&rdquo; has the meaning set forth in Section 3.12(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Post-Closing
Adjustment</B>&rdquo; has the meaning set forth in Section 2.04(b)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Post-Closing
Tax Period</B>&rdquo; means any taxable period beginning after the Closing Date and, with respect to any taxable period beginning before
and ending after the Closing Date, the portion of such taxable period beginning after the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Post-Closing
Taxes</B>&rdquo; means Taxes of the Company for any Post-Closing Tax Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Private
Programs</B>&rdquo; means any non-governmental private commercial insurance program or other payment program for medical expenses, including
health maintenance organizations, preferred provider organizations, health insurance plans, health benefit plans, insurance companies,
managed care organizations and other third party payors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Pre-Closing
Tax Period</B>&rdquo; means any taxable period ending on or before the Closing Date and, with respect to any taxable period beginning
before and ending after the Closing Date, the portion of such taxable period ending on and including the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Pre-Closing
Taxes</B>&rdquo; means Taxes of the Company for any Pre-Closing Tax Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Purchase
Price</B>&rdquo; has the meaning set forth in Section 2.02.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Purchase
Price Adjustment Escrow Amount</B>&rdquo; means $250,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Purchase
Price Adjustment Escrow Fund</B>&rdquo; has the meaning set forth in Section 2.03(a)(iii)(A).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Qualified
Benefit Plan</B>&rdquo; has the meaning set forth in Section 3.20(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Qualified
Net Revenues</B>&rdquo; has the meaning set forth in Section 2.07(c)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Real
Property</B>&rdquo; means the real property owned, leased or subleased by the Company, any Subsidiary, or any Affiliated Practice together
with all buildings, structures and facilities located thereon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Release</B>&rdquo;
means any actual or threatened release, spilling, leaking, pumping, pouring, emitting, emptying, discharging, injecting, escaping, leaching,
dumping, abandonment, disposing or allowing to escape or migrate into or through the environment (including, without limitation, ambient
air (indoor or outdoor), surface water, groundwater, land surface or subsurface strata or within any building, structure, facility or
fixture).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Representative</B>&rdquo;
means, with respect to any Person, any and all directors, officers, employees, consultants, financial advisors, counsel, accountants
and other agents of such Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Resolution
Period</B>&rdquo; has the meaning set forth in Section 2.04(c)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Restricted
Business</B>&rdquo; means telehealth, telemedicine and medical marketing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Review
Period</B>&rdquo; has the meaning set forth in Section 2.04(c)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Section
338(h)(10) Election</B>&rdquo; has the meaning set forth in Section 6.05(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Seller</B>&rdquo;
has the meaning set forth in the preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Seller
Indemnitees</B>&rdquo; has the meaning set forth in Section 8.03.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Seller
Majority</B>&rdquo; has the meaning set forth in Section 10.01.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Seller
Representative</B>&rdquo; has the meaning set forth in Section 10.01.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Seller&rsquo;s
Accountants</B>&rdquo; means Rosen &amp; Federico, Certified Public Accountants, located at 135 Crossways Park Drive Suite LL03, Woodbury,
NY 11797.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Shares</B>&rdquo;
has the meaning set forth in the recitals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Single
Employer Plan</B>&rdquo; has the meaning set forth in Section 3.20(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Statement
of Objections</B>&rdquo; has the meaning set forth in Section 2.04(c)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Straddle
Period</B>&rdquo; has the meaning set forth in Section 6.04.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Subsidiary</B>&rdquo;
means, with respect to any Person, any corporation, partnership, limited liability company, joint venture or other legal entity of any
kind of which such Person (either alone or through or together with one or more of its other Subsidiaries) owns, directly or indirectly,
(a) more than fifty percent (50%) of the capital stock or other equity interests the holders of which are generally entitled to vote
for the election of the board of directors or other governing body of such legal entity, or otherwise controls the entity or (b) generally
entitled to share in a majority of the profits or capital of such legal entity. For the avoidance of doubt, no Affiliated Practice shall
be deemed to be a Subsidiary of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Target
Payables</B>&rdquo; means $400,000, plus $3,333 for each day that the Closing extends past December 31, 2021. For example, if the Closing
occurs on January 15, 2022, then Target Payables shall mean $449,995.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Taxes</B>&rdquo;
means all federal, state, local, foreign and other income, gross receipts, sales, use, production, ad valorem, transfer, franchise, registration,
profits, license, lease, service, service use, withholding, payroll, employment, unemployment, estimated, excise, severance, environmental,
stamp, occupation, premium, property (real or personal), real property gains, windfall profits, customs, duties or other taxes, fees,
assessments or charges of any kind whatsoever, together with any interest, additions or penalties with respect thereto, whether disputed
or not or in respect of any failure to comply with any requirement regarding Tax Returns, and any interest in respect of such additions
or penalties, and any such amounts payable pursuant to any tax-sharing agreement or other agreement relating to the payment of any such
Tax, levy, impost, duty, assessment, charge or withholding, whether imposed directly, under Treasury Regulations Section 1.1502-6 (or
any similar provision of state, local, or foreign Law), as a result of being a transferee, successor, or member of an affiliated, consolidated,
unitary or combined group, by contract, or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Tax
Claim</B>&rdquo; has the meaning set forth in Section 6.05.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Tax
Return</B>&rdquo; means any return, declaration, report, claim for refund, information return or statement or other document relating
to Taxes, including any schedule or attachment thereto, and including any amendment thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Territory</B>&rdquo;
means the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Third
Party Claim</B>&rdquo; has the meaning set forth in Section 8.05(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Three-Year
Earn-Out Period</B>&rdquo; has the meaning set forth in Section 2.08(a)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Transaction
Expenses</B>&rdquo; means all fees and expenses incurred by the Company or Sellers at or prior to the Closing in connection with the
preparation, negotiation and execution of this Agreement and the Ancillary Documents, and the performance and consummation of the transactions
contemplated hereby and thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Transfer
Taxes</B>&rdquo; has the meaning set forth in Section 6.01(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Two
Year Fixed Payment</B>&rdquo; has the meaning set forth in Section 2.02(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Undisputed
Amounts</B>&rdquo; has the meaning set forth in Section 2.04(c)(iii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Union</B>&rdquo;
has the meaning set forth in Section 3.21(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>WARN
Act</B>&rdquo; means the federal Worker Adjustment and Retraining Notification Act of 1988, and similar state, local and foreign laws
related to plant closings, relocations, mass layoffs and employment losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Purchase
and sale</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
2.01 Purchase and Sale.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to the terms and
conditions set forth herein, at the Closing, Sellers shall sell to Buyer, and Buyer shall purchase from Sellers, the Shares, free and
clear of all Encumbrances, for the consideration specified in Section 2.02.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.02 <FONT STYLE="vertical-align: baseline">Purchase Price.</FONT></B> The aggregate purchase price for the Shares shall be $3,920,000,
subject to adjustment pursuant to Section 2.04 hereof (the &ldquo;<B>Purchase Price</B>&rdquo;), consisting of (a) $460,000 to be paid
at Closing (the &ldquo;<B>Initial Payment</B>&rdquo;), (b) $1,730,000 payable on or before the one year anniversary of the Closing Date
(the &ldquo;<B>One Year Fixed Payment</B>&rdquo;), and (c) $1,730,000 payable on or before the two year anniversary following the Closing
Date (the &ldquo;<B>Two Year Fixed Payment</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
2.03 Transactions to be Effected at the Closing.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
At the Closing, Buyer shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
deliver to Sellers:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
the Closing Date Payment less the Purchase Price Adjustment Escrow Amount, by wire transfer of immediately available funds to an account
designated in writing by Seller to Buyer no later than two Business Days prior to the Closing Date; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
the Ancillary Documents and all other agreements, documents, instruments or certificates required to be delivered by Buyer at or prior
to the Closing pursuant to Section 7.03 of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
deliver to the Escrow Agent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
the Purchase Price Adjustment Escrow Amount (such amount, including any interest or other amounts earned thereon and less any disbursements
therefrom in accordance with the Escrow Agreement, the &ldquo;<B>Purchase Price Adjustment Escrow Fund</B>&rdquo;) by wire transfer of
immediately available funds to accounts designated by the Escrow Agent, to be held for the purpose of securing the obligations of Sellers
in Section 2.04(d); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
the Escrow Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
At the Closing, Sellers shall deliver to Buyer:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
stock certificates evidencing the Shares, free and clear of all Encumbrances, duly endorsed in blank or accompanied by stock powers or
other instruments of transfer duly executed in blank, with all required stock transfer tax stamps affixed thereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a completed and duly executed Investor Representation Letter for each of the Sellers; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the Ancillary Documents and all other agreements, documents, instruments or certificates required to be delivered by Sellers at or prior
to the Closing pursuant to Section 7.02 of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
2.04 Purchase Price Adjustment.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Closing Adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
At the Closing, the Initial Payment shall be adjusted in the following manner:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
a decrease by the amount, if any, by which the Estimated Closing Payables (as determined in accordance with Section 2.04(a)(ii)) are
greater than the Target Payables;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
a decrease by the outstanding Indebtedness of the Company as of the open of business on the Closing Date; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)
a decrease by the amount of unpaid Transaction Expenses of the Company as of the open of business on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net amount after giving effect to the adjustments listed above shall be the &ldquo;<B>Closing Date Payment</B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
At least three Business Days before the Closing, Sellers shall prepare and deliver to Buyer a statement setting forth its good faith
estimate of Closing Payables (the &ldquo;<B>Estimated Closing Payables</B>&rdquo;), which statement shall contain an estimated balance
sheet of the Company as of the Closing Date (without giving effect to the transactions contemplated herein), a calculation of Estimated
Closing Payables (the &ldquo;<B>Estimated Closing Working Capital Statement</B>&rdquo;), and a certificate of the Chief Executive Officer
of Company that the Estimated Closing Working Capital Statement was prepared consistent with GAAP applying the same accounting methods,
practices, principles, policies and procedures, with consistent classifications, judgments and valuation and estimation methodologies
that were used in the preparation of the Financial Statements for the most recent fiscal year end as if such Estimated Closing Working
Capital Statement was being prepared and audited as of a fiscal year end.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Post-Closing Adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Within 60 days after the Closing Date, Buyer shall prepare and deliver to Seller Representative a statement setting forth its calculation
of Closing Payables, which statement shall contain a balance sheet of the Company as of the Closing Date (without giving effect to the
transactions contemplated herein), a calculation of Closing Payables (the &ldquo;<B>Closing Working Capital Statement</B>&rdquo;) and
a certificate of an officer of Buyer that the Closing Working Capital Statement was prepared consistent with GAAP applying the same accounting
methods, practices, principles, policies and procedures, with consistent classifications, judgments and valuation and estimation methodologies
that were used in the preparation of the Financial Statements for the most recent fiscal year end as if such Closing Working Capital
Statement was being prepared and audited as of a fiscal year end.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
If the Closing Payables are in excess of the Target Payables, the post-closing adjustment (the &ldquo;<B>Post-Closing Adjustment</B>&rdquo;)
shall be an amount equal to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
the Closing Payables minus the Estimated Closing Payables if the Estimated Closing Payables are at least the Target Payables; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
the Closing Payables minus the Target Payables if the Estimated Closing Payables are less than the Target Payables.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Examination and Review.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Examination. After receipt of the Closing Working Capital Statement, Seller Representative shall have 30 days (the &ldquo;<B>Review Period</B>&rdquo;)
to review the Closing Working Capital Statement. During the Review Period, Seller Representative and Seller&rsquo;s Accountants shall
have full access to the books and records of the Company, the personnel of, and work papers prepared by, Buyer and/or Buyer&rsquo;s Accountants
to the extent that they relate to the Closing Working Capital Statement and to such historical financial information (to the extent in
Buyer&rsquo;s possession) relating to the Closing Working Capital Statement as Seller Representative may reasonably request for the purpose
of reviewing the Closing Working Capital Statement and to prepare a Statement of Objections (defined below), <I>provided, that</I> such
access shall be in a manner that does not interfere with the normal business operations of Buyer or the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Objection. On or prior to the last day of the Review Period, Seller Representative may object to the Closing Working Capital Statement
by delivering to Buyer a written statement setting forth Seller Representative&rsquo;s objections in reasonable detail, indicating each
disputed item or amount and the basis for Seller Representative&rsquo;s disagreement therewith (the &ldquo;<B>Statement of Objections</B>&rdquo;).
If Seller Representative fails to deliver the Statement of Objections before the expiration of the Review Period, the Closing Working
Capital Statement and the Post-Closing Adjustment, as the case may be, reflected in the Closing Working Capital Statement shall be deemed
to have been accepted by Sellers. If Seller Representative delivers the Statement of Objections before the expiration of the Review Period,
Buyer and Seller Representative shall negotiate in good faith to resolve such objections within 30 days after the delivery of the Statement
of Objections (the &ldquo;<B>Resolution Period</B>&rdquo;), and, if the same are so resolved within the Resolution Period, the Post-Closing
Adjustment and the Closing Working Capital Statement with such changes as may have been previously agreed in writing by Buyer and Seller
Representative, shall be final and binding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Resolution of Disputes. If Seller Representative and Buyer fail to reach an agreement with respect to all of the matters set forth in
the Statement of Objections before expiration of the Resolution Period, then any amounts remaining in dispute (&ldquo;<B>Disputed Amounts</B>&rdquo;
and any amounts not so disputed, the &ldquo;<B>Undisputed Amounts</B>&rdquo;) shall be submitted for resolution to the office of RSM
US LLP or, if RSM US LLP is unable to serve, Buyer and Seller Representative shall appoint by mutual agreement the office of an impartial
nationally recognized firm of independent certified public accountants other than Seller&rsquo;s Accountants or Buyer&rsquo;s Accountants
(the &ldquo;<B>Independent Accountant</B>&rdquo;) who, acting as experts and not arbitrators, shall resolve the Disputed Amounts only
and make any adjustments to the Post-Closing Adjustment, as the case may be, and the Closing Working Capital Statement. The parties hereto
agree that all adjustments shall be made without regard to materiality. The Independent Accountant shall only decide the specific items
under dispute by the parties and their decision for each Disputed Amount must be within the range of values assigned to each such item
in the Closing Working Capital Statement and the Statement of Objections, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Fees of the Independent Accountant. The fees and expenses of the Independent Accountant shall be paid by Sellers, on the one hand, and
by Buyer, on the other hand, based upon the percentage that the amount actually contested but not awarded to Sellers or Buyer, respectively,
bears to the aggregate amount actually contested by Sellers and Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
Determination by Independent Accountant. The Independent Accountant shall make a determination as soon as practicable within 30 days
(or such other time as the parties hereto shall agree in writing) after their engagement, and their resolution of the Disputed Amounts
and their adjustments to the Closing Working Capital Statement and/or the Post-Closing Adjustment shall be conclusive and binding upon
the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Payments of Post-Closing Adjustment. Except as otherwise provided herein, any payment of the Post-Closing Adjustment, together with interest
calculated as set forth below, shall (A) be due (x) within five Business Days of acceptance of the applicable Closing Working Capital
Statement or (y) if there are Disputed Amounts, then within five Business Days of the resolution described in clause (v) above; and (B)
be paid by wire transfer of immediately available funds to such account as is directed by Buyer or Seller Representative, as the case
may be. Any payment of the Post-Closing Adjustment owed by Sellers to Buyer shall be paid by the Escrow Agent pursuant to the terms of
the Escrow Agreement: (i) from the Purchase Price Adjustment Escrow Fund; and (ii) to the extent the amount of the Post-Closing Adjustment
exceeds the amount available in the Purchase Price Adjustment Escrow Fund, pursuant to a deduction from future amounts owned Sellers
as provided under 2.08(g) or, at Buyer&rsquo;s election, from the Indemnification Escrow Fund. The amount of any Post-Closing Adjustment
shall bear interest from and including the Closing Date to but excluding the date of payment at a rate per annum equal to 5%. Such interest
shall be calculated daily on the basis of a 365 day year and the actual number of days elapsed, without compounding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Adjustments for Tax Purposes. Any payments made pursuant to Section 2.04 shall be treated as an adjustment to the Purchase Price by the
parties for Tax purposes, unless otherwise required by Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
2.05 Closing.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to the terms and conditions
of this Agreement, the purchase and sale of the Shares contemplated hereby shall take place at a closing (the &ldquo;<B>Closing</B>&rdquo;)
to be held at 12:00 p.m., Eastern Standard Time, no later than two Business Days after the last of the conditions to Closing set forth
in ARTICLE VII have been satisfied or waived (other than conditions which, by their nature, are to be satisfied on the Closing Date),
at the offices of Dorsey &amp; Whitney LLP, 51 West 52nd Street. New York, NY 10019-6119 or remotely by exchange of documents and signatures
(or their electronic counterparts), or at such other time or on such other date or at such other place as Seller Representative and Buyer
may mutually agree upon in writing (the day on which the Closing takes place being the &ldquo;<B>Closing Date</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.06 <FONT STYLE="vertical-align: baseline">Withholding Tax.</FONT></B> Buyer and the Company shall be entitled to deduct and withhold
from the Purchase Price all Taxes that Buyer and the Company may be required to deduct and withhold under any provision of Tax Law. All
such withheld amounts shall be treated as delivered to Sellers hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.07 <FONT STYLE="vertical-align: baseline">Post-Closing Fixed Payments.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
At the time of the payment of the One Year Fixed Payment, the Buyer shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Deliver to Sellers the One Year Fixed Payment, less (A) the Indemnification Escrow Amount and (B) any amounts to be deducted under Section
2.08(g) below; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Deliver to Sellers the Indemnification Escrow Amount (such amount, including any interest or other amounts earned thereon and less any
disbursements therefrom in accordance with the Escrow Agreement, the &ldquo;<B>Indemnification Escrow Fund</B>&rdquo;) by wire transfer
of immediately available funds to accounts designated by the Escrow Agent, to be held for the purpose of securing the indemnification
obligations of Sellers set forth in ARTICLE VIII and the obligations of Seller in Section 2.04(d) and Section 6.09</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
At the time of the payment of the Two Year Fixed Payment, the Buyer shall deliver to Sellers the Two Year Fixed Payment less any amounts
to be deducted under Section 2.08(g) below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.08 <FONT STYLE="vertical-align: baseline">Earn-Out.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
After the Closing, the following earn-out amounts shall be paid to Sellers as provided in this Section (each, an &ldquo;<B>Earn-Out Payment</B>&rdquo;)
upon the achievement of the following events (each, an &ldquo;<B>Earn-Out Event</B>&rdquo;) but only if fully achieved within the applicable
earn-out period (each, an &ldquo;<B>Earn-Out Period</B>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Upon the achievement of the following Earn-Out Events in the period following the Closing Date until December 31, 2024 (the &ldquo;<B>Three-Year
Earn-Out Period</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(A)
an Earn-Out Payment in the aggregate amount of $4,550,000 if and when $10,000,000 of Qualifying Net Revenue has been achieved within
a trailing period of twelve consecutive months;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(B)
an additional Earn-Out Payment in the aggregate amount of $9,100,000 if and when $20,000,000 of Qualifying Net Revenue has been achieved
within a trailing period of twelve consecutive months;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(C)
an additional Earn-Out Payment in the aggregate amount of $9,100,000 if and when $35,000,000 of Qualifying Net Revenue has been achieved
within a trailing period of twelve consecutive months; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(D)
an additional Earn-Out Payment in the aggregate amount of $9,100,000 if and when $50,000,000 of Qualifying Net Revenue has been achieved
within a trailing period of twelve consecutive months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon the achievement of the following Earn-Out Events
in the period following the Closing Date until December 31, 2025 (the &ldquo;<B>Four-Year Earn-Out Period</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(A)
an additional Earn-Out Payment in the aggregate amount of $9,100,000 if and when $75,000,000 of Qualifying Net Revenue has been achieved
within a trailing period of twelve consecutive months;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(B)
an additional Earn-Out Payment in the aggregate amount of $9,100,000 if and when $100,000,000 of Qualifying Net Revenue has been achieved
within a trailing period of twelve consecutive months; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(C)
an additional Earn-Out Payment in the aggregate amount of $22,750,000 if and when $150,000,000 of Qualifying Net Revenue has been achieved
within a trailing period of twelve consecutive months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(b)
For the avoidance of doubt, if all conditions set forth in Section 2.08(a) are satisfied within the applicable Earn-Out Period, the aggregate
amount of all Earn-Out Payments shall be $72,800,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(c)
For purposes of this Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(i)
&ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Qualifying Net Revenues</B><FONT STYLE="font-weight: normal">&rdquo;
means Gross Revenue less shipping, discounts, taxes, refunds, returns and royalties;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(ii)
&ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Gross Revenue</B><FONT STYLE="font-weight: normal">&rdquo;
means gross revenue booked by Buyer (on a consolidated basis calculated in accordance with Generally Accepted Accounting Principles (&ldquo;</FONT><B>GAAP</B><FONT STYLE="font-weight: normal">&rdquo;)
and Buyer&rsquo;s revenue recognition policies in effect during the applicable portion of the Earn-Out Period) during the applicable
period that is attributable to the Earn-Out Products. In the event that Earn-Out Products are incorporated into or &ldquo;bundled&rdquo;
with other products, services, or components and not separately invoiced to the customer or institutional partner, Qualifying Net Revenue
with respect to such sales shall be calculated in good faith pro rata on the basis of the respective prices for which such Earn-Out Products
and such other products, services or components have most recently been sold to a customer or institutional partner on a stand-alone
basis in commercial quantities pursuant to an arm&rsquo;s-length transaction</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(d)
Buyer shall promptly notify the Seller Representative after an Earn-Out Event has been achieved. Within three Business Days of notification
by Buyer to the Seller Representative of the realization of an Earn-Out Event within an applicable Earn-Out Period, Buyer shall pay or
cause to be paid the corresponding Earn-Out Payment to the Sellers. If an Earn-Out Event does not occur by the expiration of the applicable
Earn-Out Period, the corresponding Earn-Out Payment will not be due or payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(e)
Each Seller&rsquo;s allocation of the Earn-Out Payments (if any) due from Buyer pursuant to this section shall be paid in accordance
with the ownership set forth on Schedule 1 attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(f)
Subject to the terms of this Agreement, subsequent to the Closing, Buyer shall have sole discretion with regard to all matters relating
to the operation of the Company, its business and operations; provided, that Buyer shall not, directly or indirectly, take any actions
in bad faith that would have the purpose of avoiding any of the Earn-Out Payments hereunder. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(g)
Notwithstanding anything in this Agreement to the contrary, and in addition to any other remedies available to Buyer, any indemnification
obligation or other amounts owed by Sellers to Buyer under this Agreement may be deducted by Buyer only from the Indemnification Escrow
Fund and any Earn-Out Payment which may be owed to Sellers by Buyer, subject to the limitations set forth in Section 8.04(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(h)
The parties hereto understand and agree that (i) the contingent rights to receive any Earn-Out Payment shall not be represented by any
form of certificate or other instrument, are not transferable, except by operation of Laws relating to descent and distribution, divorce
and community property, and do not constitute an equity or ownership interest in Buyer, (ii) Sellers shall not have any rights as a securityholder
of Buyer as a result of Sellers&rsquo; contingent right to receive any Earn-Out Payment hereunder, and (iii) no interest is payable with
respect to any Earn-Out Payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(i)
Upon the occurrence of a Buyer Change of Control, then Buyer shall pay to the Sellers (A) if not already paid, the One Year Fixed Payment
and the Two Year Fixed Payment (subject to applicable deductions as set forth in Section 2.07 above) and (B) one&mdash;and only one&mdash;of
the payments as set forth below as may be applicable (such payment, an &ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Acceleration
Payment</B><FONT STYLE="font-weight: normal">&rdquo;) on the terms and conditions as set forth in this Section 2.08(i).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(i)
If a Buyer Change of Control shall occur before the expiration of the Three-Year Earn-Out Period, and no Earn-Out Event has been achieved
as set forth in Section 2.08(a), but $5,000,000 of Qualifying Net Revenue has been achieved either (A) since the Closing Date, or (B)
if more than twelve months have passed since the Closing Date, then within a trailing period of twelve consecutive months, then Buyer
shall pay to Sellers the Earn-Out Payment set forth in Section 2.08(a)(i)(A) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(ii)
If a Buyer Change of Control shall occur before the expiration of the Three-Year Earn-Out Period, and at least one Earn-Out Event has
been achieved as set forth in Section 2.08(a)(i) above, the Buyer shall pay to Sellers the Earn-Out Payment from the next tier of Earn-Out
Event following the most recent Earn-Out Event that has actually been achieved as set forth in Section 2.08(a)(i). Such payment shall
fulfill Buyer&rsquo;s obligation to make the Earn-Out Payment set forth in such tier. For example, if the Earn-Out Events set forth in
Section 2.08(a)(i)(A) and (B) above have been achieved, and a Buyer Change of Control shall occur within the Three-Year Earn-Out Period,
then upon the closing of the Buyer Change of Control, Buyer shall pay to Sellers the Earn-Out Payment set forth in Section 2.08(a)(i)(C)
above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(iii)
If a Buyer Change of Control shall occur before the expiration of the Four-Year Earn-Out Period, and either all of the Earn-Out Payments
set forth in Section 2.08(a)(i) or at least one Earn-Out Event has been achieved as set forth in Section 2.08(a)(ii) above, the Buyer
shall pay to Sellers the Earn-Out Payment as set forth above for the next tier of Earn-Out Event following the most recent Earn-Out Event
that has actually been achieved as set forth in Section 2.08(a). Such payment shall fulfill Buyer&rsquo;s obligation to make the Earn-Out
Payment set forth in such tier. For example, if the Earn-Out Event set forth in Section 2.08(a)(ii)(A) above has been achieved, and a
Buyer Change of Control shall occur within the Four-Year Earn-Out Period, then upon the closing of the Buyer Change of Control, then
Buyer shall pay to Sellers the Earn-Out Payment set forth in Section 2.08(a)(ii)(B) above. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(j)
For the avoidance of doubt, if an Acceleration Payment has been paid, the associated Earn-out Event cannot be achieved again. However,
any other as of yet un-achieved Earn-Out Events may still be achieved if the applicable Earn-Out Period has not expired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.09 <FONT STYLE="vertical-align: baseline">Satisfaction of Purchase Price.</FONT></B> All payments made by Buyer to Sellers hereunder
shall be made either by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
effecting a wire transfer of immediately available funds to the accounts designated by the Seller Representative;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
issuing to the Sellers shares of common stock of the Buyer (the &ldquo;<B>Buyer Shares</B>&rdquo;), having a deemed value calculated
based on the volume weighted average price of the Buyer Shares on the Nasdaq Capital Market (or another stock exchange, if the Buyer
Shares are no longer listed on the Nasdaq Capital Market) for the 20 trading days immediately preceding the fifth day before the date
of such payment (the &ldquo;<B>Equity Consideration</B>&rdquo;); or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
any combination of immediately available funds or Buyer Shares (valued in accordance with Section 2.09(b) above), as determined by the
Buyer in its sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.10 NASDAQ Limitations</B>. Notwithstanding anything to the contrary contained in this Agreement, under no circumstances whatsoever
shall the aggregate number of Buyer Shares, issued or issuable to Sellers in connection with the this Agreement exceed, in the aggregate,
19.99% of the total number of Buyer Shares outstanding or of the voting power of Buyer unless Buyer has obtained either (x) its stockholders&rsquo;
approval of the issuance of more than such number of Buyer Shares pursuant to NASDAQ Marketplace Rule 5635(d), or (y) a waiver from The
NASDAQ Stock Market of Buyer&rsquo;s compliance with Rule 5635(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III<FONT STYLE="text-transform: uppercase"><BR>
Representations and warranties of sellerS</FONT></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as set forth in the correspondingly numbered Section of the Disclosure Schedules, each Seller, jointly and severally, represents and
warrants to Buyer that the statements contained in this ARTICLE III are true and correct as of the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.01 Organization and Authority of Sellers.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For any
Seller that is an entity, such Seller is duly organized, validly existing and in good standing under the Laws of the state of its incorporation
or organization. Seller has full corporate or company power and authority to enter into this Agreement and the Ancillary Documents to
which Seller is a party, to carry out its obligations hereunder and thereunder and to consummate the transactions contemplated hereby
and thereby. The execution and delivery by Seller of this Agreement and any Ancillary Document to which Seller is a party, the performance
by Seller of its obligations hereunder and thereunder, and the consummation by Seller of the transactions contemplated hereby and thereby
have been duly authorized by all requisite corporate or company action on the part of Seller. This Agreement has been duly executed and
delivered by Seller, and (assuming due authorization, execution and delivery by Buyer) this Agreement constitutes a legal, valid and
binding obligation of Seller enforceable against Seller in accordance with its terms. When each other Ancillary Document to which Seller
is or will be a party has been duly executed and delivered by Seller (assuming due authorization, execution and delivery by each other
party thereto), such Ancillary Document will constitute a legal and binding obligation of Seller enforceable against it in accordance
with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.02 Organization, Authority and Qualification of the Company, Subsidiaries, and Affiliated Practices.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, each Subsidiary, and each of the Affiliated Practices is a corporation duly organized, validly existing and in good standing
under the Laws of the state of its incorporation and has full corporate power and authority to own, operate or lease the properties and
assets now owned, operated or leased by it and to carry on its business as it has been and is currently conducted. Section 3.02 of the
Disclosure Schedules sets forth each jurisdiction in which the Company, each Subsidiary and each of the Affiliated Practices is licensed
or qualified to do business, and the Company, each Subsidiary, and each of the Affiliated Practices is duly licensed or qualified to
do business and is in good standing in each jurisdiction in which the properties owned or leased by it or the operation of its business
as currently conducted makes such licensing or qualification necessary. All corporate actions taken by the Company, each Subsidiary,
and each of the Affiliated Practices in connection with this Agreement and the Ancillary Documents will be duly authorized on or prior
to the Closing. The Company is in compliance with all requirements of a public benefit corporation under the Delaware General Corporation
Law and all other applicable Laws. The Company and its board of directors are not in violation of any fiduciary duties related to the
Company&rsquo;s public benefit purpose as described in its organizational documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.03 Capitalization.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The (i) authorized and (ii) issued and outstanding capital stock of the Company, each Subsidiary, and each Affiliated Practice is set
forth on Section 3.03(a) of the Disclosure Schedules. All of the Shares have been duly authorized, are validly issued, fully paid and
non-assessable, and are owned of record and beneficially by Sellers, free and clear of all Encumbrances. Upon consummation of the transactions
contemplated by this Agreement, Buyer shall own all of the Shares, free and clear of all Encumbrances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
All of the Shares were issued in compliance with applicable Laws. None of the Shares were issued in violation of any agreement, arrangement
or commitment to which Sellers or the Company is a party or is subject to or in violation of any preemptive or similar rights of any
Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
There are no outstanding or authorized options, restricted stock, warrants, convertible securities or other rights, agreements, arrangements
or commitments of any character relating to the capital stock of the Company or obligating Sellers or the Company to issue or sell any
shares of capital stock of, or any other interest in, the Company. The Company does not have outstanding or authorized any stock appreciation,
phantom stock, profit participation or similar rights. There are no voting trusts, stockholder agreements, proxies or other agreements
or understandings in effect with respect to the voting or transfer of any of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.04 <FONT STYLE="vertical-align: baseline">Subsidiaries.</FONT></B> All of the direct and indirect subsidiaries of the Company are set
forth on Schedule 3.04. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary
free and clear of any Encumbrances, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued
and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.05 No Conflicts; Consents.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The execution, delivery
and performance by each Seller of this Agreement and the Ancillary Documents to which it is a party, and the consummation of the transactions
contemplated hereby and thereby, do not and will not: (a) conflict with or result in a violation or breach of, or default under, any
provision of the certificate of incorporation, by-laws or other organizational documents of any Seller, Company, any Subsidiary, or any
Affiliated Practice; (b) conflict with or result in a violation or breach of any provision of any Law or Governmental Order applicable
to any Seller, Company, any Subsidiary, or any Affiliated Practice; (c) except as set forth in Section 3.05 of the Disclosure Schedules,
require the consent, notice or other action by any Person under, conflict with, result in a violation or breach of, constitute a default
or an event that, with or without notice or lapse of time or both, would constitute a default under, result in the acceleration of or
create in any party the right to accelerate, terminate, modify or cancel any Contract to which any Seller, Company, any Subsidiary, or
any Affiliated Practice is a party or by which any Seller, Company, any Subsidiary, or any Affiliated Practice is bound or to which any
of their respective properties and assets are subject (including any Material Contract) or any Permit affecting the properties, assets
or business of the Company; or (d) result in the creation or imposition of any Encumbrance other than Permitted Encumbrances on any properties
or assets of the Company, any Subsidiary, or any Affiliated Practice. No consent, approval, Permit, Governmental Order, declaration or
filing with, or notice to, any Governmental Authority is required by or with respect to any Seller, Company, any Subsidiary, or any Affiliated
Practice in connection with the execution and delivery of this Agreement and the Ancillary Documents and the consummation of the transactions
contemplated hereby and thereby, except for such filings as may be required under the HSR Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.06 Financial Statements.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Complete copies of the
Company&rsquo;s, and each Subsidiaries&rsquo; financial statements consisting of the balance sheet of the Company as at December 31 in
each of the years 2019 and 2020 and the related statements of income and retained earnings for the years then ended (the &ldquo;<B>Financial
Statements</B>&rdquo;), and unaudited financial statements consisting of the balance sheet of the Company as at October 31, 2021 and
the related statements of income and retained earnings for the period then ended (the &ldquo;<B>Interim Financial Statements</B>&rdquo;
and together with the Financial Statements, the &ldquo;<B>Financial Statements</B>&rdquo;) are included in the Disclosure Schedules.
The Financial Statements have been prepared using methodology consistent with GAAP principles and commercially reasonable procedures,
subject to the absence of notes (that, if presented, would not differ materially from those presented in the Financial Statements), and,
in the case of the Interim Financial Statements, to normal and recurring year-end adjustments (the effect of which will not be materially
adverse). The Financial Statements are based on the books and records of the Company and the Subsidiaries, and fairly present the financial
condition of the Company as of the respective dates they were prepared and the results of the operations of the Company and the Subsidiaries
for the periods indicated. The balance sheet of the Company and the Subsidiaries as of December 31, 2020 is referred to herein as the
&ldquo;<B>Balance Sheet</B>&rdquo; and the date thereof as the &ldquo;<B>Balance Sheet Date</B>&rdquo; and the balance sheet of the Company
and the Subsidiaries as of October 31, 2021 is referred to herein as the &ldquo;<B>Interim Balance Sheet</B>&rdquo; and the date thereof
as the &ldquo;<B>Interim Balance Sheet Date</B>&rdquo;. The Company and the Subsidiaries maintain a standard system of accounting established
and administered consistent with GAAP principles and commercially reasonable procedures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.07 Undisclosed Liabilities.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither the Company,
any Subsidiary, or any Affiliated Practice has any liabilities, obligations or commitments of any nature whatsoever, asserted or unasserted,
known or unknown, absolute or contingent, accrued or unaccrued, matured or unmatured or otherwise (&ldquo;<B>Liabilities</B>&rdquo;),
except (a) those which are adequately reflected or reserved against in the Interim Balance Sheet as of the Interim Balance Sheet Date,
and (b) those which have been incurred in the ordinary course of business consistent with past practice since the Interim Balance Sheet
Date and which are not, individually or in the aggregate, material in amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.08 Absence of Certain Changes, Events and Conditions.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the Interim Balance Sheet Date, and other than in the ordinary course of business consistent with past practice, there has not been,
with respect to the Company, any Subsidiary, or any Affiliated Practice any:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
event, occurrence or development that has had, or could reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
amendment of the charter, by-laws or other organizational documents;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
split, combination or reclassification of any shares of its capital stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
issuance, sale or other disposition of any of its capital stock, or grant of any options, warrants or other rights to purchase or obtain
(including upon conversion, exchange or exercise) any of its capital stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
declaration or payment of any dividends or distributions on or in respect of any of its capital stock or redemption, purchase or acquisition
of its capital stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
material change in any method of accounting or accounting practice of the Company, except as required by GAAP or as disclosed in the
notes to the Financial Statements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
material change in its cash management practices and its policies, practices and procedures with respect to collection of accounts receivable,
establishment of reserves for uncollectible accounts, accrual of accounts receivable, inventory control, prepayment of expenses, payment
of trade accounts payable, accrual of other expenses, deferral of revenue and acceptance of customer deposits;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
entry into any Contract that would constitute a Material Contract;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
incurrence, assumption or guarantee of any indebtedness for borrowed money except unsecured current obligations and Liabilities incurred
in the ordinary course of business consistent with past practice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
transfer, assignment, sale or other disposition of any of the assets shown or reflected in the Balance Sheet or cancellation of any debts
or entitlements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
transfer or assignment of or grant of any license or sublicense under or with respect to any Company Intellectual Property or Company
IP Agreements except non-exclusive licenses or sublicenses granted in the ordinary course of business consistent with past practice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
abandonment or lapse of or failure to maintain in full force and effect any Company IP Registration, or failure to take or maintain reasonable
measures to protect the confidentiality or value of any Trade Secrets included in the Company Intellectual Property;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
material damage, destruction or loss (whether or not covered by insurance) to its property;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
any capital investment in, or any loan to, any other Person;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
acceleration, termination, material modification to or cancellation of any material Contract (including, but not limited to, any Material
Contract) to which it is a party or by which it is bound;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
any material capital expenditures;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
imposition of any Encumbrance upon any of its properties, capital stock or assets, tangible or intangible;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
(i) grant of any bonuses, whether monetary or otherwise, or increase in any wages, salary, severance, pension or other compensation or
benefits in respect of its current or former employees, officers, directors, independent contractors or consultants, other than as provided
for in any written agreements or required by applicable Law, (ii) change in the terms of employment for any employee or any termination
of any employees for which the aggregate costs and expenses exceed $10,000, or (iii) action to accelerate the vesting or payment of any
compensation or benefit for any current or former employee, officer, director, independent contractor or consultant;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
hiring or promoting any person as or to (as the case may be) an officer or hiring or promoting any employee below officer except to fill
a vacancy in the ordinary course of business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
adoption, modification or termination of any: (i) employment, severance, retention or other agreement with any current or former employee,
officer, director, independent contractor or consultant, (ii) Benefit Plan or (iii) collective bargaining or other agreement with a Union,
in each case whether written or oral;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
any loan to (or forgiveness of any loan to), or entry into any other transaction with, any of its stockholders or current or former directors,
officers and employees;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
entry into a new line of business or abandonment or discontinuance of existing lines of business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
adoption of any plan of merger, consolidation, reorganization, liquidation or dissolution or filing of a petition in bankruptcy under
any provisions of federal or state bankruptcy Law or consent to the filing of any bankruptcy petition against it under any similar Law;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
purchase, lease or other acquisition of the right to own, use or lease any property or assets for an amount in excess of $10,000, individually
(in the case of a lease, per annum) or $10,000 in the aggregate (in the case of a lease, for the entire term of the lease, not including
any option term), except for purchases of inventory or supplies in the ordinary course of business consistent with past practice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
acquisition by merger or consolidation with, or by purchase of a substantial portion of the assets or stock of, or by any other manner,
any business or any Person or any division thereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
action by it to make, change or rescind any Tax election, amend any Tax Return or take any position on any Tax Return, take any action,
omit to take any action or enter into any other transaction that would have the effect of increasing the Tax liability or reducing any
Tax asset of Buyer in respect of any Post-Closing Tax Period; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
any Contract to do any of the foregoing, or any action or omission that would result in any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.09 Material Contracts.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Section 3.09(a) of the Disclosure Schedules lists each of the following Contracts of the Company, any Subsidiary, or any Affiliated Practice
(such Contracts, together with all Contracts concerning the occupancy, management or operation of any Real Property (including without
limitation, brokerage contracts) listed or otherwise disclosed in Section 3.10(b) of the Disclosure Schedules and all Company IP Agreements
set forth in Section 3.12(b) of the Disclosure Schedules, being &ldquo;<B>Material Contracts</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
each Contract of the Company, any Subsidiary, or any Affiliated Practice involving aggregate consideration in excess of $10,000 and which,
in each case, cannot be cancelled by the Company without penalty or without more than 90 days&rsquo; notice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all Contracts that require the Company, any Subsidiary, or any Affiliated Practice to purchase its total requirements of any product
or service from a third party or that contain &ldquo;take or pay&rdquo; provisions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
all Contracts that provide for the indemnification by the Company, any Subsidiary, or any Affiliated Practice of any Person or the assumption
of any Tax, environmental or other Liability of any Person;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
all Contracts that relate to the acquisition or disposition of any business, a material amount of stock or assets of any other Person
or any real property (whether by merger, sale of stock, sale of assets or otherwise);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
all broker, distributor, dealer, manufacturer&rsquo;s representative, franchise, agency, sales promotion, market research, marketing
consulting and advertising Contracts to which the Company, any Subsidiary, or any Affiliated Practice is a party;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
all employment agreements and Contracts with independent contractors or consultants (or similar arrangements) to which the Company, any
Subsidiary, or any Affiliated Practice is a party and which are not cancellable without material penalty or without more than 90 days&rsquo;
notice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
except for Contracts relating to trade payables, all Contracts relating to indebtedness (including, without limitation, guarantees) of
the Company, any Subsidiary, or any Affiliated Practice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
all Contracts with any Governmental Authority to which the Company, any Subsidiary, or any Affiliated Practice is a party (&ldquo;<B>Government
Contracts</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
all Contracts that limit or purport to limit the ability of the Company, any Subsidiary, or any Affiliated Practice to compete in any
line of business or with any Person or in any geographic area or during any period of time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
any Contracts to which the Company, any Subsidiary, or any Affiliated Practice is a party that provide for any joint venture, partnership
or similar arrangement by the Company, any Subsidiary, or any Affiliated Practice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)
all Contracts between or among the Company, any Subsidiary, or any Affiliated Practice on the one hand and Seller or any Affiliate of
Seller (other than the Company) on the other hand;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)
all collective bargaining agreements or Contracts with any Union to which the Company, any Subsidiary, or any Affiliated Practice is
a party; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)
any other Contract that is material to the Company, any Subsidiary, or any Affiliated Practice and not previously disclosed pursuant
to this Section 3.09.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each Material Contract is valid and binding on the Company, any Subsidiary, or any Affiliated Practice in accordance with its terms and
is in full force and effect. None of the Company, any Subsidiary, or any Affiliated Practice or, to Seller&rsquo;s Knowledge, any other
party thereto is in breach of or default under (or is alleged to be in breach of or default under), or has provided or received any notice
of any intention to terminate, any Material Contract. No event or circumstance has occurred that, with notice or lapse of time or both,
would constitute an event of default under any Material Contract or result in a termination thereof or would cause or permit the acceleration
or other changes of any right or obligation or the loss of any benefit thereunder. Complete and correct copies of each Material Contract
(including all modifications, amendments and supplements thereto and waivers thereunder) have been made available to Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.10 Title to Assets; Real Property.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company, each Subsidiary, and each Affiliated Practice has good and valid (and, in the case of owned Real Property, good and marketable
fee simple) title to, or a valid leasehold interest in, all Real Property and personal property and other assets reflected in the Financial
Statements or acquired after the Balance Sheet Date, other than properties and assets sold or otherwise disposed of in the ordinary course
of business consistent with past practice since the Balance Sheet Date. All such properties and assets (including leasehold interests)
are free and clear of Encumbrances except for the following (collectively referred to as &ldquo;<B>Permitted Encumbrances</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
liens for Taxes not yet due and payable;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
mechanics, carriers&rsquo;, workmen&rsquo;s, repairmen&rsquo;s or other like liens arising or incurred in the ordinary course of business
consistent with past practice or amounts that are not delinquent and which are not, individually or in the aggregate, material to the
business of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
easements, rights of way, zoning ordinances and other similar encumbrances affecting Real Property which are not, individually or in
the aggregate, material to the business of the Company; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
other than with respect to owned Real Property, liens arising under original purchase price conditional sales contracts and equipment
leases with third parties entered into in the ordinary course of business consistent with past practice which are not, individually or
in the aggregate, material to the business of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Section 3.10(b) of the Disclosure Schedules lists (i) the street address of each parcel of Real Property; (ii) if such property is leased
or subleased by the Company, any Subsidiary, or any Affiliated Practice, the landlord under the lease, the rental amount currently being
paid, and the expiration of the term of such lease or sublease for each leased or subleased property; and (iii) the current use of such
property. With respect to owned Real Property, Seller has delivered or made available to Buyer true, complete and correct copies of the
deeds and other instruments (as recorded) by which the Company acquired such Real Property, and copies of all title insurance policies,
opinions, abstracts and surveys in the possession of Seller or the Company, any Subsidiary, or any Affiliated Practice and relating to
the Real Property. With respect to leased Real Property, Seller has delivered or made available to Buyer true, complete and correct copies
of any leases affecting the Real Property. Neither the Company, any Subsidiary, or any Affiliated Practice is a sublessor or grantor
under any sublease or other instrument granting to any other Person any right to the possession, lease, occupancy or enjoyment of any
leased Real Property. The use and operation of the Real Property in the conduct of the Company&rsquo;s business do not violate in any
material respect any Law, covenant, condition, restriction, easement, license, permit or agreement. No material improvements constituting
a part of the Real Property encroach on real property owned or leased by a Person other than the Company, any Subsidiary, or any Affiliated
Practice. There are no Actions pending nor, to the Seller&rsquo;s Knowledge, threatened against or affecting the Real Property or any
portion thereof or interest therein in the nature or in lieu of condemnation or eminent domain proceedings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.11 Condition and Sufficiency of Assets.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The buildings,
plants, structures, furniture, fixtures, machinery, equipment, vehicles and other items of tangible personal property of the Company,
any Subsidiary, or any Affiliated Practice are structurally sound, are in good operating condition and repair, and are adequate for the
uses to which they are being put, and none of such buildings, plants, structures, furniture, fixtures, machinery, equipment, vehicles
and other items of tangible personal property is in need of maintenance or repairs except for ordinary, routine maintenance and repairs
that are not material in nature or cost. The buildings, plants, structures, furniture, fixtures, machinery, equipment, vehicles and other
items of tangible personal property currently owned or leased by the Company, each Subsidiary, and each Affiliated Practice, together
with all other properties and assets of the Company, each Subsidiary, and each Affiliated Practice, are sufficient for the continued
conduct of the Company&rsquo;s business after the Closing in substantially the same manner as conducted prior to the Closing and constitute
all of the rights, property and assets necessary to conduct the business of the Company as currently conducted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.12 Intellectual Property.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Section 3.12(a) of the Disclosure Schedules contains a correct, current, and complete list of: (i) all Company IP Registrations, specifying
as to each, as applicable: the title, mark, or design; the record owner and inventor(s), if any; the jurisdiction by or in which it has
been issued, registered, or filed; the patent, registration, or application serial number; the issue, registration, or filing date; and
the current status (ii) all unregistered Trademarks included in the Company Intellectual Property; (iii) all proprietary Software of
the Company, each Subsidiary, and each Affiliated Practice; and (iv) all other Company Intellectual Property used or held for use in
the Company&rsquo;s business as currently conducted and as proposed to be conducted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Section 3.12(b) of the Disclosure Schedules contains a correct, current, and complete list of all Company IP Agreements, specifying for
each the date, title, and parties thereto, and separately identifying the Company IP Agreements: (i) under which the Company, any Subsidiary,
or any Affiliated Practice is a licensor or otherwise grants to any Person any right or interest relating to any Company Intellectual
Property; (ii) under which the Company, any Subsidiary, or any Affiliated Practice is a licensee or otherwise granted any right or interest
relating to the Intellectual Property of any Person; and (iii) which otherwise relate to the Company, any Subsidiary, or any Affiliated
Practice&rsquo;s ownership or use of Intellectual Property, in each case identifying the Intellectual Property covered by such Company
IP Agreement. Sellers have provided Buyer with true and complete copies (or in the case of any oral agreements, a complete and correct
written description) of all Company IP Agreements, including all modifications, amendments and supplements thereto and waivers thereunder.
Each Company IP Agreement is valid and binding on the Company, any Subsidiary, or any Affiliated Practice in accordance with its terms
and is in full force and effect. Neither the Company, any Subsidiary, or any Affiliated Practice nor any other party thereto is, or is
alleged to be, in breach of or default under, or has provided or received any notice of breach of, default under, or intention to terminate
(including by non-renewal), any Company IP Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company is the sole and exclusive legal and beneficial, and with respect to the Company IP Registrations, record, owner of all right,
title, and interest in and to the Company Intellectual Property, and has the valid and enforceable right to use all other Intellectual
Property used or held for use in or necessary for the conduct of the Company&rsquo;s business as currently conducted and as proposed
to be conducted, in each case, free and clear of Encumbrances other than Permitted Encumbrances. The Company has entered into binding,
valid and enforceable, written Contracts with each current and former employee and independent contractor who is or was involved in or
has contributed to the invention, creation, or development of any Intellectual Property during the course of employment or engagement
with the Company whereby such employee or independent contractor (i) acknowledges the Company&rsquo;s exclusive ownership of all Intellectual
Property invented, created, or developed by such employee or independent contractor within the scope of his or her employment or engagement
with the Company; (ii) grants to the Company a present, irrevocable assignment of any ownership interest such employee or independent
contractor may have in or to such Intellectual Property, to the extent such Intellectual Property does not constitute a &ldquo;work made
for hire&rdquo; under applicable Law; and (iii) irrevocably waives any right or interest, including any moral rights, regarding any such
Intellectual Property, to the extent permitted by applicable Law. Sellers have provided Buyer with true and complete copies of all such
Contracts. All assignments and other instruments necessary to establish, record, and perfect the Company&rsquo;s ownership interest in
the Company IP Registrations have been validly executed, delivered, and filed with the relevant Governmental Authorities and authorized
registrars.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Neither the execution, delivery or performance of this Agreement, nor the consummation of the transactions contemplated hereunder, will
result in the loss or impairment of, or require the consent of any other Person in respect of, the Company&rsquo;s right to own or use
any Company Intellectual Property or Licensed Intellectual Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
All of the Company Intellectual Property and Licensed Intellectual Property are valid and enforceable, and all Company IP Registrations
are subsisting and in full force and effect. The Company has taken all necessary steps to maintain and enforce the Company Intellectual
Property and Licensed Intellectual Property and to preserve the confidentiality of all Trade Secrets included in the Company Intellectual
Property, including by requiring all Persons having access thereto to execute binding, written non-disclosure agreements. All required
filings and fees related to the Company IP Registrations have been timely submitted with and paid to the relevant Governmental Authorities
and authorized registrars. Sellers have provided Buyer with true and complete copies of all file histories, documents, certificates,
office actions, correspondence, assignments, and other instruments relating to the Company IP Registrations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The conduct of the Company&rsquo;s business as currently and formerly conducted and as proposed to be conducted, including the use of
the Company Intellectual Property and Licensed Intellectual Property in connection therewith, and the products, processes and services
of the Company have not infringed, misappropriated or otherwise violated, and will not infringe, misappropriate or otherwise violate,
the Intellectual Property or other rights of any Person. No Person has infringed, misappropriated or otherwise violated any Company Intellectual
Property or Licensed Intellectual Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
There are no Actions (including any opposition, cancellation, revocation, review, or other proceeding), whether settled, pending, or
threatened (including in the form of offers to obtain a license): (i) alleging any infringement, misappropriation, or other violation
by the Company, any Subsidiary, or any Affiliated Practice of the Intellectual Property of any Person; (ii) challenging the validity,
enforceability, registrability, patentability, or ownership of any Company Intellectual Property or Licensed Intellectual Property or
the Company, any Subsidiary, or any Affiliated Practice&rsquo;s right, title, or interest in or to any Company Intellectual Property
or Licensed Intellectual Property or (iii) by the Company, any Subsidiary, or any Affiliated Practice or by the owner of any Licensed
Intellectual Property alleging any infringement, misappropriation, or other violation by any Person of the Company Intellectual Property
or such Licensed Intellectual Property. Neither Seller nor the Company, any Subsidiary, or any Affiliated Practice is aware of any facts
or circumstances that could reasonably be expected to give rise to any such Action. Neither the Company, any Subsidiary, or any Affiliated
Practice is not subject to any outstanding or prospective Governmental Order (including any motion or petition therefor) that does or
could reasonably be expected to restrict or impair the use of any Company Intellectual Property or Licensed Intellectual Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Section 3.12(h) of the Disclosure Schedules contains a correct, current, and complete list of all social media accounts used in the Company,
each Subsidiary, and each Affiliated Practice&rsquo;s business. The Company, each Subsidiary, and each Affiliated Practice has complied
with all terms of use, terms of service, and other Contracts and all associated policies and guidelines relating to its use of any social
media platforms, sites, or services (collectively, &ldquo;<B>Platform Agreements</B>&rdquo;). There are no Actions, whether settled,
pending, or threatened, alleging any (A) breach or other violation of any Platform Agreement by the Company, any Subsidiary, or any Affiliated
Practice; or (B) defamation, violation of publicity rights of any Person, or any other violation by the Company, any Subsidiary, or any
Affiliated Practice in connection with its use of social media.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
All Company IT Systems are in good working condition and are sufficient for the operation of the Company&rsquo;s business as currently
conducted and as proposed to be conducted. In the past three years, there has been no malfunction, failure, continued substandard performance,
denial-of-service, or other cyber incident, including any cyberattack, or other impairment of the Company IT Systems that has resulted
or is reasonably likely to result in disruption or damage to the business of the Company, any Subsidiary, or any Affiliated Practice.
The Company has taken all commercially reasonable steps to safeguard the confidentiality, availability, security, and integrity of the
Company IT Systems, including implementing and maintaining appropriate backup, disaster recovery, and Software and hardware support arrangements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
The Company, each Subsidiary, and each Affiliated Practice has complied with all applicable Laws and all internal or publicly posted
policies, notices, and statements concerning the collection, use, processing, storage, transfer, and security of personal information
in the conduct of the Company&rsquo;s business. In the past three years, the Company has not (i) experienced any actual, alleged, or
suspected data breach or other security incident involving personal information in its possession or control or (ii) been subject to
or received any written notice of any audit, investigation, complaint, or other Action by any Governmental Authority or other Person
concerning the Company, any Subsidiary, or any Affiliated Practice&rsquo;s collection, use, processing, storage, transfer, or protection
of personal information or actual, alleged, or suspected violation of any applicable Law concerning privacy, data security, or data breach
notification, and to Seller&rsquo;s Knowledge, there are no facts or circumstances that could reasonably be expected to give rise to
any such Action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.13 Inventory.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All inventory of the Company, whether
or not reflected in the Balance Sheet, consists of a quality and quantity usable and salable in the ordinary course of business consistent
with past practice, except for obsolete, damaged, defective or slow-moving items that have been written off or written down to fair market
value or for which adequate reserves have been established. All such inventory is owned by the Company free and clear of all Encumbrances,
and no inventory is held on a consignment basis. The quantities of each item of inventory (whether raw materials, work-in-process or
finished goods) are not excessive, but are reasonable in the present circumstances of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.14 Accounts Receivable.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accounts receivable
reflected on the Interim Balance Sheet and the accounts receivable arising after the date thereof (a) have arisen from bona fide transactions
entered into by the Company involving the sale of goods or the rendering of services in the ordinary course of business consistent with
past practice; (b) constitute only valid, undisputed claims of the Company not subject to claims of set-off or other defenses or counterclaims
other than normal cash discounts accrued in the ordinary course of business consistent with past practice; and (c) subject to a reserve
for bad debts shown on the Interim Balance Sheet or, with respect to accounts receivable arising after the Interim Balance Sheet Date,
on the accounting records of the Company, are collectible in full within 90 days after billing. The reserve for bad debts shown on the
Interim Balance Sheet or, with respect to accounts receivable arising after the Interim Balance Sheet Date, on the accounting records
of the Company have been determined in accordance with GAAP, consistently applied, subject to normal year-end adjustments and the absence
of disclosures normally made in footnotes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.15 Customers and Suppliers.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Section 3.15(a) of the Disclosure Schedules sets forth each customer who is contracted to pay aggregate consideration to the Company,
any Subsidiary, or any Affiliated Practice for goods or services rendered in an amount greater than or equal to $10,000 (collectively,
the &ldquo;<B>Material Customers</B>&rdquo;); and (ii) the amount of consideration to be paid by each Material Customer during the upcoming
twelve months. Neither the Company, any Subsidiary, or any Affiliated Practice has received any notice, and has no reason to believe,
that any of its Material Customers has ceased, or intends to cease after the Closing, to use its goods or services or to otherwise terminate
or materially reduce its relationship with the Company, any Subsidiary, or any Affiliated Practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Section 3.15(b) of the Disclosure Schedules sets forth (i) each supplier to whom the Company, any Subsidiary, or any Affiliated Practice
has paid consideration for goods or services rendered in an amount greater than or equal to $10,000 for each of the two most recent fiscal
years (collectively, the &ldquo;<B>Material Suppliers</B>&rdquo;); and (ii) the amount of purchases from each Material Supplier during
such periods. Neither the Company, any Subsidiary, or any Affiliated Practice has received any notice, and has no reason to believe,
that any of its Material Suppliers has ceased, or intends to cease, to supply goods or services to the Company, any Subsidiary, or any
Affiliated Practice or to otherwise terminate or materially reduce its relationship with the Company, any Subsidiary, or any Affiliated
Practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.16 Insurance.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 3.16 of the Disclosure Schedules
sets forth a true and complete list of all current policies or binders of fire, liability, product liability, umbrella liability, real
and personal property, workers&rsquo; compensation, vehicular, directors&rsquo; and officers&rsquo; liability, fiduciary liability and
other casualty and property insurance maintained by Seller or its Affiliates (including the Company, any Subsidiary, or any Affiliated
Practice) and relating to the assets, business, operations, employees, officers and directors of the Company, any Subsidiary, or any
Affiliated Practice (collectively, the &ldquo;<B>Insurance Policies</B>&rdquo;) and true and complete copies of such Insurance Policies
have been made available to Buyer. Such Insurance Policies are in full force and effect and shall remain in full force and effect following
the consummation of the transactions contemplated by this Agreement. Neither the Seller nor any of its Affiliates (including the Company,
any Subsidiary, or any Affiliated Practice) has received any written notice of cancellation of, premium increase with respect to, or
alteration of coverage under, any of such Insurance Policies. All premiums due on such Insurance Policies have either been paid or, if
due and payable prior to Closing, will be paid prior to Closing in accordance with the payment terms of each Insurance Policy. The Insurance
Policies do not provide for any retrospective premium adjustment or other experience-based liability on the part of the Company. All
such Insurance Policies (a) are valid and binding in accordance with their terms; (b) are provided by carriers who are financially solvent;
and (c) have not been subject to any lapse in coverage. There are no claims related to the business of the Company, any Subsidiary, or
any Affiliated Practice pending under any such Insurance Policies as to which coverage has been questioned, denied or disputed or in
respect of which there is an outstanding reservation of rights. None of Seller or any of its Affiliates (including the Company, any Subsidiary,
or any Affiliated Practice) is in default under, or has otherwise failed to comply with, in any material respect, any provision contained
in any such Insurance Policy. The Insurance Policies are of the type and in the amounts customarily carried by Persons conducting a business
similar to the Company, any Subsidiary, or any Affiliated Practice and are sufficient for compliance with all applicable Laws and Contracts
to which the Company, any Subsidiary, or any Affiliated Practice is a party or by which it is bound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.17 Legal Proceedings; Governmental Orders.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
There are no Actions pending or, to Seller&rsquo;s Knowledge, threatened (a) against or by the Company, any Subsidiary, or any Affiliated
Practice affecting any of its properties or assets (or by or against Seller or any Affiliate thereof and relating to the Company, any
Subsidiary, or any Affiliated Practice); or (b) against or by the Company, any Subsidiary, or any Affiliated Practice, Seller or any
Affiliate of Seller that challenges or seeks to prevent, enjoin or otherwise delay the transactions contemplated by this Agreement. No
event has occurred or circumstances exist that may give rise to, or serve as a basis for, any such Action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
There are no outstanding Governmental Orders and no unsatisfied judgments, penalties or awards against or affecting the Company or any
of its properties or assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.18 <FONT STYLE="vertical-align: baseline">Compliance With Laws.</FONT></B> The Company, each Subsidiary, and each Affiliated Practice
has complied, and is now complying, with all Laws applicable to it or its business, properties or assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.19 Environmental Matters.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company, each Subsidiary, and each Affiliated Practice is currently and has been in compliance with all Environmental Laws and has
not, and the Sellers have not, received from any Person any: (i) Environmental Notice or Environmental Claim; or (ii) written request
for information pursuant to Environmental Law, which, in each case, either remains pending or unresolved, or is the source of ongoing
obligations or requirements as of the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company, each Subsidiary, and each Affiliated Practice has obtained and is in material compliance with all Environmental Permits
(each of which is disclosed in Section 3.19(b) of the Disclosure Schedules) necessary for the ownership, lease, operation or use of the
business or assets of the Company, each Subsidiary, and each Affiliated Practice and all such Environmental Permits are in full force
and effect and shall be maintained in full force and effect by Sellers through the Closing Date in accordance with Environmental Law,
and neither Sellers or any of their Affiliates (including the Company, any Subsidiary, or any Affiliated Practice) is aware of any condition,
event or circumstance that might prevent or impede, after the Closing Date, the ownership, lease, operation or use of the business or
assets of the Company, each Subsidiary, and each Affiliated Practice as currently carried out. With respect to any such Environmental
Permits, Seller has undertaken, or will undertake prior to the Closing Date, all measures necessary to facilitate transferability of
the same, and neither the Company, any Subsidiary, or any Affiliated Practice nor the Sellers are aware of any condition, event or circumstance
that might prevent or impede the transferability of the same, nor have they received any Environmental Notice or written communication
regarding any material adverse change in the status or terms and conditions of the same.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
No real property currently or formerly owned, operated or leased by the Company, any Subsidiary, or any Affiliated Practice is listed
on, or has been proposed for listing on, the National Priorities List (or CERCLIS) under CERCLA, or any similar state list.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
There has been no Release of Hazardous Materials in contravention of Environmental Law with respect to the business or assets of the
Company, any Subsidiary, or any Affiliated Practice or any real property currently or formerly owned, operated or leased by the Company,
and neither the Company, any Subsidiary, or any Affiliated Practice nor Sellers have received an Environmental Notice that any real property
currently or formerly owned, operated or leased in connection with the business of the Company, any Subsidiary, or any Affiliated Practice
(including soils, groundwater, surface water, buildings and other structure located on any such real property) has been contaminated
with any Hazardous Material which could reasonably be expected to result in an Environmental Claim against, or a violation of Environmental
Law or term of any Environmental Permit by, Seller or the Company, any Subsidiary, or any Affiliated Practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Section 3.19(e) of the Disclosure Schedules contains a complete and accurate list of all active or abandoned aboveground or underground
storage tanks owned or operated by the Company, any Subsidiary, or any Affiliated Practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Section 3.19(f) of the Disclosure Schedules contains a complete and accurate list of all off-site Hazardous Materials treatment, storage,
or disposal facilities or locations used by the Company, any Subsidiary, or any Affiliated Practice or Seller and any predecessors as
to which the Company or Seller may retain liability, and none of these facilities or locations has been placed or proposed for placement
on the National Priorities List (or CERCLIS) under CERCLA, or any similar state list, and neither Seller nor the Company, any Subsidiary,
or any Affiliated Practice has received any Environmental Notice regarding potential liabilities with respect to such off-site Hazardous
Materials treatment, storage, or disposal facilities or locations used by the Company, any Subsidiary, or any Affiliated Practice or
Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Neither Sellers nor the Company, any Subsidiary, or any Affiliated Practice has retained or assumed, by contract or operation of Law,
any liabilities or obligations of third parties under Environmental Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Sellers have provided or otherwise made available to Buyer and listed in Section 3.19(h) of the Disclosure Schedules: (i) any and all
environmental reports, studies, audits, records, sampling data, site assessments, risk assessments, economic models and other similar
documents with respect to the business or assets of the Company, any Subsidiary, or any Affiliated Practice or any currently or formerly
owned, operated or leased real property which are in the possession or control of the Sellers or Company, any Subsidiary, or any Affiliated
Practice related to compliance with Environmental Laws, Environmental Claims or an Environmental Notice or the Release of Hazardous Materials;
and (ii) any and all material documents concerning planned or anticipated capital expenditures required to reduce, offset, limit or otherwise
control pollution and/or emissions, manage waste or otherwise ensure compliance with current or future Environmental Laws (including,
without limitation, costs of remediation, pollution control equipment and operational changes).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Neither the Sellers nor the Company, any Subsidiary, or any Affiliated Practice are aware of or reasonably anticipates, as of the Closing
Date, any condition, event or circumstance concerning the Release or regulation of Hazardous Materials that might, after the Closing
Date, prevent, impede or materially increase the costs associated with the ownership, lease, operation, performance or use of the business
or assets of the Company, any Subsidiary, or any Affiliated Practice as currently carried out.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Sellers own and control all Environmental Attributes (a complete and accurate list of which is set forth in Section 3.19(j) of the Disclosure
Schedules) and has not entered into any contract or pledge to transfer, lease, license, guarantee, sell, mortgage, pledge or otherwise
dispose of or encumber any Environmental Attributes as of the date hereof. Neither Seller nor the Company is aware of any condition,
event or circumstance that might prevent, impede or materially increase the costs associated with the transfer (if required) to Buyer
of any Environmental Attributes after the Closing Date</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.20 Employee Benefit Matters.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Section 3.20(a) of the Disclosure Schedules contains a true and complete list of each pension, benefit, retirement, compensation, employment,
consulting, profit-sharing, deferred compensation, incentive, bonus, performance award, phantom equity, stock or stock-based, change
in control, retention, severance, vacation, paid time off (PTO), medical, vision, dental, disability, welfare, Code Section 125 cafeteria,
fringe benefit and other similar agreement, plan, policy, program or arrangement (and any amendments thereto), in each case whether or
not reduced to writing and whether funded or unfunded, including each &ldquo;employee benefit plan&rdquo; within the meaning of Section
3(3) of ERISA, whether or not tax-qualified and whether or not subject to ERISA, which is or has been maintained, sponsored, contributed
to, or required to be contributed to by the Company, any Subsidiary, or any Affiliated Practice for the benefit of any current or former
employee, officer, director, retiree, independent contractor or consultant of the Company, any Subsidiary, or any Affiliated Practice
or any spouse or dependent of such individual, or under which the Company, any Subsidiary, or any Affiliated Practice or any of its ERISA
Affiliates has or may have any Liability, or with respect to which Buyer or any of its Affiliates would reasonably be expected to have
any Liability, contingent or otherwise (as listed on Section 3.20(a) of the Disclosure Schedules, each, a &ldquo;<B>Benefit Plan</B>&rdquo;).
The Company has separately identified in Section 3.20(a) of the Disclosure Schedules each Benefit Plan that contains a change in control
provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
With respect to each Benefit Plan, Seller has made available to Buyer accurate, current and complete copies of each of the following:
(i) where the Benefit Plan has been reduced to writing, the plan document together with all amendments; (ii) where the Benefit Plan has
not been reduced to writing, a written summary of all material plan terms; (iii) where applicable, copies of any trust agreements or
other funding arrangements, custodial agreements, insurance policies and contracts, administration agreements and similar agreements,
and investment management or investment advisory agreements, now in effect or required in the future as a result of the transactions
contemplated by this Agreement or otherwise; (iv) copies of any summary plan descriptions, summaries of material modifications, summaries
of benefits and coverage, COBRA communications, employee handbooks and any other written communications (or a description of any oral
communications) relating to any Benefit Plan; (v) in the case of any Benefit Plan that is intended to be qualified under Section 401(a)
of the Code, a copy of the most recent determination, opinion or advisory letter from the Internal Revenue Service and any legal opinions
issued thereafter with respect to such Benefit Plan&rsquo;s continued qualification; (vi) in the case of any Benefit Plan for which a
Form 5500 must be filed, a copy of the two most recently filed Forms 5500, with all corresponding schedules and financial statements
attached; (vii) actuarial valuations and reports related to any Benefit Plans with respect to the two most recently completed plan years;
(viii) the most recent nondiscrimination tests performed under the Code; and (ix) copies of material notices, letters or other correspondence
from the Internal Revenue Service, Department of Labor, Department of Health and Human Services, Pension Benefit Guaranty Corporation
or other Governmental Authority relating to the Benefit Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Each Benefit Plan and any related trust (other than any multiemployer plan within the meaning of Section 3(37) of ERISA (each a &ldquo;<B>Multiemployer
Plan</B>&rdquo;)) has been established, administered and maintained in accordance with its terms and in compliance with all applicable
Laws (including ERISA, the Code and any applicable local Laws). Each Benefit Plan that is intended to be qualified within the meaning
of Section 401(a) of the Code (a &ldquo;<B>Qualified Benefit Plan</B>&rdquo;) is so qualified and received a favorable and current determination
letter from the Internal Revenue Service with respect to the most recent five year filing cycle, or with respect to a prototype or volume
submitter plan, can rely on an opinion letter from the Internal Revenue Service to the prototype plan or volume submitter plan sponsor,
to the effect that such Qualified Benefit Plan is so qualified and that the plan and the trust related thereto are exempt from federal
income taxes under Sections 401(a) and 501(a), respectively, of the Code, and nothing has occurred that could reasonably be expected
to adversely affect the qualified status of any Qualified Benefit Plan. Nothing has occurred with respect to any Benefit Plan that has
subjected or could reasonably be expected to subject the Company, any Subsidiary, or any Affiliated Practice or any of its ERISA Affiliates
or, with respect to any period on or after the Closing Date, Buyer or any of its Affiliates, to a penalty under Section 502 of ERISA
or to tax or penalty under Sections 4975 or 4980H of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
pension plan (other than a Multiemployer Plan) which is subject to minimum funding requirements, including any multiple employer plan,
(each, a &ldquo;<B>Single Employer Plan</B>&rdquo;) in which employees of the Company, any Subsidiary, or any Affiliated Practice or
any ERISA Affiliate participate or have participated has an &ldquo;accumulated funding deficiency&rdquo;, whether or not waived, or is
subject to a lien for unpaid contributions under Section 303(k) of ERISA or Section 430(k) of the Code. No Single Employer Plan covering
employees of the Company which is a defined benefit plan has an &ldquo;adjusted funding target attainment percentage,&rdquo; as defined
in Section 436 of the Code, less than 80%. All benefits, contributions and premiums relating to each Benefit Plan have been timely paid
in accordance with the terms of such Benefit Plan and all applicable Laws and accounting principles, and all benefits accrued under any
unfunded Benefit Plan have been paid, accrued or otherwise adequately reserved to the extent required by, and in accordance with, GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Neither the Company, any Subsidiary, or any Affiliated Practice nor any of its ERISA Affiliates has (i) incurred or reasonably expects
to incur, either directly or indirectly, any material Liability under Title I or Title IV of ERISA or related provisions of the Code
or applicable local Law relating to employee benefit plans; (ii) failed to timely pay premiums to the Pension Benefit Guaranty Corporation;
(iii) withdrawn from any Benefit Plan; (iv) engaged in any transaction which would give rise to liability under Section 4069 or Section
4212(c) of ERISA; (v) incurred taxes under Section 4971 of the Code with respect to any Single Employer Plan; or (vi) participated in
a multiple employer welfare arrangements (MEWA).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
With respect to each Benefit Plan (i) no such plan is a Multiemployer Plan, and (A) all contributions required to be paid by the Company
or its ERISA Affiliates have been timely paid to the applicable Multiemployer Plan; (B) neither the Company nor any ERISA Affiliate has
incurred any withdrawal liability under Title IV of ERISA which remains unsatisfied, and (C) a complete withdrawal from all such Multiemployer
Plans at the Closing Date would not result in any material liability to the Company and no Multiemployer Plan is in critical, endangered
or seriously endangered status or has suffered a mass withdrawal; (ii) no such plan is a &ldquo;multiple employer plan&rdquo; within
the meaning of Section 413(c) of the Code or a &ldquo;multiple employer welfare arrangement&rdquo; (as defined in Section 3(40) of ERISA);
(iii) no Action has been initiated by the Pension Benefit Guaranty Corporation to terminate any such plan or to appoint a trustee for
any such plan; (iv) no such plan or the plan of any ERISA Affiliate maintained or contributed to within the last six (6) years is a Single
Employer Plan subject to Title IV of ERISA; and (v) no &ldquo;reportable event,&rdquo; as defined in Section 4043 of ERISA, with respect
to which the reporting requirement has not been waived has occurred with respect to any such plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Each Benefit Plan can be amended, terminated or otherwise discontinued after the Closing in accordance with its terms, without material
liabilities to Buyer, the Company or any of their Affiliates other than ordinary administrative expenses typically incurred in a termination
event. Neither the Company, any Subsidiary, or any Affiliated Practice has any commitment or obligation and has not made any representations
to any employee, officer, director, independent contractor or consultant, whether or not legally binding, to adopt, amend, modify or
terminate any Benefit Plan or any collective bargaining agreement, in connection with the consummation of the transactions contemplated
by this Agreement or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Other than as required under Sections 601 to 608 of ERISA or other applicable Law, no Benefit Plan provides post-termination or retiree
health benefits to any individual for any reason, and neither the Company, any Subsidiary, or any Affiliated Practice nor any of its
ERISA Affiliates has any Liability to provide post-termination or retiree health benefits to any individual or ever represented, promised
or contracted to any individual that such individual would be provided with post-termination or retiree health benefits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
There is no pending or, to Seller&rsquo;s Knowledge, threatened Action relating to a Benefit Plan (other than routine claims for benefits),
and no Benefit Plan has within the three years prior to the date hereof been the subject of an examination or audit by a Governmental
Authority or the subject of an application or filing under or is a participant in, an amnesty, voluntary compliance, self-correction
or similar program sponsored by any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
There has been no amendment to, announcement by Seller, the Company, any Subsidiary, or any Affiliated Practice or any of their Affiliates
relating to, or change in employee participation or coverage under, any Benefit Plan or collective bargaining agreement that would increase
the annual expense of maintaining such plan above the level of the expense incurred for the most recently completed fiscal year (other
than on a de minimis basis) with respect to any director, officer, employee, independent contractor or consultant, as applicable. None
of Seller, the Company, any Subsidiary, or any Affiliated Practice, nor any of their Affiliates has any commitment or obligation or has
made any representations to any director, officer, employee, independent contractor or consultant, whether or not legally binding, to
adopt, amend, modify or terminate any Benefit Plan or any collective bargaining agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Each Benefit Plan that is subject to Section 409A of the Code has been administered in compliance with its terms and the operational
and documentary requirements of Section 409A of the Code and all applicable regulatory guidance (including notices, rulings and proposed
and final regulations) thereunder. The Company, any Subsidiary, or any Affiliated Practice does not have any obligation to gross up,
indemnify or otherwise reimburse any individual for any excise taxes, interest or penalties incurred pursuant to Section 409A of the
Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Each individual who is classified by the Company, any Subsidiary, or any Affiliated Practice as an independent contractor has been properly
classified for purposes of participation and benefit accrual under each Benefit Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
Neither the execution of this Agreement nor any of the transactions contemplated by this Agreement will (either alone or upon the occurrence
of any additional or subsequent events): (i) entitle any current or former director, officer, employee, independent contractor or consultant
of the Company, any Subsidiary, or any Affiliated Practice to severance pay or any other payment; (ii) accelerate the time of payment,
funding or vesting, or increase the amount of compensation (including stock-based compensation) due to any such individual; (iii) limit
or restrict the right of the Company, any Subsidiary, or any Affiliated Practice to merge, amend, or terminate any Benefit Plan; (iv)
increase the amount payable under or result in any other material obligation pursuant to any Benefit Plan; (v) result in &ldquo;excess
parachute payments&rdquo; within the meaning of Section 280G(b) of the Code; or (vi) require a &ldquo;gross-up&rdquo; or other payment
to any &ldquo;disqualified individual&rdquo; within the meaning of Section 280G(c) of the Code. Sellers have made available to Buyer
true and complete copies of any Section 280G calculations prepared (whether or not final) with respect to any disqualified individual
in connection with the transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.21 Employment Matters.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Section 3.21(a) of the Disclosure Schedules contains a list of all persons who are employees, independent contractors or consultants
of the Company, any Subsidiary, or any Affiliated Practice as of the date hereof, including any employee who is on a leave of
absence of any nature, paid or unpaid, authorized or unauthorized, and sets forth for each such individual the following: (i) name;
(ii) title or position (including whether full-time or part-time); (iii) hire or retention date; (iv) current annual base
compensation rate or contract fee; (v) commission, bonus or other incentive-based compensation; (vi) whether each employee is
classified as exempt from the overtime requirements of the Fair Labor Standards Act, and if so, the basis for the employee&rsquo;s
exempt status; (vii) for each independent contractor or consultant, a description of the services provided by each independent
contractor or consultant; (viii) a description of the fringe benefits provided to each employee, independent contractor, or
consultant as of the date hereof. As of the date hereof, all compensation, including wages, commissions, bonuses, fees and other
compensation, payable to all employees, independent contractors or consultants of the Company, any Subsidiary, or any Affiliated
Practice for services performed on or prior to the date hereof have been paid in full (or accrued in full on the balance sheet
contained in the Closing Working Capital Statement) and there are no outstanding agreements, understandings or commitments of the
Company, any Subsidiary, or any Affiliated Practice with respect to any compensation, commissions, bonuses or fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company, any Subsidiary, or any Affiliated Practice is not, and has not been for the past three years, a party to, bound by, or negotiating
any collective bargaining agreement or other Contract with a union, works council or labor organization (collectively, &ldquo;<B>Union</B>&rdquo;),
and there is not, and has not been for the past three years, any Union representing or purporting to represent any employee of the Company,
any Subsidiary, or any Affiliated Practice, and, to Seller&rsquo;s Knowledge, no Union or group of employees is seeking or has sought
to organize employees for the purpose of collective bargaining. There has never been, nor has there been any threat of, any strike, slowdown,
work stoppage, lockout, concerted refusal to work overtime or other similar labor disruption or dispute affecting the Company, any Subsidiary,
or any Affiliated Practice or any of its employees. The Company has no duty to bargain with any Union.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
All employment agreements and all independent contractor agreements between the Company, any Subsidiary, or any Affiliated Practice and
any employee or independent contractor as of the date hereof has been made available to Buyer for inspection. No employees or independent
contractors of the Company, any Subsidiary, or any Affiliated Practice are subject to an oral employment contract or oral independent
contractor agreement and no employees of the Company, any Subsidiary, or any Affiliated Practice have any oral entitlements in addition
to their entitlements under their written employment contracts with the Company, any Subsidiary, or any Affiliated Practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company, each Subsidiary, and each Affiliated Practice is and has been in compliance with all applicable Laws pertaining to employment
and employment practices, including, but not limited to, all Laws relating to labor relations, equal employment opportunities, fair employment
practices, employment discrimination, harassment, retaliation, reasonable accommodation, disability rights or benefits, immigration,
wages, hours, overtime compensation, child labor, hiring, promotion and termination of employees, working conditions, meal and break
periods, privacy, health and safety, workers&rsquo; compensation, leaves of absence, paid sick leave, tax withholding, record keeping,
and unemployment insurance. All individuals characterized and treated by the Company, any Subsidiary, or any Affiliated Practice as independent
contractors or consultants are properly treated as independent contractors under all applicable Laws. The Company, each Subsidiary, and
each Affiliated Practice (i) has withheld and reported all amounts required by applicable Law and regulations or by agreement to be withheld
and reported with respect to wages, salaries and other payments to employees, (ii) is not liable for any arrears of wages, severance
pay or any taxes or any penalty for failure to comply with any of the foregoing, and (iii) is not liable for any payment to any trust
or other fund governed by or maintained by or on behalf of any governmental authority, with respect to unemployment compensation benefits,
social security or other benefits or obligations for employees (other than routine payments to be made in the normal course of business
and consistent with past practice). All employees of the Company, any Subsidiary, or any Affiliated Practice classified as exempt under
the Fair Labor Standards Act and state and local wage and hour laws are properly classified. The Company, each Subsidiary, and each Affiliated
Practice is in compliance with and has complied with all immigration laws, including Form I-9 requirements and any applicable mandatory
E-Verify obligations. There are no Actions against the Company, any Subsidiary, or any Affiliated Practice pending, or to the Seller&rsquo;s
Knowledge, threatened to be brought or filed, by or with any Governmental Authority or arbitrator in connection with the employment of
any current or former applicant, employee, consultant, volunteer, intern or independent contractor of the Company, any Subsidiary, or
any Affiliated Practice, including, without limitation, any charge, investigation or claim relating to unfair labor practices, equal
employment opportunities, fair employment practices, employment discrimination, harassment, retaliation, reasonable accommodation, disability
rights or benefits, immigration, wages, hours, overtime compensation, employee classification, child labor, hiring, promotion and termination
of employees, working conditions, meal and break periods, privacy, health and safety, workers&rsquo; compensation, leaves of absence,
paid sick leave, unemployment insurance or any other employment related matter arising under applicable Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
No notice in writing has been received by any Seller, the Company, any Subsidiary, or any Affiliated Practice of any complaint filed
by any of their current or former employees against any the Company, any Subsidiary, or any Affiliated Practice or any current or former
director or officer thereof or is threatened or pending, claiming or alleging that the Company, any Subsidiary, or any Affiliated Practice
has violated any law applicable to the employee or human rights or of any complaints or actions of any kind involving the Company, any
Subsidiary, or any Affiliated Practice or any of the employees of each.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
There is no notice of assessment, provisional assessment, reassessment, supplementary assessment, penalty assessment or increased assessment
which the Company, any Subsidiary, or any Affiliated Practice has received before the date of this Agreement during the past five years
from any workplace safety and insurance or workers compensation board or similar governmental authority in any jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
There are no outstanding orders nor any pending charges made under any workers compensation law relating to any employee of the Company,
any Subsidiary, or any Affiliated Practice and there have been no fatal or critical accidents within the last five years that might reasonably
be expected to lead to charges the Company, any Subsidiary, or any Affiliated Practice. The Company, each Subsidiary, and each Affiliated
Practice has complied with all governmental orders issued under all applicable workers compensation laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
The Company, each Subsidiary, and each Affiliated Practice has not made any representations regarding equity incentives or other compensation
to any officer or employee of the Company, each Subsidiary, and each Affiliated Practice that are inconsistent with the amounts and terms
set forth in the written agreements with the officer or employee disclosed in Section 3.21(c) of the Disclosure Schedules. All written
agreements providing for equity incentives to any officer or employee of the Company, each Subsidiary, and each Affiliated Practice have
been disclosed in Section 3.21(c) of the Disclosure Schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Company, each Subsidiary, and each Affiliated Practice has complied in all material respects with the WARN Act, and it has no plans
to undertake any action in the future that would trigger the WARN Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.22 Taxes.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All Tax Returns required to be filed on or before the Closing Date by the Company, each Subsidiary, and each Affiliated Practice have
been, or will be, timely filed. Such Tax Returns are, or will be, true, complete and correct in all respects. All Taxes due and owing
by the Company, each Subsidiary, and each Affiliated Practice (whether or not shown on any Tax Return) have been, or will be, timely
paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company, each Subsidiary, and each Affiliated Practice has withheld and paid each Tax required to have been withheld and paid in
connection with amounts paid or owing to any employee, independent contractor, creditor, customer, shareholder or other party, and complied
with all information reporting and backup withholding provisions of applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
No claim has been made by any taxing authority in any jurisdiction where the Company, each Subsidiary, and each Affiliated Practice does
not file Tax Returns that it is, or may be, subject to Tax by that jurisdiction. Section 3.22(c) of the Disclosure Schedules sets forth
each state, county, local municipal, domestic or foreign jurisdiction or Governmental Authority in or with which the Company (i) files
a Tax Return, (ii) is registered for any Tax purpose, (iii) treats itself as liable for any Tax on a &ldquo;nexus&rdquo; basis, (iv)
is qualified to do business, (v) owns or regularly uses property on anything other than a transient basis, (vi) has any employee or in
which any employee is regularly present, or (vii) has any agent, Representative or distributor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
No extensions or waivers of statutes of limitations have been given or requested with respect to any Taxes of the Company, each Subsidiary,
and each Affiliated Practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The amount of the Company, each Subsidiary, and each Affiliated Practice&rsquo;s Liability for unpaid Taxes for all periods ending on
or before October 31, 2021 does not, in the aggregate, exceed the amount of accruals for Taxes (excluding reserves for deferred Taxes)
reflected on the Financial Statements. The amount of the Company&rsquo;s Liability for unpaid Taxes for all periods following the end
of the recent period covered by the Financial Statements shall not, in the aggregate, exceed the amount of accruals for Taxes (excluding
reserves for deferred Taxes) as adjusted for the passage of time in accordance with the past custom and practice of the Company, each
Subsidiary, and each Affiliated Practice (and which accruals shall not exceed comparable amounts incurred in similar periods in prior
years).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Section 3.22(f) of the Disclosure Schedules sets forth:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the taxable years of the Company as to which the applicable statutes of limitations on the assessment and collection of Taxes have not
expired;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
those years for which examinations by the taxing authorities have been completed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
those taxable years for which examinations by taxing authorities are presently being conducted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
All deficiencies asserted, or assessments made, against the Company, any Subsidiary, or any Affiliated Practice as a result of any examinations
by any taxing authority have been fully paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
The Company, any Subsidiary, or any Affiliated Practice is not a party to any Action by any taxing authority. There are no pending or
threatened Actions by any taxing authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Seller has delivered to Buyer copies of all federal, state, local and foreign income, franchise and similar Tax Returns, examination
reports, and statements of deficiencies assessed against, or agreed to by, the Company, any Subsidiary, or any Affiliated Practice for
all Tax periods ending after December 31, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
There are no Encumbrances for Taxes (other than for current Taxes not yet due and payable) upon the assets of the Company, any Subsidiary,
or any Affiliated Practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Neither the Company, any Subsidiary, nor any Affiliated Practice is a party to, or bound by, any Tax indemnity, Tax sharing or Tax allocation
agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
No private letter rulings, technical advice memoranda or similar agreement or rulings have been requested, entered into or issued by
any taxing authority with respect to the Company, any Subsidiary, or any Affiliated Practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
Neither the Company, any Subsidiary, nor any Affiliated Practice has been a member of an affiliated, combined, consolidated or unitary
Tax group for Tax purposes. Neither the Company, any Subsidiary, nor any Affiliated Practice has any Liability for Taxes of any Person
(other than the Company) under Treasury Regulations Section 1.1502-6 (or any corresponding provision of state, local or foreign Law),
as transferee or successor, by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
Neither the Company, any Subsidiary, nor any Affiliated Practice will be required to include any item of income in, or exclude any item
or deduction from, taxable income for any taxable period or portion thereof ending after the Closing Date as a result of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
any change in a method of accounting under Section 481 of the Code (or any comparable provision of state, local or foreign Tax Laws),
or use of an improper method of accounting;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
an installment sale or open transaction occurring on or prior to the Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
a prepaid amount received on or before the Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
any closing agreement under Section 7121 of the Code, or similar provision of state, local or foreign Law; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
any election under Section 108(i) of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
Seller is not a &ldquo;foreign person&rdquo; as that term is used in Treasury Regulations Section 1.1445-2. Neither the Company, any
Subsidiary, nor any Affiliated Practice is, nor has it been, a United States real property holding corporation (as defined in Section
897(c)(2) of the Code) during the applicable period specified in Section 897(c)(1)(a) of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
Neither the Company, any Subsidiary, nor any Affiliated Practice has been a &ldquo;distributing corporation&rdquo; or a &ldquo;controlled
corporation&rdquo; in connection with a distribution described in Section 355 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
Neither the Company, any Subsidiary, nor any Affiliated Practice is, nor has been, a party to, or a promoter of, a &ldquo;reportable
transaction&rdquo; within the meaning of Section 6707A(c)(1) of the Code and Treasury Regulations Section 1.6011 4(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
There is currently no limitation on the utilization of net operating losses, capital losses, built-in losses, tax credits or similar
items of the Company, any Subsidiary, or any Affiliated Practice under Sections 269, 382, 383, 384 or 1502 of the Code and the Treasury
Regulations thereunder (and comparable provisions of state, local or foreign Law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
Section 3.22(s) of the Disclosure Schedules sets forth all foreign jurisdictions in which the Company, any Subsidiary, or any Affiliated
Practice is subject to Tax, is engaged in business or has a permanent establishment. The Company, any Subsidiary, or any Affiliated Practice
has not entered into a gain recognition agreement pursuant to Treasury Regulations Section 1.367(a)-8. Neither the Company, any Subsidiary,
nor any Affiliated Practice has transferred an intangible the transfer of which would be subject to the rules of Section 367(d) of the
Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
No property owned by the Company, any Subsidiary, or any Affiliated Practice is (i) required to be treated as being owned by another
person pursuant to the so-called &ldquo;safe harbor lease&rdquo; provisions of former Section 168(f)(8) of the Internal Revenue Code
of 1954, as amended, (ii) subject to Section 168(g)(1)(A) of the Code, or (iii) subject to a disqualified leaseback or long-term agreement
as defined in Section 467 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
Neither the Company, any Subsidiary, nor any Affiliated Practice (i) is, nor has ever been, a party to any loan issued pursuant to the
Paycheck Protection Program, (ii) has deferred any Tax pursuant to Section 2302 of the CARES Act, pursuant to the Payroll Tax Executive
Order, or any similar provision of Law, or (iii) has applied for or received a refund of Employee retention tax credits pursuant to Section
2301 of the CARES Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.23 Books and Records.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The minute books and stock
record books of the Company, each Subsidiary, and each Affiliated Practice, all of which have been made available to Buyer, are complete
and correct and have been maintained in accordance with sound business practices. The minute books of the Company, each Subsidiary, and
each Affiliated Practice contain accurate and complete records of all meetings, and actions taken by written consent of, the stockholders,
the board of directors and any committees of the board of directors of the Company, each Subsidiary, and each Affiliated Practice, and
no meeting, or action taken by written consent, of any such stockholders, board of directors or committee has been held for which minutes
have not been prepared and are not contained in such minute books. At the Closing, all of those books and records will be in the possession
of the Company, each Subsidiary, and each Affiliated Practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.24 <FONT STYLE="vertical-align: baseline">Brokers.</FONT></B> No broker, finder or investment banker is entitled to any brokerage,
finder&rsquo;s or other fee or commission in connection with the transactions contemplated by this Agreement or any other Ancillary Document
based upon arrangements made by or on behalf of any Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.25 <FONT STYLE="vertical-align: baseline">Health Care Regulations.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the Company, each Subsidiary,
and each Affiliated Practice has, since January 1, 2020, been, and currently is, in compliance with all Health Care Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(b)
Neither the Company, any Subsidiary, nor any Affiliated Practice has received any written subpoenas, demands or other notices from any
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governmental Authority <FONT STYLE="font-weight: normal; vertical-align: baseline">inquiring
into, or otherwise relating to, any actual or potential violation of any Health Care Laws, and, to the Seller&rsquo;s Knowledge, neither
the Company, any Subsidiary, nor any Affiliated Practice is under investigation by any </FONT>Governmental Authority <FONT STYLE="font-weight: normal; vertical-align: baseline">for
a violation of any Health Care Laws, and to the Seller&rsquo;s Knowledge, there are no facts and circumstances which would reasonably
be expected to form the basis for any such violation.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Neither the Company, <FONT STYLE="font-weight: normal; vertical-align: baseline">any Subsidiary, </FONT>any Affiliated Practice, nor
any of the Company Personnel or Affiliated Practices Personnel, is now or has ever been, subject to or bound by any consent decree, judgment,
corporate integrity agreement, deferred prosecution agreement, certification of compliance agreement, settlement agreement or similar
agreement with any Governmental Authority concerning compliance with any Health Care Laws. Neither the Company, <FONT STYLE="font-weight: normal; vertical-align: baseline">any
Subsidiary, </FONT>nor any Affiliated Practice is a defendant or named party in any unsealed qui tam/False Claims Act litigation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Neither the Company. <FONT STYLE="font-weight: normal; vertical-align: baseline">any Subsidiary, </FONT>nor any Affiliated Practice has,
since January 1, 2020, been the subject of any inspection, investigation, survey, audit, monitoring or other form of review by any Governmental
Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Neither the Company, <FONT STYLE="font-weight: normal; vertical-align: baseline">any Subsidiary, </FONT>any Affiliated Practice, nor,
to the <FONT STYLE="font-weight: normal; vertical-align: baseline">Seller</FONT>&rsquo;s Knowledge, any of any of the Company Personnel,
Affiliated Practices Personnel, any supplier or agents of the Company, <FONT STYLE="font-weight: normal; vertical-align: baseline">any
Subsidiary, </FONT>or any Affiliated Practice: (i) has had a civil monetary penalty assessed against him, her or it pursuant to 42 U.S.C.
&sect;1320a-7a; (ii) has been excluded, suspended, terminated or debarred from participation, or is otherwise ineligible to participate,
in any Federal Health Care Program or threatened with or currently subject to an investigation or proceeding that could result in suspension,
exclusion or debarment from participation in any Federal Health Care Program; or (iii) has been convicted (as the term is defined in
42 C.F.R. &sect;1001.2) of, charged with, or investigated for a violation of any Health Care Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Neither the Company, <FONT STYLE="font-weight: normal; vertical-align: baseline">any Subsidiary, </FONT>any Affiliated Practice, nor,
to the <FONT STYLE="font-weight: normal; vertical-align: baseline">Seller</FONT>&rsquo;s Knowledge, any of any of the Company Personnel
or Affiliated Practices Personnel have, directly or indirectly, made or offered to make, or solicited or received, any contribution,
gift, bribe, rebate, payoff, influence payment, kickback or inducement to any Person or entered into any financial arrangement, regardless
of form, in violation of any Health Care Law or to obtain or maintain favorable treatment in securing business in violation of any Health
Care Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
All billings by the Affiliated Practices for services, including billings to all Federal Health Care Programs and Private Programs, have
been true and correct in all material respects and in material compliance with all applicable Health Care Laws. Section 3.25 of the Disclosure
Schedules sets forth all notices, subpoenas and material correspondence related to utilization, reimbursement or other government or
third party audits or investigations targeted at the Company, <FONT STYLE="font-weight: normal; vertical-align: baseline">any Subsidiary,
</FONT>or any Affiliated Practice, conducted during the six (6) year period prior to the date hereof. Except as permitted by Law, to
the <FONT STYLE="font-weight: normal; vertical-align: baseline">Seller</FONT>&rsquo;s Knowledge, none of the Affiliated Practices have
waived or discounted patient responsibility for any services provided by any of the Affiliated Practices. No Private Program or Federal
Health Care Program has requested or threatened any material recoupment, refund, or set-off from the Company, <FONT STYLE="font-weight: normal; vertical-align: baseline">any
Subsidiary, </FONT>or any of the Affiliated Practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Each of the Affiliated Practices: (i) is certified for participation and reimbursement under all Federal Health Care Programs from which
it receives reimbursement, and (ii) has current supplier or provider numbers and supplier or provider agreements for such Federal Health
Care Program. Each of the Affiliated Practices has been and is eligible to receive payments under each Federal Health Care Program and
Private Program under which it has received or is receiving payments. The Company, each Subsidiary and each Affiliated Practice is in
material compliance with all requirements, including all billing requirements, of each Federal Health Care Program and each Private Program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
All agreements between the Company, each Subsidiary, and each Affiliated Practice and any physician or other health care professional
for services are in writing, describe bona fide services and provide for compensation that is no more than fair market value for such
services determined as of the date such agreement was entered into. All payments made by the Company, each Subsidiary, and each Affiliated
Practice to any physician or other health care professional for services rendered by such physician or other health care professional
have been made at fair market value determined as of the date such agreement was entered into.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
The Company, each Subsidiary, and each of the Affiliated Practices have used, collected, disclosed, disseminated and protected all personal
information and other information related to individuals, in compliance with all applicable Material Contracts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
The data collection, access, maintenance, transmission, use and disclosure by the Company, each Subsidiary, and each Affiliated Practice
with respect to personal information is, and at all times has been in compliance with all applicable Information Laws. The Company, each
Subsidiary, and each Affiliated Practice maintain and have maintained policies and procedures regarding data security, privacy and the
use of data and maintain administrative, technical, and physical safeguards that are commercially reasonable and, in any event, in compliance
with all applicable Information Laws and all Material Contracts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
None of the Company, any Subsidiary, or any Affiliated Practice has had any security or data breaches compromising or otherwise involving
personal information. None of the Company, any Subsidiary, or any Affiliated Practice has received any written or, to the <FONT STYLE="font-weight: normal; vertical-align: baseline">Seller</FONT>&rsquo;s
Knowledge, oral claim or notice from any Governmental Authority, alleging or referencing the investigation of any breach, violation of
its Information Systems as defined under HIPAA or the improper use, disclosure or access to any personally identifiable information in
its possession, custody or control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.26 <FONT STYLE="vertical-align: baseline">Permits.</FONT></B> The Company, each Subsidiary, and each Affiliated Practice validly holds
and has in full force and effect all material Permits necessary for the Company, each Subsidiary and each Affiliated Practice to carry
on its or their businesses as now conducted, and there has occurred no violation of, or default (with or without notice or lapse of time
or both) under, or event giving to any Governmental Authority any right of termination, amendment or cancellation of, any such Permit.
The Company, each Subsidiary, and each Affiliated Practice has complied in all material respects with the terms and conditions of all
Permits issued to or held by the Company, each Subsidiary, and each Affiliated Practice, and such Permits will not be subject to suspension,
modification, revocation or nonrenewal as a result of the execution and delivery of this Agreement or the consummation of the transactions
contemplated hereunder. No Action is pending or, to the Knowledge of the <FONT STYLE="font-weight: normal; vertical-align: baseline">Seller</FONT>,
threatened seeking the revocation or limitation of any Permit. Section 3.26 of the Disclosure Schedules lists each Permit issued or granted
to or held by the Company, each Subsidiary, and each Affiliated Practice (and which of the Company, each Subsidiary, and each Affiliated
Practice such Permit relates).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.27 <FONT STYLE="vertical-align: baseline">Affiliated Practices.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Section 3.27(a) of the Disclosure Schedules sets forth each Affiliated Practice which is, or at any time since January 1, 2019 has been,
party to a management and physician services agreement, professional services agreement, succession agreement or any other similar type
of agreement with the Company (the <I>&ldquo;</I><B>Affiliated Practices Agreements</B><I>&rdquo;</I>). To the <FONT STYLE="font-weight: normal; vertical-align: baseline">Seller</FONT>&rsquo;s
Knowledge, none of the Affiliated Practices is in material breach or material violation of, or default under, or has materially breached
or materially violated, any of its organizational documents. Section 3.27(a) of the Disclosure Schedules sets forth each of the Affiliated
Practices Agreements, which, as of the date hereof, are each enforceable against each party to such Affiliated Practices Agreements,
and are in full force and effect. Neither the Company, and Subsidiary, nor any of the Affiliated Practices or, to the <FONT STYLE="font-weight: normal; vertical-align: baseline">Seller</FONT>&rsquo;s
Knowledge, any other party to any Affiliated Practices Agreement, is in material breach or material violation of, or default under, or
has repudiated any material provision of, any Affiliated Practices Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each of the Affiliated Practices is maintaining historic and current staffing levels of physicians and other health care professionals,
except such changes as are reasonably deemed necessary by the Company operating in the ordinary course of business. To the <FONT STYLE="font-weight: normal; vertical-align: baseline">Seller</FONT>&rsquo;s
Knowledge, as of the date hereof, all of the written employment agreements between each Affiliated Practice and its respective physicians
and other health care professionals performing the same or similar services (&ldquo;<B>Affiliated Practices Employment Agreements</B>&rdquo;)
are enforceable against each party to such Affiliated Practices Employment Agreements, and are in full force and effect. Neither the
Company, and Subsidiary, nor any of the Affiliated Practices or, to the <FONT STYLE="font-weight: normal; vertical-align: baseline">Seller</FONT>&rsquo;s
Knowledge, any other party to any Affiliated Practices Employment Agreement, is in material breach or material violation of, or default
under, or has repudiated any material provision of, any Affiliated Practices Employment Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
(i) each of the Affiliated Practices is solvent, (ii) with respect to each obligation under a Contract of any Affiliated Practice in
respect of which the Company has entered into a guarantee of the obligations of the Affiliated Practice or is otherwise responsible for
the obligations of the Affiliated Practice, such Affiliated Practice is not in material breach of or default under, and has complied
with, the terms of such Contract in all material respects and no event has occurred, is pending or threatened, which, after the giving
of notice, lapse of time or otherwise, would constitute a breach or default by any of the Affiliated Practices under any such obligation
under the Contract or any other party to such Contract, and (iii) since January 1, 2019, no Affiliated Practice has (x) commenced or
been subject to a proceeding seeking liquidation, reorganization or other relief with respect to itself or its debts under Title 11 of
the United States Code or any similar Legal Requirements or seeking the appointment of a trustee, receiver, liquidator, custodian or
other similar official, (y) consented to the entry of or been subject to an order for relief in such proceeding, or (z) made a general
assignment for the benefit of creditors or dissolved, terminated its existence or ceased its business operations (or any material portion
thereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
To the <FONT STYLE="font-weight: normal; vertical-align: baseline">Seller</FONT>&rsquo;s Knowledge, since January 1, 2019, none of the
Affiliated Practices has received any written notice of any claimed material violation of any Laws by such Affiliated Practice, and each
of the Affiliated Practices has been operated since January 1, 2019, in compliance in all material respects with all Legal Requirements
(including Legal Requirements relating to the corporate practice of medicine, fee splitting, licensure laws, and naming and/or marketing
restrictions) and has been in material compliance with all of their respective Permits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
As of the date hereof and immediately prior to the Closing, (i) the business of each of the Affiliated Practices as currently conducted
does not require any insurance license or laboratory license under Legal Requirements, (ii) none of the Affiliated Practices have engaged
in any activity which constituted a material loss, limitation, restriction, revocation or suspension of any Permit, except for such losses,
limitations, restrictions, revocations or suspension as would not, individually or in the aggregate, have a Material Adverse Effect on
any of the Affiliated Practices, and (iii) each physician, physician assistant, nurse, technician, assistant and other clinical staff
employed by or under contract with each of the Affiliated Practices has all Permits necessary to practice his or her profession in each
of the states in which such individual practices on behalf of any of the Affiliated Practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
As of the date hereof and immediately prior to the Closing, with respect to each Contract of the Company, and Subsidiary, or any of the
Affiliated Practices with an insurance carrier, other provider or managed care organization, (i) neither the Company, any Subsidiary,
nor any such Affiliated Practice is in material breach of or default under any such Contract and no other party to such Contract is in
breach thereof or default thereunder, (ii) no event has occurred, is pending or threatened, which, after the giving of notice, lapse
of time or otherwise, would constitute a breach or default by the Company, any Subsidiary, or any of the Affiliated Practices under any
such Contract or any other party to such Contract, and (iii) all such Contracts are in material compliance with all applicable Laws including
federal and state antitrust laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(g)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the <FONT STYLE="font-weight: normal; vertical-align: baseline">Seller</FONT>&rsquo;s
Knowledge, no physician or other health care professional at any of the Affiliated Practices is subject to a pending disciplinary proceeding
under the bylaws or rules of procedure of such Affiliated Practices or any state law. All disciplinary actions, imposition of restrictions
or conditions, revocation or non-renewal of rights and privileges for reasons requiring reporting to local, state, federal or quasi-public
authorities that are required of any of the Affiliated Practices since January 1, 2019 have been effected as required. To the <FONT STYLE="font-weight: normal; vertical-align: baseline">Seller</FONT>&rsquo;s
Knowledge, there is no Action pending or threatened with respect to denial or revocation of physician staff privileges or licensure of
any health care professional at any of the Affiliated Practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.28 <FONT STYLE="vertical-align: baseline">Full Disclosure.</FONT></B> No representation or warranty by Sellers in this Agreement and
no statement contained in the Disclosure Schedules to this Agreement or any certificate or other document furnished or to be furnished
to Buyer pursuant to this Agreement contains any untrue statement of a material fact, or omits to state a material fact necessary to
make the statements contained therein, in light of the circumstances in which they are made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.29 No Other Representations and Warranties.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for the representations and warranties contained in this ARTICLE III (including the related portions of the Disclosure Schedules), none
of Sellers, the Company or any other Person has made or makes any other express or implied representation or warranty, either written
or oral, on behalf of Sellers or the Company, including any representation or warranty as to the accuracy or completeness of any information
regarding the Company furnished or made available to Buyer and its Representatives (including any information, documents or material
made available to Buyer in any data room, management presentations or in any other form in expectation of the transactions contemplated
hereby) or as to the future revenue, profitability or success of the Company, or any representation or warranty arising from statute
or otherwise in law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Representations
and warranties of buyer</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as set forth in the correspondingly numbered Section of the Disclosure Schedules, Buyer represents and warrants to Seller that the statements
contained in this ARTICLE IV are true and correct as of the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
4.01 Organization and Authority of Buyer.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer is
a corporation duly organized, validly existing and in good standing under the Laws of the state of Delaware. Buyer has full corporate
power and authority to enter into this Agreement and the Ancillary Documents to which Buyer is a party, to carry out its obligations
hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution and delivery by Buyer of this
Agreement and any Ancillary Document to which Buyer is a party, the performance by Buyer of its obligations hereunder and thereunder
and the consummation by Buyer of the transactions contemplated hereby and thereby have been duly authorized by all requisite corporate
action on the part of Buyer. This Agreement has been duly executed and delivered by Buyer, and (assuming due authorization, execution
and delivery by Seller) this Agreement constitutes a legal, valid and binding obligation of Buyer enforceable against Buyer in accordance
with its terms. When each Ancillary Document to which Buyer is or will be a party has been duly executed and delivered by Buyer (assuming
due authorization, execution and delivery by each other party thereto), such Ancillary Document will constitute a legal and binding obligation
of Buyer enforceable against it in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
4.02 No Conflicts; Consents.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The execution, delivery
and performance by Buyer of this Agreement and the Ancillary Documents to which it is a party, and the consummation of the transactions
contemplated hereby and thereby, do not and will not: (a) conflict with or result in a violation or breach of, or default under, any
provision of the certificate of incorporation, by-laws or other organizational documents of Buyer; (b) conflict with or result in a violation
or breach of any provision of any Law or Governmental Order applicable to Buyer; or (c) require the consent, notice or other action by
any Person under any Contract to which Buyer is a party. No consent, approval, Permit, Governmental Order, declaration or filing with,
or notice to, any Governmental Authority is required by or with respect to Buyer in connection with the execution and delivery of this
Agreement and the Ancillary Documents and the consummation of the transactions contemplated hereby and thereby, except for such filings
as may be required under the HSR Act and such consents, approvals, Permits, Governmental Orders, declarations, filings or notices which,
in the aggregate, would not have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
4.03 Investment Purpose.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer is acquiring the Shares
solely for its own account for investment purposes and not with a view to, or for offer or sale in connection with, any distribution
thereof. Buyer acknowledges that the Shares are not registered under the Securities Act of 1933, as amended, or any state securities
laws, and that the Shares may not be transferred or sold except pursuant to the registration provisions of the Securities Act of 1933,
as amended or pursuant to an applicable exemption therefrom and subject to state securities laws and regulations, as applicable. Buyer
is able to bear the economic risk of holding the Shares for an indefinite period (including total loss of its investment), and has sufficient
knowledge and experience in financial and business matters so as to be capable of evaluating the merits and risk of its investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
4.04 Brokers.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No broker, finder or investment banker
is entitled to any brokerage, finder&rsquo;s or other fee or commission in connection with the transactions contemplated by this Agreement
or any Ancillary Document based upon arrangements made by or on behalf of Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.05 <FONT STYLE="vertical-align: baseline">Legal Proceedings.</FONT></B> There are no Actions pending or, to Buyer&rsquo;s knowledge,
threatened against or by Buyer or any Affiliate of Buyer that challenge or seek to prevent, enjoin or otherwise delay the transactions
contemplated by this Agreement. No event has occurred or circumstances exist that may give rise or serve as a basis for any such Action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
4.06 Sufficiency of Funds. </B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer has sufficient
cash on hand or other sources of immediately available funds to enable it to satisfy in full the Purchase Price, the Target Payables,
and the <FONT STYLE="font-weight: normal; vertical-align: baseline">amount necessary to purchase and effect a valid transfer of the ALK
Note (as such term is defined below).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.07 <FONT STYLE="vertical-align: baseline">Independent Investigation.</FONT></B> Buyer has conducted its own independent investigation,
review and analysis of the business, results of operations, prospects, condition (financial or otherwise) or assets of the Company, and
acknowledges that it has been provided adequate access to the personnel, properties, assets, premises, books and records, and other documents
and data of Sellers and the Company for such purpose. Buyer acknowledges and agrees that: (a) in making its decision to enter into this
Agreement and to consummate the transactions contemplated hereby, Buyer has relied solely upon its own investigation and the express
representations and warranties of Seller set forth in ARTICLE III of this Agreement (including the related portions of the Disclosure
Schedules); and (b) none of Sellers, the Company or any other Person has made any representation or warranty as to Sellers, the Company
or this Agreement, except as expressly set forth in ARTICLE III of this Agreement (including the related portions of the Disclosure Schedules).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
4.08 Director and Officer Insurance.</B> <FONT STYLE="font-weight: normal">Buyer maintains </FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">directors&rsquo;
and officers&rsquo; liability insurance for its directors and officers and the directors and officers of its subsidiaries, and newly
acquired subsidiaries are added in accordance with the terms of Buyer&rsquo;s policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Covenants</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
5.01 Conduct of Business Prior to the Closing.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
the date hereof until the Closing, except as otherwise provided in this Agreement or consented to in writing by Buyer (which consent
shall not be unreasonably withheld, conditioned or delayed), Sellers shall, and shall cause the Company, each Subsidiary, and each Affiliated
Practice to, (x) conduct the business of the Company, each Subsidiary, and each Affiliated Practice in the ordinary course of business
consistent with past practice; and (y) use reasonable best efforts to maintain and preserve intact the current organization, business
and franchise of the Company, each Subsidiary, and each Affiliated Practice and to preserve the rights, franchises, goodwill and relationships
of its employees, customers, lenders, suppliers, regulators and others having business relationships with the Company, each Subsidiary,
and each Affiliated Practice. Without limiting the foregoing, from the date hereof until the Closing Date, Sellers shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
cause the Company, each Subsidiary, and each Affiliated Practice to preserve and maintain all of its Permits;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
cause the Company, each Subsidiary, and each Affiliated Practice to pay its debts, Taxes and other obligations when due;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
cause the Company, each Subsidiary, and each Affiliated Practice to maintain the properties and assets owned, operated or used in the
same condition as they were on the date of this Agreement, subject to reasonable wear and tear;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
cause the Company, each Subsidiary, and each Affiliated Practice to continue in full force and effect without modification all Insurance
Policies, except as required by applicable Law;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
cause the Company, each Subsidiary, and each Affiliated Practice to defend and protect its properties and assets from infringement or
usurpation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
cause the Company, each Subsidiary, and each Affiliated Practice to perform all of its obligations under all Contracts relating to or
affecting its properties, assets or business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
cause the Company, each Subsidiary, and each Affiliated Practice to maintain its books and records in accordance with past practice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
cause the Company, each Subsidiary, and each Affiliated Practice to comply in all material respects with all applicable Laws; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
cause the Company, each Subsidiary, and each Affiliated Practice not to take or permit any action that would cause any of the changes,
events or conditions described in Section 3.08 to occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
5.02 Access to Information.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From the date hereof
until the Closing, Sellers shall, and shall cause the Company, each Subsidiary, and each Affiliated Practice to, (a) afford Buyer and
its Representatives full and free access to and the right to inspect all of the Real Property, properties, assets, premises, books and
records, Contracts and other documents and data related to the Company, each Subsidiary, and each Affiliated Practice; (b) furnish Buyer
and its Representatives with such financial, operating and other data and information related to the Company, each Subsidiary, and each
Affiliated Practice as Buyer or any of its Representatives may reasonably request; and (c) instruct the Representatives of Sellers and
the Company, each Subsidiary, and each Affiliated Practice to cooperate with Buyer in its investigation of the Company, each Subsidiary,
and each Affiliated Practice. Any investigation pursuant to this Section 5.02 shall be conducted in such manner as not to interfere unreasonably
with the conduct of the business of Sellers or the Company, each Subsidiary, and each Affiliated Practice. No investigation by Buyer
or other information received by Buyer shall operate as a waiver or otherwise affect any representation, warranty or agreement given
or made by any Seller in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
5.03 No Solicitation of Other Bids.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Sellers shall not, and shall not authorize or permit any of its Affiliates (including the Company, each Subsidiary, and each Affiliated
Practice) or any of its or their Representatives to, directly or indirectly, (i) encourage, solicit, initiate, facilitate or continue
inquiries regarding an Acquisition Proposal; (ii) enter into discussions or negotiations with, or provide any information to, any Person
concerning a possible Acquisition Proposal; or (iii) enter into any agreements or other instruments (whether or not binding) regarding
an Acquisition Proposal. Sellers shall immediately cease and cause to be terminated, and shall cause its Affiliates (including the Company,
each Subsidiary, and each Affiliated Practice) and all of its and their Representatives to immediately cease and cause to be terminated,
all existing discussions or negotiations with any Persons conducted heretofore with respect to, or that could lead to, an Acquisition
Proposal. For purposes hereof, &ldquo;<B>Acquisition Proposal</B>&rdquo; shall mean any inquiry, proposal or offer from any Person (other
than Buyer or any of its Affiliates) concerning (i) a merger, consolidation, liquidation, recapitalization, share exchange or other business
combination transaction involving the Company, any Subsidiary, or any Affiliated Practice; (ii) the issuance or acquisition of shares
of capital stock or other equity securities of the Company, any Subsidiary, or any Affiliated Practice; or (iii) the sale, lease, exchange
or other disposition of any significant portion of the Company, any Subsidiary, or any Affiliated Practice &lsquo;s properties or assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In addition to the other obligations under this Section 5.03, Sellers shall promptly (and in any event within three Business Days after
receipt thereof by Sellers or its Representatives) advise Buyer orally and in writing of any Acquisition Proposal, any request for information
with respect to any Acquisition Proposal, or any inquiry with respect to or which could reasonably be expected to result in an Acquisition
Proposal, the material terms and conditions of such request, Acquisition Proposal or inquiry, and the identity of the Person making the
same.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Sellers agree that the rights and remedies for noncompliance with this Section 5.03 shall include having such provision specifically
enforced by any court having equity jurisdiction, it being acknowledged and agreed that any such breach or threatened breach shall cause
irreparable injury to Buyer and that money damages would not provide an adequate remedy to Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
5.04 Notice of Certain Events.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until the Closing, Sellers shall promptly notify Buyer in writing of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
any fact, circumstance, event or action the existence, occurrence or taking of which (A) has had, or could reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect, (B) has resulted in, or could reasonably be expected to result in,
any representation or warranty made by any Seller hereunder not being true and correct or (C) has resulted in, or could reasonably be
expected to result in, the failure of any of the conditions set forth in Section 7.02 to be satisfied;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
any notice or other communication from any Person alleging that the consent of such Person is or may be required in connection with the
transactions contemplated by this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
any notice or other communication from any Governmental Authority in connection with the transactions contemplated by this Agreement;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
any Actions commenced or, to Seller&rsquo;s Knowledge, threatened against, relating to or involving or otherwise affecting any Seller
or the Company, any Subsidiary, or any Affiliated Practice that, if pending on the date of this Agreement, would have been required to
have been disclosed pursuant to Section 3.17 or that relates to the consummation of the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Buyer&rsquo;s receipt of information pursuant to this Section 5.04 shall not operate as a waiver or otherwise affect any representation,
warranty or agreement given or made by Seller in this Agreement (including Section 8.02 and Section 9.01(b)) and shall not be deemed
to amend or supplement the Disclosure Schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
5.05 Resignations.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sellers shall deliver to Buyer
written resignations, effective as of the Closing Date, of the officers and directors of the Company, each Subsidiary, and each Affiliated
Practice requested by Buyer at least five Business Days prior to the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.06 <FONT STYLE="vertical-align: baseline">Confidentiality.</FONT></B> From and after the Closing, each Seller shall, and shall cause
its Affiliates to, hold, and shall use its reasonable best efforts to cause its or their respective Representatives to hold, in confidence
any and all information, whether written or oral, concerning the Company, any Subsidiary, or any Affiliated Practice, except to the extent
that Seller can show that such information (a) is generally available to and known by the public through no fault of Seller, any of its
Affiliates or their respective Representatives; or (b) is lawfully acquired by Seller, any of its Affiliates or their respective Representatives
from and after the Closing from sources which are not prohibited from disclosing such information by a legal, contractual or fiduciary
obligation. If any Seller or any of its Affiliates or their respective Representatives are compelled to disclose any information by judicial
or administrative process or by other requirements of Law, Seller shall promptly notify Buyer in writing and shall disclose only that
portion of such information which Seller is advised by its counsel in writing is legally required to be disclosed, provided that Seller
shall use reasonable best efforts to obtain an appropriate protective order or other reasonable assurance that confidential treatment
will be accorded such information. In addition to the foregoing, the Company, each Subsidiary, each Affiliated Practice, and each Seller
shall comply, and shall cause their Affiliates to comply, in all respects with that certain Mutual Non-Disclosure Agreement by and between
the Company and Buyer dated July 21, 2021 (the &ldquo;<B>Mutual Non-Disclosure Agreement</B>&rdquo;), which shall survive this Agreement
and the Closing. In the event of any conflict between the provisions of this Agreement and the Mutual Non-Disclosure Agreement, this
Agreement shall control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
5.07 Governmental Approvals and Consents.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Each party hereto shall, as promptly as possible, (i) make, or cause or be made, all filings and submissions (including those under the
HSR Act) required under any Law applicable to such party or any of its Affiliates; and (ii) use reasonable best efforts to obtain, or
cause to be obtained, all consents, authorizations, orders and approvals from all Governmental Authorities that may be or become necessary
for its execution and delivery of this Agreement and the performance of its obligations pursuant to this Agreement and the Ancillary
Documents. Each party shall cooperate fully with the other party and its Affiliates in promptly seeking to obtain all such consents,
authorizations, orders and approvals. The parties hereto shall not willfully take any action that will have the effect of delaying, impairing
or impeding the receipt of any required consents, authorizations, orders and approvals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each Seller and Buyer shall use reasonable best efforts to give all notices to, and obtain all consents from, all third parties that
are described in Section 3.05 of the Disclosure Schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 65; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Without limiting the generality of the parties&rsquo; undertakings pursuant to subsections (a) and (b) above, each of the parties hereto
shall use all reasonable best efforts to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
respond to any inquiries by any Governmental Authority regarding antitrust or other matters with respect to the transactions contemplated
by this Agreement or the any Ancillary Document;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
avoid the imposition of any order or the taking of any action that would restrain, alter or enjoin the transactions contemplated by this
Agreement or any Ancillary Document; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
in the event any Governmental Order adversely affecting the ability of the parties to consummate the transactions contemplated by this
Agreement or any Ancillary Document has been issued, to have such Governmental Order vacated or lifted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If any consent, approval or authorization necessary to preserve any right or benefit under any Contract to which the Company, any Subsidiary,
and any Affiliated Practice is a party is not obtained prior to the Closing, each Seller shall, subsequent to the Closing, cooperate
with Buyer and the Company in attempting to obtain such consent, approval or authorization as promptly thereafter as practicable. If
such consent, approval or authorization cannot be obtained, each Seller shall use its reasonable best efforts to provide the Company
with the rights and benefits of the affected Contract for the term thereof, and, if Sellers provide such rights and benefits, the Company
shall assume all obligations and burdens thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
All analyses, appearances, meetings, discussions, presentations, memoranda, briefs, filings, arguments, and proposals made by or on behalf
of either party before any Governmental Authority or the staff or regulators of any Governmental Authority, in connection with the transactions
contemplated hereunder (but, for the avoidance of doubt, not including any interactions between Sellers or the Company, any Subsidiary,
and any Affiliated Practice with Governmental Authorities in the ordinary course of business, any disclosure which is not permitted by
Law or any disclosure containing confidential information) shall be disclosed to the other party hereunder in advance of any filing,
submission or attendance, it being the intent that the parties will consult and cooperate with one another, and consider in good faith
the views of one another, in connection with any such analyses, appearances, meetings, discussions, presentations, memoranda, briefs,
filings, arguments, and proposals. Each party shall give notice to the other party with respect to any meeting, discussion, appearance
or contact with any Governmental Authority or the staff or regulators of any Governmental Authority, with such notice being sufficient
to provide the other party with the opportunity to attend and participate in such meeting, discussion, appearance or contact.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 66; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Notwithstanding the foregoing, nothing in this Section 5.09 shall require, or be construed to require, Buyer or any of its Affiliates
to agree to (i) sell, hold, divest, discontinue or limit, before or after the Closing Date, any assets, businesses or interests of Buyer,
the Company or any of their respective Affiliates; (ii) any conditions relating to, or changes or restrictions in, the operations of
any such assets, businesses or interests which, in either case, could reasonably be expected to result in a Material Adverse Effect or
materially and adversely impact the economic or business benefits to Buyer of the transactions contemplated by this Agreement; or (iii)
any material modification or waiver of the terms and conditions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
5.08 Books and Records.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
In order to facilitate the resolution of any claims made against or incurred by Sellers prior to the Closing, or for any other reasonable
purpose, for a period of three years after the Closing, Buyer shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
retain the books and records (including personnel files) of the Company, each Subsidiary, and each Affiliated Practices relating to periods
prior to the Closing in a manner determined by the Buyer in its reasonable discretion sufficient for Buyer to fulfill its obligations
under this Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
upon reasonable notice, afford the Representatives of Seller reasonable access (including the right to make, at Seller&rsquo;s expense,
photocopies), during normal business hours, to such books and records;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>provided,
however</I>, that any books and records related to Tax matters shall be retained pursuant to the periods set forth in ARTICLE VI.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In order to facilitate the resolution of any claims made by or against or incurred by Buyer or the Company, any Subsidiary, and any Affiliated
Practices after the Closing, or for any other reasonable purpose, for a period of three years following the Closing, Sellers shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
retain the books and records (including personnel files) of Sellers which relate to the Company, each Subsidiary, and each Affiliated
Practices and its operations for periods prior to the Closing; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
upon reasonable notice, afford the Representatives of Buyer or the Company reasonable access (including the right to make, at Buyer&rsquo;s
expense, photocopies), during normal business hours, to such books and records;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>provided,
however</I>, that any books and records related to Tax matters shall be retained pursuant to the periods set forth in ARTICLE VI.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 67; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Neither Buyer nor Sellers shall be obligated to provide the other party with access to any books or records (including personnel files)
pursuant to this Section 5.10 where such access would violate any Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
5.09 Closing Conditions</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From the date hereof until
the Closing, each party hereto shall, and Sellers shall cause the Company, each Subsidiary, and each Affiliated Practices to, use reasonable
best efforts to take such actions as are necessary to expeditiously satisfy the closing conditions set forth in ARTICLE VII hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.10 <FONT STYLE="vertical-align: baseline">Public Announcements.</FONT></B> Unless otherwise required by applicable Law or stock exchange
requirements (based upon the reasonable advice of counsel), no party to this Agreement shall make any public announcements in respect
of this Agreement or the transactions contemplated hereby or otherwise communicate with any news media without the prior written consent
of the other party (which consent shall not be unreasonably withheld, conditioned or delayed), and the parties shall cooperate as to
the timing and contents of any such announcement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
5.11 Release of Claims.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective as of the Closing,
each of the Sellers will agree as part of their Investor Representation Letter or otherwise, that, on behalf of himself, herself, or
itself and his, her, or its successors, assigns, representatives, administrators, executors and agents, and any other person or entity
claiming by, through or under any of the foregoing, he/it does hereby unconditionally and irrevocably release, waive and forever discharge
the Buyer and the Company and each of their past and present directors, officers, employees, agents, predecessors, successors, assigns,
subsidiaries and Affiliates, from any and all claims, demands, damages, judgments, causes of action and liabilities of any nature whatsoever,
whether or not known, suspected or claimed, arising directly or indirectly from any act, omission, event or transaction occurring (or
any circumstances existing) with respect to Company on or prior to the Closing (collectively, &ldquo;<B>Company Claims</B>&rdquo;), including
without limitation any and all Company Claims arising out of or relating to: (i) such individual&rsquo;s capacity as a current or former
shareholder, officer or director, manager, employee or agent of Company or any of its predecessors or Affiliates (or his capacity as
a current or former trustee, director, officer, manager, employee or agent of any other entity in which capacity he is or was serving
at the request of Company); or (ii) any contract, agreement or other arrangement (whether written or verbal) with Company entered into
or established prior to the Closing, including any shareholders agreements, equity purchase agreements, incentive grant documents, employment
agreements or previous noncompetition agreements. Notwithstanding the foregoing, the above will not release the Company or other parties
for obligations pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.12 <FONT STYLE="vertical-align: baseline">Further Assurances.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Following the Closing, each of the parties hereto shall, and shall cause their respective Affiliates to, execute and deliver such additional
documents, instruments, conveyances and assurances and take such further actions as may be reasonably required to carry out the provisions
hereof and give effect to the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 68; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Following the Closing, Buyer shall use commercially reasonable efforts to maintain available liquidity so as to be able to make the One
Year Fixed Payment and Two Year Fixed Payment at the times they become due.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Following the Closing, Buyer hereby agrees to assume all liability with respect to the Closing Payables and to pay in full the Closing
Payables in a timely manner as they become due, provided that the payables have all back-up and other documentation required to verify
the payables as may be required by Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Immediately following the transfer of the ALK Note to Buyer, Buyer shall cancel the ALK Note in full and no amounts shall be owed to
Buyer under the ALK Note by the Company, Sellers, or any other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VI</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Tax
matters</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
6.01 Tax Covenants.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Without the prior written consent of Buyer, Sellers (and, prior to the Closing, the Company, each Subsidiary, and each Affiliated Practices,
its Affiliates and their respective Representatives) shall not, to the extent it may affect, or relate to, the Company, each Subsidiary,
and each Affiliated Practices, make, change or rescind any Tax election, amend any Tax Return or take any position on any Tax Return,
take any action, omit to take any action or enter into any other transaction that would have the effect of increasing the Tax liability
or reducing any Tax asset of Buyer or the Company, each Subsidiary, and each Affiliated Practices in respect of any Post-Closing Tax
Period. Sellers agree that Buyer is to have no liability for any Tax resulting from any action of Sellers, the Company, each Subsidiary,
and each Affiliated Practices, its Affiliates or any of their respective Representatives, and agrees to indemnify and hold harmless Buyer
(and, after the Closing Date, the Company) against any such Tax or reduction of any Tax asset.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
All transfer, documentary, sales, use, stamp, registration, value added and other such Taxes and fees (including any penalties and interest)
incurred in connection with this Agreement and the Ancillary Documents (including any real property transfer Tax and any other similar
Tax) (&ldquo;<B>Transfer Taxes</B>&rdquo;) shall be borne and paid by Sellers when due. Sellers shall, at their own expense, timely file
any Tax Return or other document with respect to such Taxes or fees (and Buyer shall cooperate with respect thereto as necessary).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 69; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Buyer shall prepare, or cause to be prepared, at Sellers&rsquo; expense, all Tax Returns required to be filed by the Company after the
Closing Date with respect to a Pre-Closing Tax Period. Any such Tax Return shall be prepared in a manner consistent with past practice
(unless otherwise required by Law) and shall be submitted by Buyer to Sellers (together with schedules, statements and, to the extent
requested by Seller Representative, supporting documentation) at least 20 days prior to the due date (including extensions) of such Tax
Return. If Seller Representative objects to any item on any such Tax Return, it shall, within 5 days after delivery of such Tax Return,
notify Buyer in writing that it so objects, specifying with particularity any such item and stating the specific factual or legal basis
for any such objection. If a notice of objection shall be duly delivered, Buyer and Seller Representative shall negotiate in good faith
and use their reasonable best efforts to resolve such items. If Buyer and Seller Representative are unable to reach such agreement within
ten days after receipt by Buyer of such notice, the disputed items shall be resolved by the Independent Accountant and any determination
by the Independent Accountant shall be final. The Independent Accountant shall resolve any disputed items within twenty days of having
the item referred to it pursuant to such procedures as it may require. If the Independent Accountant is unable to resolve any disputed
items before the due date for such Tax Return, the Tax Return shall be filed as prepared by Buyer and then amended to reflect the Independent
Accountant&rsquo;s resolution. The costs, fees and expenses of the Independent Accountant shall be borne equally by Buyer and Seller.
The preparation and filing of any Tax Return of the Company that does not relate to a Pre-Closing Tax Period shall be exclusively within
the control of Buyer. Seller will, no later than 5 days following the due date of any such Tax Return, timely pay to Buyer any and all
Indemnified Taxes shown as due on such Tax Returns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
6.02 Termination of Existing Tax Sharing Agreements.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
and all existing Tax sharing agreements (whether written or not) binding upon the Company, any Subsidiary, and any Affiliated Practices
shall be terminated as of the Closing Date. After such date none of the Company, any Subsidiary, and any Affiliated Practices, Sellers
nor any of Seller&rsquo;s Affiliates and their respective Representatives shall have any further rights or liabilities thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
6.03 Tax Indemnification.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except to the extent treated
as a liability in the calculation of Closing Working Capital, Sellers shall indemnify the Company, Buyer, and each Buyer Indemnitee and
hold them harmless from and against any Indemnified Taxes. In each of the above cases, Sellers shall reimburse Buyer for any Indemnified
Taxes within 5 Business Days after payment of such Taxes by Buyer or the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
6.04 Straddle Period.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the case of Taxes that are
payable with respect to a taxable period that begins before and ends after the Closing Date (each such period, a &ldquo;<B>Straddle Period</B>&rdquo;),
the portion of any such Taxes that are treated as Indemnified Taxes for purposes of this Agreement shall be:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
in the case of Taxes (i) based upon, or related to, income, receipts, profits, wages, capital or net worth, (ii) imposed in connection
with the sale, transfer or assignment of property, or (iii) required to be withheld, deemed equal to the amount which would be payable
if the taxable year ended with the Closing Date; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 70; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
in the case of other Taxes, deemed to be the amount of such Taxes for the entire period multiplied by a fraction the numerator of which
is the number of days in the period ending on the Closing Date and the denominator of which is the number of days in the entire period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
6.05 Contests.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer agrees to give notice to Seller
Representative of the receipt of any written notice by the Company, Buyer or any of Buyer&rsquo;s Affiliates which involves the assertion
of any claim, or the commencement of any Action, in respect of which an indemnity may be sought by Buyer pursuant to this ARTICLE VI
(a &ldquo;<B>Tax Claim</B>&rdquo;); <I>provided, that</I> failure to comply with this provision shall not affect Buyer&rsquo;s right
to indemnification hereunder. Buyer shall control the contest or resolution of any Tax Claim; <I>provided, however</I>, that Buyer shall
obtain the prior written consent of Seller Representative (which consent shall not be unreasonably withheld, conditioned or delayed)
before entering into any settlement of a claim or ceasing to defend such claim; and, <I>provided further</I>, that Seller Representative
shall be entitled to participate in the defense of such claim and to employ counsel of its choice for such purpose, the fees and expenses
of which separate counsel shall be borne solely by Sellers. Seller shall reimburse Buyer for any expenses associated with the defense
of any Tax Claim to the extent such Tax Claim relates solely to a Pre-Closing Tax Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
6.06 Cooperation and Exchange of Information.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sellers
and Buyer shall provide each other with such cooperation and information as either of them reasonably may request of the other in filing
any Tax Return pursuant to this ARTICLE VI or in connection with any audit or other proceeding in respect of Taxes of the Company. Such
cooperation and information shall include providing copies of relevant Tax Returns or portions thereof, together with accompanying schedules,
related work papers and documents relating to rulings or other determinations by tax authorities. Each of Sellers and Buyer shall retain
all Tax Returns, schedules and work papers, records and other documents in its possession relating to Tax matters of the Company for
any taxable period beginning before the Closing Date until the expiration of the statute of limitations of the taxable periods to which
such Tax Returns and other documents relate, without regard to extensions except to the extent notified by the other party in writing
of such extensions for the respective Tax periods. Prior to transferring, destroying or discarding any Tax Returns, schedules and work
papers, records and other documents in its possession relating to Tax matters of the Company for any taxable period beginning before
the Closing Date, Sellers or Buyer (as the case may be) shall provide the other party with reasonable written notice and offer the other
party the opportunity to take custody of such materials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
6.07 Tax Treatment of Indemnification Payments.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
indemnification payments pursuant to this ARTICLE VI shall be treated as an adjustment to the Purchase Price by the parties for Tax purposes,
unless otherwise required by Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6.08 Payments to Buyer.</B> Any amounts payable to Buyer pursuant to this ARTICLE VI shall be satisfied: (i) from the Indemnification
Escrow Fund; and (ii) to the extent such amounts exceed the amount available to Buyer in the Indemnification Escrow Fund, from Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 71; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
6.09 Survival.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding anything in this Agreement
to the contrary, the provisions of Section 3.22 and this ARTICLE VI shall survive for the full period of all applicable statutes of limitations
(giving effect to any waiver, mitigation or extension thereof) plus 60 days.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
6.10 Overlap.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent that any obligation or
responsibility pursuant to ARTICLE VIII may overlap with an obligation or responsibility pursuant to this ARTICLE VI, the provisions
of this ARTICLE VI shall govern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VII</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Conditions
to closing</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
7.01 Conditions to Obligations of All Parties.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of each party to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment, at or prior
to the Closing, of each of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The filings of Buyer and Sellers pursuant to the HSR Act, if any, shall have been made and the applicable waiting period and any extensions
thereof shall have expired or been terminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Governmental Order which is in effect and
has the effect of making the transactions contemplated by this Agreement illegal, otherwise restraining or prohibiting consummation of
such transactions or causing any of the transactions contemplated hereunder to be rescinded following completion thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Sellers shall have received all consents, authorizations, orders and approvals from the Governmental Authorities referred to in Section
3.05 and Buyer shall have received all consents, authorizations, orders and approvals from the Governmental Authorities referred to in
Section 4.02, in each case, in form and substance reasonably satisfactory to Buyer and Seller Representative, and no such consent, authorization,
order and approval shall have been revoked.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
7.02 Conditions to Obligations of Buyer.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The obligations
of Buyer to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment or Buyer&rsquo;s waiver, at
or prior to the Closing, of each of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Other than the representations and warranties of Sellers contained in Section 3.01, Section 3.02, Section 3.03, Section 3.06 and Section
3.24, the representations and warranties of Sellers contained in this Agreement, the Ancillary Documents and any certificate or other
writing delivered pursuant hereto shall be true and correct in all respects (in the case of any representation or warranty qualified
by materiality or Material Adverse Effect) or in all material respects (in the case of any representation or warranty not qualified by
materiality or Material Adverse Effect) on and as of the date hereof and on and as of the Closing Date with the same effect as though
made at and as of such date (except those representations and warranties that address matters only as of a specified date, the accuracy
of which shall be determined as of that specified date in all respects). The representations and warranties of Sellers contained in Section
3.01, Section 3.02, Section 3.03, Section 3.06 and Section 3.24 shall be true and correct in all respects on and as of the date hereof
and on and as of the Closing Date with the same effect as though made at and as of such date (except those representations and warranties
that address matters only as of a specified date, the accuracy of which shall be determined as of that specified date in all respects).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 72; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Sellers shall have duly performed and complied in all material respects with all agreements, covenants and conditions required by this
Agreement and each of the Ancillary Documents to be performed or complied with by it prior to or on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
No Action shall have been commenced against Buyer, Sellers, the Company, any Subsidiary, or any Affiliated Practice which would prevent
the Closing. No injunction or restraining order shall have been issued by any Governmental Authority, and be in effect, which restrains
or prohibits any transaction contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
All approvals, consents and waivers that are listed on Section 3.05 of the Disclosure Schedules shall have been received, and executed
counterparts thereof shall have been delivered to Buyer at or prior to the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
From the date of this Agreement, there shall not have occurred any Material Adverse Effect, nor shall any event or events have occurred
that, individually or in the aggregate, with or without the lapse of time, could reasonably be expected to result in a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The Ancillary Documents shall have been executed and delivered by the parties thereto and true and complete copies thereof shall have
been delivered to Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Buyer shall have received resignations of the directors and officers of the Company pursuant to Section 5.05.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Sellers shall have delivered to Buyer the Estimated Closing Working Capital Statement contemplated in Section 2.04(a)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Sellers shall have delivered to Buyer a good standing certificate (or its equivalent) for the Company, each Subsidiary, and each Affiliated
Practice from the secretary of state or similar Governmental Authority of the jurisdiction under the Laws in which the Company is organized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Sellers shall have delivered to Buyer a certificate pursuant to Treasury Regulations Section 1.1445-2(b) that Sellers are not foreign
persons within the meaning of Section 1445 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 73; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Sellers shall have delivered, or caused to be delivered, to Buyer stock certificates evidencing the Shares, free and clear of Encumbrances,
duly endorsed in blank or accompanied by stock powers or other instruments of transfer duly executed in blank and with all required stock
transfer tax stamps affixed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
Buyer shall have received a certificate, dated the Closing Date and signed by a duly authorized officer of the Company, that each of
the conditions set forth in Section 7.02(a) and Section 7.02(b) have been satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
Buyer shall have received a certificate of the Secretary or an Assistant Secretary (or equivalent officer) of the Company certifying
that attached thereto are true and complete copies of all resolutions adopted by the board of directors of the Company authorizing the
execution, delivery and performance of this Agreement and the Ancillary Documents and the consummation of the transactions contemplated
hereby and thereby, and that all such resolutions are in full force and effect and are all the resolutions adopted in connection with
the transactions contemplated hereby and thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
Buyer shall have received a certificate of the Secretary or an Assistant Secretary (or equivalent officer) of the Company certifying
the names and signatures of the officers of the Company authorized to sign this Agreement, the Ancillary Documents and the other documents
to be delivered hereunder and thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
Sellers shall have validly converted the Company from a Delaware public benefit corporation to a Delaware stock corporation, in compliance
with Delaware General Corporation Law, and shall deliver evidence of such conversion from the Delaware Secretary of State to Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
Buyer shall have obtained retro-active products liability and medical malpractice or professional liability insurance, or an irrevocable
quote to obtain such insurance, covering the historical operations of the Company, and its Subsidiaries, upon terms acceptable to Buyer
in its sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
The Company has validly effectuated either (i) an amendment to its Certificate of Incorporation increasing the number of its authorized
Shares, or (ii) a reverse stock split of the Shares, such that the amount of authorized but unissued Shares is sufficient to convert
all outstanding convertible notes and any other outstanding securities or options into issued and outstanding Shares, and Sellers shall
deliver to Buyer evidence of the effectiveness of such amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
Each outstanding convertible note issued by the Company shall have been converted into Shares of the Company in accordance with the terms
thereof, and all holders thereof shall have executed joinders to this Agreement as Sellers hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 74; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
Buyer shall have received Key Employee Agreements duly executed and delivered by each Key Employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
Buyer shall have received a completed and duly executed Investor Representation Letter from each Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
All of ALK-Abell&oacute;, Inc.&rsquo;s right, title and interest in and to that certain Convertible Promissory Note, dated March 31,
2021, issued by the Company to ALK-Abell&oacute;, Inc. (the &ldquo;ALK Note&rdquo;), shall have been validly transferred to Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
Buyer or the Company shall have obtained the consents, waivers, releases, acknowledgments, or other documents as set forth on Section
7.02(v) of the Disclosure Schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
Sellers shall have delivered to Buyer such other documents or instruments as Buyer reasonably requests and are reasonably necessary to
consummate the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
7.03 Conditions to Obligations of Sellers.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The obligations
of Sellers to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment or Seller Representative&rsquo;s
waiver, at or prior to the Closing, of each of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Other than the representations and warranties of Buyer contained in Section 4.01 and Section 4.04, the representations and warranties
of Buyer contained in this Agreement, the Ancillary Documents and any certificate or other writing delivered pursuant hereto shall be
true and correct in all respects (in the case of any representation or warranty qualified by materiality or Material Adverse Effect)
or in all material respects (in the case of any representation or warranty not qualified by materiality or Material Adverse Effect) on
and as of the date hereof and on and as of the Closing Date with the same effect as though made at and as of such date (except those
representations and warranties that address matters only as of a specified date, the accuracy of which shall be determined as of that
specified date in all respects). The representations and warranties of Buyer contained in Section 4.01 and Section 4.04 shall be true
and correct in all respects on and as of the date hereof and on and as of the Closing Date with the same effect as though made at and
as of such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Buyer shall have duly performed and complied in all material respects with all agreements, covenants and conditions required by this
Agreement and each of the Ancillary Documents to be performed or complied with by it prior to or on the Closing Date; <I>provided, that</I>,
with respect to agreements, covenants and conditions that are qualified by materiality, Buyer shall have performed such agreements, covenants
and conditions, as so qualified, in all respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
No injunction or restraining order shall have been issued by any Governmental Authority, and be in effect, which restrains or prohibits
any material transaction contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 75; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Ancillary Documents shall have been executed and delivered by the parties thereto and true and complete copies thereof shall have
been delivered to Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Buyer shall have delivered to Seller Representative cash or Buyer Shares, in accordance with Section 2.09 hereof, in an amount equal
to the Closing Date Payment less the Purchase Price Adjustment Escrow Amount, to an account or accounts designated at least two Business
Days prior to the Closing Date by Seller Representative in a written notice to Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Buyer shall have delivered to the Escrow Agent by wire transfer of immediately available funds the Purchase Price Adjustment Escrow Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Seller Representative shall have received a certificate, dated the Closing Date and signed by a duly authorized officer of Buyer, that
each of the conditions set forth in Section 7.03(a) and Section 7.03(b) have been satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Seller Representative shall have received a certificate of the Secretary or an Assistant Secretary (or equivalent officer) of Buyer certifying
that attached thereto are true and complete copies of all resolutions adopted by the board of directors of Buyer authorizing the execution,
delivery and performance of this Agreement and the Ancillary Documents and the consummation of the transactions contemplated hereby and
thereby, and that all such resolutions are in full force and effect and are all the resolutions adopted in connection with the transactions
contemplated hereby and thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Seller Representative shall have received a certificate of the Secretary or an Assistant Secretary (or equivalent officer) of Buyer certifying
the names and signatures of the officers of Buyer authorized to sign this Agreement, the Ancillary Documents and the other documents
to be delivered hereunder and thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Buyer shall have delivered to Seller Representative such other documents or instruments as Seller Representative reasonably requests
and are reasonably necessary to consummate the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 76; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VIII</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Indemnification</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
8.01 Survival.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to the limitations and other
provisions of this Agreement, the representations and warranties contained herein (other than any representations or warranties contained
in Section 3.22 which are subject to ARTICLE VI) shall survive the Closing and shall remain in full force and effect until the date that
is three years from the Closing Date; <I>provided, that</I> the representations and warranties in Section 3.01, Section 3.02, Section
3.03, Section 3.04, Section 3.24, Section 4.01 and Section 4.04 shall survive indefinitely. All covenants and agreements of the parties
contained herein (other than any covenants or agreements contained in ARTICLE VI which are subject to ARTICLE VI) shall survive the Closing
indefinitely or for the period explicitly specified therein. Notwithstanding the foregoing, any claims asserted in good faith with reasonable
specificity (to the extent known at such time) and in writing by notice from the non-breaching party to the breaching party prior to
the expiration date of the applicable survival period shall not thereafter be barred by the expiration of the relevant representation
or warranty and such claims shall survive until finally resolved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
8.02 Indemnification By Sellers.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to the other
terms and conditions of this ARTICLE VIII, each Seller shall, jointly and severally, indemnify and defend each of Buyer and its Affiliates
(including the Company) and their respective Representatives (collectively, the &ldquo;<B>Buyer Indemnitees</B>&rdquo;) against, and
shall hold each of them harmless from and against, and shall pay and reimburse each of them for, any and all Losses incurred or sustained
by, or imposed upon, the Buyer Indemnitees based upon, arising out of, with respect to or by reason of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
any inaccuracy in or breach of any of the representations or warranties of any Seller contained in this Agreement or in any certificate
or instrument delivered by or on behalf of any Seller pursuant to this Agreement (other than in respect of Section 3.22, it being understood
that the sole remedy for any such inaccuracy in or breach thereof shall be pursuant to ARTICLE VI), as of the date such representation
or warranty was made or as if such representation or warranty was made on and as of the Closing Date (except for representations and
warranties that expressly relate to a specified date, the inaccuracy in or breach of which will be determined with reference to such
specified date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
any breach or non-fulfillment of any covenant, agreement or obligation to be performed by any Seller pursuant to this Agreement (other
than any breach or violation of, or failure to fully perform, any covenant, agreement, undertaking or obligation in ARTICLE VI, it being
understood that the sole remedy for any such breach, violation or failure shall be pursuant to ARTICLE VI);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
any Transaction Expenses or Indebtedness of the Company outstanding as of the Closing to the extent not deducted from the Purchase Price
in the determination of the Closing Date Payment pursuant to Section 2.04(a)(i);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
any Indemnified Liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 77; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
8.03 Indemnification By Buyer.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to the other
terms and conditions of this ARTICLE VIII, Buyer shall indemnify and defend each Seller and its Affiliates and their respective Representatives
(collectively, the &ldquo;<B>Seller Indemnitees</B>&rdquo;) against, and shall hold each of them harmless from and against, and shall
pay and reimburse each of them for, any and all Losses incurred or sustained by, or imposed upon, the Seller Indemnitees based upon,
arising out of, with respect to or by reason of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
any inaccuracy in or breach of any of the representations or warranties of Buyer contained in this Agreement or in any certificate or
instrument delivered by or on behalf of Buyer pursuant to this Agreement, as of the date such representation or warranty was made or
as if such representation or warranty was made on and as of the Closing Date (except for representations and warranties that expressly
relate to a specified date, the inaccuracy in or breach of which will be determined with reference to such specified date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
any breach or non-fulfillment of any covenant, agreement or obligation to be performed by Buyer pursuant to this Agreement (other than
ARTICLE VI, it being understood that the sole remedy for any such breach thereof shall be pursuant to ARTICLE VI).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
8.04 Certain Limitations.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The indemnification provided
for in Section 8.02 and Section 8.03 shall be subject to the following limitations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Sellers shall not be liable to the Buyer Indemnitees for indemnification under Section 8.02(a) except where Losses from any individual
claim or series of related claims in respect of indemnification under Section 8.02(a) exceeds $10,000 (the &ldquo;<B>De Minimus Amount</B>&rdquo;),
in which event Sellers shall be required to pay or be liable for all such Losses from the first dollar. The aggregate amount of all Losses
for which Sellers shall be liable pursuant to Section 8.02(a) shall not exceed $1,500,000 (the &ldquo;<B>Cap</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Buyer shall not be liable to the Seller Indemnitees for indemnification under Section 8.03(a) except where Losses from any individual
claim or series of related claims in respect of indemnification under Section 8.03(a) exceeds the De Minimus Amount, in which event Buyer
shall be required to pay or be liable for all such Losses from the first dollar. The aggregate amount of all Losses for which Buyer shall
be liable pursuant to Section 8.03(a) shall not exceed the Cap.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Buyer Indemnitees&rsquo; sole recourse for the indemnification by Sellers set forth in Section 8.04(a) above shall be limited to the
amounts in the Indemnification Escrow Fund, and the Buyer&rsquo;s right of set-off against any Earn-Out Payments due to Sellers as set
forth in Section 2.08(g) herein. For the avoidance of doubt, Buyer Indemnitees shall not have a right of set-off against the Initial
Payment, One Year Fixed Payment, or Two Year Fixed Payment, except for the amounts in the Indemnification Escrow Fund.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 78; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Notwithstanding the foregoing, the limitations set forth in Section 8.04(a) and Section 8.04(b) shall not apply to Losses based upon,
arising out of, with respect to or by reason of any inaccuracy in or breach of any representation or warranty in Section 3.01, Section
3.03, Section 3.19, Section 3.20, Section 3.24, Section 4.01 and Section 4.04.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
For purposes of this ARTICLE VIII, any inaccuracy in or breach of any representation or warranty shall be determined without regard to
any materiality, Material Adverse Effect or other similar qualification contained in or otherwise applicable to such representation or
warranty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
In no event shall any Indemnifying Party (as defined below) be liable to any Indemnified Party (as defined below) for any punitive, special
or indirect damages, relating to the breach or alleged breach of this Agreement, or diminution of value or any damages based on any type
of multiple (other than indemnification for amounts paid or payable to third parties in respect of any third-party claim for which indemnification
hereunder is otherwise required).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Each Indemnified Party shall take, and cause its Affiliates to take, commercially reasonable steps to mitigate any Loss upon becoming
aware of any event or circumstance that would be reasonably expected to, or does, give rise to any Losses that are indemnifiable hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 79; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
8.05 Indemnification Procedures.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The party making
a claim under this ARTICLE VIII is referred to as the &ldquo;<B>Indemnified Party</B>&rdquo;, and the party against whom such claims
are asserted under this ARTICLE VIII is referred to as the &ldquo;<B>Indemnifying Party</B>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Third Party Claims. If any Indemnified Party receives notice of the assertion or commencement of any Action made or brought by any Person
who is not a party to this Agreement or an Affiliate of a party to this Agreement or a Representative of the foregoing (a &ldquo;<B>Third
Party Claim</B>&rdquo;) against such Indemnified Party with respect to which the Indemnifying Party is obligated to provide indemnification
under this Agreement, the Indemnified Party shall give the Indemnifying Party reasonably prompt written notice thereof, but in any event
not later than 30 calendar days after receipt of such notice of such Third Party Claim. The failure to give such prompt written notice
shall not, however, relieve the Indemnifying Party of its indemnification obligations, except and only to the extent that the Indemnifying
Party forfeits rights or defenses by reason of such failure. Such notice by the Indemnified Party shall describe the Third Party Claim
in reasonable detail, shall include copies of all material written evidence thereof and shall indicate the estimated amount, if reasonably
practicable, of the Loss that has been or may be sustained by the Indemnified Party. The Indemnifying Party shall have the right to participate
in, or by giving written notice to the Indemnified Party, to assume the defense of any Third Party Claim at the Indemnifying Party&rsquo;s
expense and by the Indemnifying Party&rsquo;s own counsel, and the Indemnified Party shall cooperate in good faith in such defense; <I>provided,
that</I> if the Indemnifying Party is a Seller, such Indemnifying Party shall not have the right to defend or direct the defense of any
such Third Party Claim that (x) is asserted directly by or on behalf of a Person that is a supplier or customer of the Company, or (y)
seeks an injunction or other equitable relief against the Indemnified Party. In the event that the Indemnifying Party assumes the defense
of any Third Party Claim, subject to Section 8.05(b), it shall have the right to take such action as it deems necessary to avoid, dispute,
defend, appeal or make counterclaims pertaining to any such Third Party Claim in the name and on behalf of the Indemnified Party. The
Indemnified Party shall have the right to participate in the defense of any Third Party Claim with counsel selected by it subject to
the Indemnifying Party&rsquo;s right to control the defense thereof. The fees and disbursements of such counsel shall be at the expense
of the Indemnified Party, <I>provided, that</I> if in the reasonable opinion of counsel to the Indemnified Party, (A) there are legal
defenses available to an Indemnified Party that are different from or additional to those available to the Indemnifying Party; or (B)
there exists a conflict of interest between the Indemnifying Party and the Indemnified Party that cannot be waived, the Indemnifying
Party shall be liable for the reasonable fees and expenses of counsel to the Indemnified Party in each jurisdiction for which the Indemnified
Party determines counsel is required. If the Indemnifying Party elects not to compromise or defend such Third Party Claim, fails to promptly
notify the Indemnified Party in writing of its election to defend as provided in this Agreement, or fails to diligently prosecute the
defense of such Third Party Claim, the Indemnified Party may, subject to Section 8.05(b), pay, compromise, defend such Third Party Claim
and seek indemnification for any and all Losses based upon, arising from or relating to such Third Party Claim. Seller and Buyer shall
cooperate with each other in all reasonable respects in connection with the defense of any Third Party Claim, including making available
(subject to the provisions of Section 5.06) records relating to such Third Party Claim and furnishing, without expense (other than reimbursement
of actual out-of-pocket expenses) to the defending party, management employees of the non-defending party as may be reasonably necessary
for the preparation of the defense of such Third Party Claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 80; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Settlement of Third Party Claims. Notwithstanding any other provision of this Agreement, the Indemnifying Party shall not enter into
settlement of any Third Party Claim without the prior written consent of the Indemnified Party, except as provided in this Section 8.05(b).
If a firm offer is made to settle a Third Party Claim without leading to liability or the creation of a financial or other obligation
on the part of the Indemnified Party and provides, in customary form, for the unconditional release of each Indemnified Party from all
liabilities and obligations in connection with such Third Party Claim and the Indemnifying Party desires to accept and agree to such
offer, the Indemnifying Party shall give written notice to that effect to the Indemnified Party. If the Indemnified Party fails to consent
to such firm offer within ten days after its receipt of such notice, the Indemnified Party may continue to contest or defend such Third
Party Claim and in such event, the maximum liability of the Indemnifying Party as to such Third Party Claim shall not exceed the amount
of such settlement offer. If the Indemnified Party fails to consent to such firm offer and also fails to assume defense of such Third
Party Claim, the Indemnifying Party may settle the Third Party Claim upon the terms set forth in such firm offer to settle such Third
Party Claim. If the Indemnified Party has assumed the defense pursuant to Section 8.05(a), it shall not agree to any settlement without
the written consent of the Indemnifying Party (which consent shall not be unreasonably withheld, conditioned or delayed).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Direct Claims. Any Action by an Indemnified Party on account of a Loss which does not result from a Third Party Claim (a &ldquo;<B>Direct
Claim</B>&rdquo;) shall be asserted by the Indemnified Party giving the Indemnifying Party reasonably prompt written notice thereof,
but in any event not later than 30 days after the Indemnified Party becomes aware of such Direct Claim. The failure to give such prompt
written notice shall not, however, relieve the Indemnifying Party of its indemnification obligations, except and only to the extent that
the Indemnifying Party forfeits rights or defenses by reason of such failure. Such notice by the Indemnified Party shall describe the
Direct Claim in reasonable detail, shall include copies of all material written evidence thereof and shall indicate the estimated amount,
if reasonably practicable, of the Loss that has been or may be sustained by the Indemnified Party. The Indemnifying Party shall have
30 days after its receipt of such notice to respond in writing to such Direct Claim. The Indemnified Party shall allow the Indemnifying
Party and its professional advisors to investigate the matter or circumstance alleged to give rise to the Direct Claim, and whether and
to what extent any amount is payable in respect of the Direct Claim and the Indemnified Party shall assist the Indemnifying Party&rsquo;s
investigation by giving such information and assistance (including access to the Company&rsquo;s premises and personnel and the right
to examine and copy any accounts, documents or records) as the Indemnifying Party or any of its professional advisors may reasonably
request. If the Indemnifying Party does not so respond within such 30 day period, the Indemnifying Party shall be deemed to have rejected
such claim, in which case the Indemnified Party shall be free to pursue such remedies as may be available to the Indemnified Party on
the terms and subject to the provisions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Tax Claims. Notwithstanding any other provision of this Agreement, the control of any claim, assertion, event or proceeding in respect
of Taxes of the Company (including, but not limited to, any such claim in respect of a breach of the representations and warranties in
Section 3.22 hereof or any breach or violation of or failure to fully perform any covenant, agreement, undertaking or obligation in ARTICLE
VI) shall be governed exclusively by ARTICLE VI hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 81; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.06 <FONT STYLE="vertical-align: baseline">Payments; Indemnification Escrow Fund.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once a Loss is agreed to by the Indemnifying Party or
finally adjudicated to be payable pursuant to this ARTICLE VIII, the Indemnifying Party shall satisfy its obligations within 15 Business
Days of such final, non-appealable adjudication by wire transfer of immediately available funds (or, if Buyer is the Indemnified Party,
Buyer may set-off such Loss against the next applicable Earn-Out Payment, as set forth in Section 2.08(g) herein). The parties hereto
agree that should an Indemnifying Party not make full payment of any such obligations within such 15 Business Day period, any amount
payable shall accrue interest from and including the date of agreement of the Indemnifying Party or final, non-appealable adjudication
to but excluding the date such payment has been made at a rate per annum equal to 5%. Such interest shall be calculated daily on the
basis of a 365 day year and the actual number of days elapsed, without compounding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any Losses payable to a Buyer Indemnitee pursuant to this ARTICLE VIII shall be satisfied: (i) from the Indemnification Escrow Fund;
and (ii) to the extent the amount of Losses exceeds the amounts available to the Buyer Indemnitee in the Indemnification Escrow Fund,
from Sellers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
8.07 Tax Treatment of Indemnification Payments.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
indemnification payments made under this Agreement shall be treated by the parties as an adjustment to the Purchase Price for Tax purposes,
unless otherwise required by Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
8.08 Effect of Investigation.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The representations,
warranties and covenants of the Indemnifying Party, and the Indemnified Party&rsquo;s right to indemnification with respect thereto,
shall not be affected or deemed waived by reason of any investigation made by or on behalf of the Indemnified Party (including by any
of its Representatives) or by reason of the fact that the Indemnified Party or any of its Representatives knew or should have known that
any such representation or warranty is, was or might be inaccurate or by reason of the Indemnified Party&rsquo;s waiver of any condition
set forth in Section 7.02 or Section 7.03, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
8.09 Exclusive Remedies.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to Section 2.04(b)
and Section 10.12, the parties acknowledge and agree that their sole and exclusive remedy with respect to any and all claims (other than
claims arising from fraud, criminal activity or willful misconduct on the part of a party hereto in connection with the transactions
contemplated by this Agreement) for any breach of any representation, warranty, covenant, agreement or obligation set forth herein or
otherwise relating to the subject matter of this Agreement, shall be pursuant to the indemnification provisions set forth in ARTICLE
VI and this ARTICLE VIII. In furtherance of the foregoing, each party hereby waives, to the fullest extent permitted under Law, any and
all rights, claims and causes of action for any breach of any representation, warranty, covenant, agreement or obligation set forth herein
or otherwise relating to the subject matter of this Agreement it may have against the other parties hereto and their Affiliates and each
of their respective Representatives arising under or based upon any Law, except pursuant to the indemnification provisions set forth
in ARTICLE VI and this ARTICLE VIII. Nothing in this Section 8.09 shall limit any Person&rsquo;s right to seek and obtain any equitable
relief to which any Person shall be entitled or to seek any remedy on account of any party&rsquo;s fraudulent, criminal or intentional
misconduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 82; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IX</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Termination</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
9.01 Termination.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement may be terminated
at any time prior to the Closing:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
by the mutual written consent of Seller Representative and Buyer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
by Buyer by written notice to Seller Representative if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Buyer is not then in material breach of any provision of this Agreement and there has been a breach, inaccuracy in or failure to perform
any representation, warranty, covenant or agreement made by any Seller pursuant to this Agreement that would give rise to the failure
of any of the conditions specified in ARTICLE VII and such breach, inaccuracy or failure has not been cured by such Seller within ten
days of Seller Representative receipt of written notice of such breach from Buyer; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
any of the conditions set forth in Section 7.01 or Section 7.02 shall not have been, or if it becomes apparent that any of such conditions
will not be, fulfilled by December 24, 2021 (provided, however, that Buyer may elect, in its sole discretion, to extend such deadline
to January 31, 2022), unless such failure is due to the failure of Buyer to perform or comply with any of the covenants, agreements or
conditions hereof to be performed or complied with by it prior to the Closing;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
by Seller Representative by written notice to Buyer if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
No Seller is then in material breach of any provision of this Agreement and there has been a breach, inaccuracy in or failure to perform
any representation, warranty, covenant or agreement made by Buyer pursuant to this Agreement that would give rise to the failure of any
of the conditions specified in ARTICLE VII and such breach, inaccuracy or failure has not been cured by Buyer within ten days of Buyer&rsquo;s
receipt of written notice of such breach from Seller Representative; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
any of the conditions set forth in Section 7.01 or Section 7.03 shall not have been, or if it becomes apparent that any of such conditions
will not be, fulfilled by January 31, 2022, unless such failure shall be due to the failure of Seller to perform or comply with any of
the covenants, agreements or conditions hereof to be performed or complied with by it prior to the Closing; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
by Buyer or Seller Representative in the event that (i) there shall be any Law that makes consummation of the transactions contemplated
by this Agreement illegal or otherwise prohibited or (ii) any Governmental Authority shall have issued a Governmental Order restraining
or enjoining the transactions contemplated by this Agreement, and such Governmental Order shall have become final and non-appealable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 83; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
9.02 Effect of Termination.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event of the termination
of this Agreement in accordance with this Article, this Agreement shall forthwith become void and there shall be no liability on the
part of any party hereto except:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
as set forth in this ARTICLE IX and Section 5.06 and ARTICLE X hereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
that nothing herein shall relieve any party hereto from liability for any willful breach of any provision hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
X</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Miscellaneous</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
10.01 <FONT STYLE="vertical-align: baseline">Seller Representative.</FONT></B> By executing and delivering a counterpart to this Agreement,
Sellers shall have irrevocably authorized and appointed Cleared Technologies Administrator, LLC (the &ldquo;<B>Seller Representative</B>&rdquo;)
as the representative, attorney-in-fact and agent to act on behalf of each Seller for all purposes in connection with this Agreement,
and all agreements ancillary hereto and to take any and all action and make any decisions or required to be taken by the Sellers pursuant
to this Agreement, including, without limitation, the exercise of the power to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(a)
give and receive notices and communications; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(b)
agree to, negotiate, enter into settlements and compromises of, and comply with orders of court and with respect to claims for indemnification
made by Buyer pursuant to this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(c)
litigate, arbitrate, resolve, settle or compromise any claim for indemnification pursuant to this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(d)
execute and deliver, effectuate and bind the Sellers to all documents necessary or desirable to carry out the intent of this Agreement
and any other Transaction Documents; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(e)
make all elections or decisions contemplated by this Agreement; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(f)
engage, employ or assist any agents or representatives (including attorneys, accountants and consultants) to assist the Seller Representative
in complying with its duties and obligations; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">(g)
take all action necessary or appropriate in the good faith judgment of the Seller Representative for the accomplishment of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 84; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">In
dealing with this Agreement and any instruments, documents or agreements relating to this Agreement, and in exercising or failing to
exercise all or any of the powers conferred upon the Seller Representative, the Sellers agree: (i) that the Seller Representative shall
not assume any, and shall incur no, liability whatsoever to any of the Sellers because of any error in judgment or other act or omission
performed or omitted to be performed under this Agreement or in relation to this Agreement, except with respect to Seller Representative&rsquo;s
gross negligence, recklessness, or willful misconduct; and (ii) except to the extent of Seller Representative&rsquo;s gross negligence,
recklessness, or willful misconduct, to indemnify defend and hold harmless the Seller Representative for any losses incurred, arising
out of or in connection with the Seller Representative carrying out its duties hereunder. Buyer shall have no liability to the Sellers
for any act or omission by the Seller Representative. Buyer shall be entitled to deal exclusively with the Seller Representative on all
matters relating to this Agreement. Any decision or action by Seller Representative hereunder, including any agreement between Seller
Representative and Buyer relating to the defense, payment or settlement of any claims for indemnification hereunder, shall constitute
a decision or action of all Sellers and shall be final, binding and conclusive upon each such Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; vertical-align: baseline">The
Seller Representative may resign at any time, and may be removed for any reason or no reason by the vote or written consent of the Sellers
that held a majority of the Shares prior to the Closing (the &ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Seller
Majority</B><FONT STYLE="font-weight: normal">&rdquo;); provided, however, in no event shall the Seller Representative be removed by
the Seller Majority without the Seller Majority having first appointed a new Seller Representative who shall assume such duties immediately
upon the removal of the Seller Representative. In the event of the death, incapacity, resignation or removal of the Seller Representative,
a new Seller Representative shall be appointed by the vote or written consent of the Seller Majority. Notice of such vote or a copy of
the written consent appointing such new Seller Representative shall be sent to Buyer, such appointment to be effective upon the later
of the date indicated in such consent or the date such notice is received by Buyer; provided, that until such notice is received, Buyer
shall be entitled to rely on the decisions and actions of the prior Seller Representative.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
10.02 <FONT STYLE="vertical-align: baseline">Expenses.</FONT></B> Except as otherwise expressly provided herein, all costs and expenses,
including, without limitation, fees and disbursements of counsel, financial advisors and accountants, incurred in connection with this
Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses, whether or not the Closing
shall have occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
10.03 Conflict Waiver. </B><FONT STYLE="font-weight: normal">The parties hereto acknowledge that </FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telos
Arete, P.C., counsel for the Company <FONT STYLE="font-weight: normal; vertical-align: baseline">(the &ldquo;</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Company
Law Firm</B><FONT STYLE="font-weight: normal">&rdquo;) only represents the Company with respect to the transaction(s) contemplated under
this Agreement, and that the Company Law Firm does not represent any Sellers or other parties to this Agreement. The Sellers and Buyer
expressly waive any conflict(s) of interest that may arise from the Buyer reimbursing certain of the Company&rsquo;s Transaction Expenses
owed to the Company Law Firm, and hereby waive any action that they may have against the Company Law Firm regarding such conflict(s).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 85; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
10.04 Notices.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All notices, requests, consents, claims,
demands, waivers and other communications hereunder shall be in writing and shall be deemed to have been given (a) when delivered by
hand (with written confirmation of receipt); (b) when received by the addressee if sent by a nationally recognized overnight courier
(receipt requested); (c) on the date sent by e-mail of a PDF document (with confirmation of transmission) if sent during normal business
hours of the recipient, and on the next Business Day if sent after normal business hours of the recipient or (d) on the third day after
the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must be sent to the
respective parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance
with this Section 10.04):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to Seller:</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    the address and email provided in the Seller&rsquo;s signature panel, or as otherwise provided to the Buyer in writing by any Seller.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to Buyer:</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">800
    Third Avenue, Suite 2800</FONT></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, NY 10022</FONT></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
    legal@lifemd.com</FONT></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    General Counsel</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
    a copy to:</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dorsey
    &amp; Whitney LLP</FONT></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51
    West 52nd Street</FONT></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, NY 10019-6119</FONT></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
    Marsico.anthony@dorsey.com</FONT></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    Anthony J. Marsico</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
10.05 Interpretation.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of this Agreement,
(a) the words &ldquo;include,&rdquo; &ldquo;includes&rdquo; and &ldquo;including&rdquo; shall be deemed to be followed by the words &ldquo;without
limitation&rdquo;; (b) the word &ldquo;or&rdquo; is not exclusive; and (c) the words &ldquo;herein,&rdquo; &ldquo;hereof,&rdquo; &ldquo;hereby,&rdquo;
&ldquo;hereto&rdquo; and &ldquo;hereunder&rdquo; refer to this Agreement as a whole. Unless the context otherwise requires, references
herein: (x) to Articles, Sections, Disclosure Schedules and Exhibits mean the Articles and Sections of, and Disclosure Schedules and
Exhibits attached to, this Agreement; (y) to an agreement, instrument or other document means such agreement, instrument or other document
as amended, supplemented and modified from time to time to the extent permitted by the provisions thereof and (z) to a statute means
such statute as amended from time to time and includes any successor legislation thereto and any regulations promulgated thereunder.
This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the party
drafting an instrument or causing any instrument to be drafted. The Disclosure Schedules and Exhibits referred to herein shall be construed
with, and as an integral part of, this Agreement to the same extent as if they were set forth verbatim herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
10.06 Headings.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The headings in this Agreement are
for reference only and shall not affect the interpretation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 86; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
10.07 Severability.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If any term or provision of this
Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability shall not affect
any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction.
Upon such determination that any term or other provision is invalid, illegal or unenforceable, the parties hereto shall negotiate in
good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable
manner in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
10.08 Entire Agreement.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement and the Ancillary
Documents constitute the sole and entire agreement of the parties to this Agreement with respect to the subject matter contained herein
and therein, and supersede all prior and contemporaneous understandings and agreements, both written and oral, with respect to such subject
matter. In the event of any inconsistency between the statements in the body of this Agreement and those in the Ancillary Documents,
the Exhibits and Disclosure Schedules (other than an exception expressly set forth as such in the Disclosure Schedules), the statements
in the body of this Agreement will control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
10.09 Successors and Assigns.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement shall
be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. Neither party
may assign its rights or obligations hereunder without the prior written consent of the other party, which consent shall not be unreasonably
withheld, conditioned or delayed; <I>provided, however</I>, that prior to the Closing Date, Buyer may, without the prior written consent
of Seller, assign all or any portion of its rights under this Agreement to one or more of its direct or indirect wholly-owned subsidiaries.
No assignment shall relieve the assigning party of any of its obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
10.10 No Third-party Beneficiaries.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as provided
in Section 6.03 and ARTICLE VIII, this Agreement is for the sole benefit of the parties hereto and their respective successors and permitted
assigns and nothing herein, express or implied, is intended to or shall confer upon any other Person or entity any legal or equitable
right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
10.11 Amendment and Modification; Waiver.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement
may only be amended, modified or supplemented by an agreement in writing signed by each party hereto. No waiver by any party of any of
the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any
party shall operate or be construed as a waiver in respect of any failure, breach or default not expressly identified by such written
waiver, whether of a similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay
in exercising, any right, remedy, power or privilege arising from this Agreement shall operate or be construed as a waiver thereof; nor
shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof
or the exercise of any other right, remedy, power or privilege.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 87; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
10.12 Governing Law; Submission to Jurisdiction; Waiver of Jury Trial.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York without giving effect
to any choice or conflict of law provision or rule (whether of the State of New York or any other jurisdiction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
ANY LEGAL SUIT, ACTION OR PROCEEDING ARISING OUT OF OR BASED UPON THIS AGREEMENT, THE ANCILLARY DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED
HEREBY OR THEREBY MAY BE INSTITUTED IN THE FEDERAL COURTS OF THE UNITED STATES OF AMERICA OR THE COURTS OF THE STATE OF NEW YORK IN EACH
CASE LOCATED IN THE CITY OF NEW YORK, AND EACH PARTY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF SUCH COURTS IN ANY SUCH SUIT,
ACTION OR PROCEEDING. SERVICE OF PROCESS, SUMMONS, NOTICE OR OTHER DOCUMENT BY MAIL TO SUCH PARTY&rsquo;S ADDRESS SET FORTH HEREIN SHALL
BE EFFECTIVE SERVICE OF PROCESS FOR ANY SUIT, ACTION OR OTHER PROCEEDING BROUGHT IN ANY SUCH COURT. THE PARTIES IRREVOCABLY AND UNCONDITIONALLY
WAIVE ANY OBJECTION TO THE LAYING OF VENUE OF ANY SUIT, ACTION OR ANY PROCEEDING IN SUCH COURTS AND IRREVOCABLY WAIVE AND AGREE NOT TO
PLEAD OR CLAIM IN ANY SUCH COURT THAT ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT
FORUM.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT OR THE ANCILLARY DOCUMENTS IS LIKELY TO
INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE
TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE ANCILLARY DOCUMENTS OR THE TRANSACTIONS
CONTEMPLATED HEREBY OR THEREBY. EACH PARTY TO THIS AGREEMENT CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE OF ANY OTHER PARTY
HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT SEEK TO ENFORCE THE FOREGOING WAIVER IN THE EVENT OF A LEGAL
ACTION, (B) SUCH PARTY HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) SUCH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (D) SUCH PARTY
HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 10.12(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
10.13 Specific Performance.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The parties agree that
irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof and that the
parties shall be entitled to specific performance of the terms hereof, in addition to any other remedy to which they are entitled at
law or in equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
10.14 Counterparts.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement may be executed
in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement.
A signed copy of this Agreement delivered by facsimile, e-mail or other means of electronic transmission shall be deemed to have the
same legal effect as delivery of an original signed copy of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[signature
pageS follow]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 88; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first written above by their respective
officers thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BUYER:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIFEMD,
    INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>signatures
continued on following pages</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 89; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLER:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Taylor</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>signatures
continued on following pages</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 90; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLER:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">R
    FUNDS, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ryan
    Rockefeller</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&bull;]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>signatures
continued on following pages</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 91; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLER:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maya
    Baratz</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>signatures
continued on following pages</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 92; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLER:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Blaiss</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>signatures
continued on following pages</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 93; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLER:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zeeshan
    Kaba</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>signatures
continued on following pages</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 94; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLER:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payel
    Gupta</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>signatures
continued on following pages</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 95; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLER:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephanie
    Kennedy</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>signatures
continued on following pages</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 96; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLER:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wei
    Wei Li</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>signatures
continued on following pages</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 97; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLER:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RIVERPARK
    VENTURES III, L.P.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RP
    VENTURES INVESTMENTS III, LLC, its General Partner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 98; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF ESCROW AGREEEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[to
be attached]</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 99; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
B</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF INVESTOR REPRESENTATION LETTER</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[to
be attached]</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 100; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
C-1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF KEY EMPLOYEE AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[to
be attached]</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 101; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
C-2</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF KEY EMPLOYEE AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[to
be attached]</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 102; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
1</FONT></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SELLER
LIST AND PRE-CLOSING OWNERSHIP<B><SUP>1</SUP></B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of Shares</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">R
    Funds, LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,000,000</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Taylor</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,000,000</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zeeshan
    Kaba</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">168,000</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payel
    Gupta</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,115,000</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maya
    Baratz</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,000</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Blaiss</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,000</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephanie
    Kennedy</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101,300</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wei
    Wei Li</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,500</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IMA
    Creative LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,533</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">River
    Park Ventures III, L.P.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,284,620</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AVG
    &ndash; FV Cleared 2020 Trust</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">174,931</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Green
    Egg Ventures, LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">233,354</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Victoria
    Grove, LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">231,076</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jesse
    Morris</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,243</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mindset
    Holdings, Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">92,901</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purple
    Sage Ventures, LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,217</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CL
    Fund I, a series of Wisdom Partners, LP</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">580,663</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP>Assuming vesting of all outstanding shares and achievement of all conditions to closing as set forth in this Agreement on or before
January 17, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 103; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
2</FONT></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADJUSTMENTS
TO CLOSING PAYABLES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 104; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
IMMEDIATE RELEASE </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
12, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contact:
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric
Herman</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>eherman@kivvit.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LifeMD
Expands Patient Offerings by Acquiring </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Leading
Allergy Telehealth Platform </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Acquisition
of Cleared Further Diversifies LifeMD&rsquo;s Telehealth Offerings to Encompass </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Allergy,
Asthma, and Immunology </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Acquisition
Expected to Synergize with LifeMD Virtual Primary Care Platform</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Acquisition
Expected to Contribute to Growth and Value for LifeMD Shareholders</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>NEW
</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YORK, January </FONT></B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12<B>,
2022 &mdash; </B><U>LifeMD, Inc</U>. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced it has acquired
Cleared, a rapidly growing nationwide allergy telehealth platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cleared
(www.getcleared.com) is a telehealth brand that provides personalized treatments for allergy, asthma, and immunology. Its offerings include
in-home tests for both environmental and food allergies, prescriptions for allergies and asthma, and FDA-approved immunotherapies for
treating chronic allergies. It boasts a network of medical professionals and providers in all 50 states, a growing pipeline of pharmaceutical
partners, and treatments and tests that cost up to 50 percent less than the brand-name competition. The offerings include free consultations
and ongoing care from U.S.-licensed allergists and nurses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;This
acquisition represents a major step forward for LifeMD&rsquo;s mission of redefining and elevating American healthcare. Cleared is a
transformational addition to our growing portfolio of telehealth capabilities and moves us beyond treating lifestyle conditions into
chronic conditions with large addressable market demand,&rdquo; said LifeMD Chairman and CEO Justin Schreiber. &ldquo;Cleared is at a
stage of rapid growth. We&rsquo;re excited to work with their talented team to continue advancing the way Americans with allergies and
respiratory conditions receive treatment.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">More
than 75 million Americans, or 1 in 3 adults, suffer from allergies or asthma. In the U.S. alone, patients make approximately 24 million
visits to a doctor for allergies or asthma each year, spending $11 billion on allergy and asthma medications and about $2.5 billion on
visits to allergists.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cleared
has strategic partnerships with several biotech companies that have proprietary, FDA-approved medications and in-home diagnostics that
are best-in-class for asthma and allergies. These partnerships allow Cleared to offer patients lower-priced allergy treatments by leveraging
the efficiencies of a vertically integrated supply chain. Its direct, &ldquo;B2B&rdquo; relationships with pharmaceutical companies give
Cleared direct access to new treatments, including home-testing and disease modifying medicines.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acquisition marks the latest stage in LifeMD&rsquo;s journey. It follows a year in which LifeMD served record numbers of patients and
customers, hit record volumes in telemedicine orders, added highly respected experts to its Board of Directors, and is launching its
own primary care platform. Cleared, for its part, has quickly become a &ldquo;one-stop shop&rdquo; for allergy, asthma, and immunology.
With its easy online process and roster of board-certified and licensed allergists and immunologists, Cleared is on a path to becoming
the largest allergy-treatment network in the country.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;This
highly synergistic acquisition marries LifeMD&rsquo;s robust telehealth and marketing infrastructure with Cleared&rsquo;s bold vision
of providing bespoke medical treatment to patients with allergies and immunological conditions,&rdquo; said LifeMD President Alex Mironov.
&ldquo;The vertical integration between cutting edge at-home diagnostics, virtual allergist/immunologist visits, FDA-approved medications,
and immunotherapies has created a first-in-class destination for end-to-end allergy treatment. We expect this acquisition will accelerate
growth and enhance value for LifeMD shareholders.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;I
am thrilled to be pairing up with LifeMD, a company that has quickly become a leader in telehealth,&rdquo; said Cleared co-founder and
CEO Ryan Rockefeller. &ldquo;Both LifeMD and Cleared share the same values of helping patients and transforming healthcare to be patient-centric,
transparent, affordable and convenient. I look forward to working with LifeMD to continue developing a robust ecosystem of treatments
and medical support.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to accelerating LifeMD&rsquo;s revenue growth, the acquisition of Cleared is expected to be accretive to LifeMD&rsquo;s Adjusted
EBITDA in 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Compelling
Strategic Benefits</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LifeMD&rsquo;s
                                            technology infrastructure and marketing expertise expected to catalyze Cleared growth:</B>
                                            LifeMD brings commercial, medical, regulatory and technology infrastructure and expertise,
                                            helping to rapidly accelerate Cleared&rsquo;s growth in the $13.5 billion U.S. allergy market.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cleared&rsquo;s
                                            offering is synergistic with LifeMD&rsquo;s current portfolio:</B> Cleared will bring to
                                            LifeMD a portfolio of personalized treatments and diagnostics that is highly relevant to
                                            LifeMD&rsquo;s current patient population and impending virtual primary care patients. LifeMD
                                            expects this transaction to serve as a framework for future partnerships and/or acquisitions
                                            in the traditional healthcare product world.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accelerates
                                            LifeMD&rsquo;s Revenue and Adjusted EBITDA Growth:</B> Cleared was launched in 2019 and addresses
                                            significant addressable markets in allergy and other immunologic conditions. In addition
                                            to accelerating LifeMD&rsquo;s revenue growth, the acquisition of Cleared is expected to
                                            be neutral to accretive to LifeMD&rsquo;s Adjusted EBITDA in 2022 and significantly accretive
                                            thereafter<B>.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Transaction
Terms </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the agreement, LifeMD will acquire all outstanding shares of Cleared at closing in exchange for a $460,000 upfront cash
payment, and non-contingent milestone payments for total of $3.46 million ($1.73 million each on or before first and second anniversaries
following the Closing Date). LifeMD will purchase a convertible note from a strategic pharmaceutical investor for $507,000. LifeMD also
agreed to a performance-based earnout based on Cleared&rsquo;s future net sales, payable in cash or shares at LifeMD&rsquo;s discretion.
The acquisition is subject to customary closing conditions, including applicable regulatory approvals and is expected to close in the
first quarter of 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
LifeMD</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LifeMD,
Inc. is a rapidly growing direct-to-patient telehealth company that offers cash-pay virtual medical care across all 50 states. LifeMD&rsquo;s
telemedicine platform enables virtual access to affordable and convenient medical treatment from licensed providers and, when appropriate,
prescription medications and over-the-counter products delivered directly to the patient&rsquo;s home. To learn more, go to&#8239;<U>LifeMD.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Cleared </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cleared
is a direct-to-consumer telehealth destination that provides end-to-end personalized care for allergy, asthma and immunology. Cleared&rsquo;s
strategic partnerships and ever-expanding network of US-licensed Allergists &amp; Immunologists provide patients with fairly priced prescription
allergy medications and immunotherapies via its telehealth clinic. For additional information on the Company, please visit its website
at <U>http://www.getcleared.com</U> The information on its website does not, however, form a part of this press release.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cautionary
Note Regarding Forward Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section
21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform
Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: &ldquo;believe,&rdquo;
&ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;project,&rdquo; &ldquo;should,&rdquo; &ldquo;plan,&rdquo; &ldquo;will,&rdquo;
&ldquo;may,&rdquo; &ldquo;intend,&rdquo; &ldquo;estimate,&rdquo; predict,&rdquo; &ldquo;continue,&rdquo; and &ldquo;potential,&rdquo;
or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking
statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance
and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving
regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the
effects of any of the foregoing on our future results of operations or financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations,
beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy,
and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements
relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult
to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may
differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited
to, &ldquo;Risk Factors&rdquo; identified in our filings with the Securities and Exchange Commission, including, but not limited to,
our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results,
performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative
of our actual results, performance, or financial condition in subsequent periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
forward-looking statement made in the news release is based on information currently available to us as of the date on which this release
is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future
events, or otherwise, except as may be required under applicable law or regulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Contact </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LifeMD,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marc
Benathen, CFO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Email
Contact</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ashley
Robinson</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LifeSci
Advisors, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>arr@lifesciadvisors.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric
Herman</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kivvit</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>eherman@kivvit.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "? 1,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;N*:#4F,5N-I(F.#D8Q['.:)2O)22",;1<7(\XE\6Z](UU+%+,(?$),>C?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>lfmd-20220111.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaCOabP9z5Z8OekhvWB+bYnKzyYnr6WExSmqjK4mATsI -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:LFMD="http://lifemd.com/20220111" elementFormDefault="qualified" targetNamespace="http://lifemd.com/20220111">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://lifemd.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="lfmd-20220111_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="lfmd-20220111_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="lfmd-20220111_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="LFMD_CommonStockParValue0.01PerShareMember" name="CommonStockParValue0.01PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember" name="SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>lfmd-20220111_def.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://lifemd.com/role/Cover" xlink:href="lfmd-20220111.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20220111.xsd#LFMD_CommonStockParValue0.01PerShareMember" xlink:label="loc_LFMDCommonStockParValue0.01PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LFMDCommonStockParValue0.01PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20220111.xsd#LFMD_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember" xlink:label="loc_LFMDSeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LFMDSeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>lfmd-20220111_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20220111.xsd#LFMD_CommonStockParValue0.01PerShareMember" xlink:label="LFMD_CommonStockParValue0.01PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CommonStockParValue0.01PerShareMember" xlink:to="LFMD_CommonStockParValue0.01PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CommonStockParValue0.01PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.01 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20220111.xsd#LFMD_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember" xlink:label="LFMD_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember" xlink:to="LFMD_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>lfmd-20220111_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://lifemd.com/role/Cover" xlink:href="lfmd-20220111.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20220111.xsd#LFMD_CommonStockParValue0.01PerShareMember" xlink:label="loc_LFMDCommonStockParValue0.01PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LFMDCommonStockParValue0.01PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20220111.xsd#LFMD_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember" xlink:label="loc_LFMDSeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LFMDSeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139841265075192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 11, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 11,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39785<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIFEMD,
INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000948320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">76-0238453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">800
Third Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 2800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New
York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(866)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">351-5907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=LFMD_CommonStockParValue0.01PerShareMember', window );">Common Stock, par value $0.01 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value
                                                                             $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LFMD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=LFMD_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember', window );">Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Series A Cumulative Perpetual
    Preferred Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LFMDP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=LFMD_CommonStockParValue0.01PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=LFMD_CommonStockParValue0.01PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=LFMD_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=LFMD_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:LFMD="http://lifemd.com/20220111"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lfmd-20220111.xsd" xlink:type="simple"/>
    <context id="From2022-01-11to2022-01-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000948320</identifier>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="From2022-01-112022-01-11_custom_CommonStockParValue0.01PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000948320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFMD:CommonStockParValue0.01PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="From2022-01-112022-01-11_custom_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000948320</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFMD:SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-01-11to2022-01-11">0000948320</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-01-11to2022-01-11">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-01-11to2022-01-11">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-01-11to2022-01-11">2022-01-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-01-11to2022-01-11">LIFEMD, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-01-11to2022-01-11">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-01-11to2022-01-11">001-39785</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-01-11to2022-01-11">76-0238453</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-01-11to2022-01-11">800 Third Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-01-11to2022-01-11">Suite 2800</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-01-11to2022-01-11">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-01-11to2022-01-11">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-01-11to2022-01-11">10022</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-01-11to2022-01-11">(866)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-01-11to2022-01-11">351-5907</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-01-11to2022-01-11">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-01-11to2022-01-11">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-01-11to2022-01-11">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-01-11to2022-01-11">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-01-112022-01-11_custom_CommonStockParValue0.01PerShareMember">Common Stock, par value                                                                              $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-01-112022-01-11_custom_CommonStockParValue0.01PerShareMember">LFMD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-01-112022-01-11_custom_CommonStockParValue0.01PerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-01-112022-01-11_custom_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember">Series A Cumulative Perpetual     Preferred Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-01-112022-01-11_custom_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember">LFMDP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-01-112022-01-11_custom_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-01-11to2022-01-11">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M*S*NR;?E\D3^<+TJ,EK8/L4]^C]DXR1)@:P*L$*V$K#P>WJ6WX\BKE<VGU]
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ &X<L5*K$(A8S 0  (@(   \
M  !X;"]W;W)K8F]O:RYX;6R-4=%NPC ,_)4J'[ 6M"$-45Y VY"F#8V)]]"Z
MU"*)*\>%C:^?VZH:TE[VE-S9NMQ=%A?BTX'HE'QY%V)N:I%FGJ:QJ,';>$<-
M!)U4Q-Z*0CZFL6&P9:P!Q+MTFF6SU%L,9KD8M;:<W@(2* 0I*-D1>X1+_)UW
M,#ECQ ,ZE._<]'<')O$8T.,5RMQD)HDU75Z(\4I!K-L53,[E9C(,]L""Q1]Z
MUYG\M(?8,V(/'U:-Y&:6J6"%'*7?Z/6M>CR#+@^H%7I")\!K*_#,U#88CIV,
MIDAO8O0]C.=0XIS_4R-5%1:PIJ+U$&3HD<%U!D.LL8DF"=9#;E9T!N[RZ .;
M<L@F:NJF*9ZC#GA3#O9&3R54&*!\4YFHO/93;#GICEYG>O\P>=0>6N=6RKV'
M5[+E&''\GN4/4$L#!!0    ( !N'+%0D'INBK0   /@!   :    >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S
M(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.
MXS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X\ \PO%WH
MJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W
M1:[-XPFNWPQP>'3^ 5!+ P04    "  ;ARQ499!YDAD!  #/ P  $P   %M#
M;VYT96YT7U1Y<&5S72YX;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M=< %C3QJK
M_I-G6M+;,T[:2J 2%85-K'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4'3F(=(GBN
MM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!-F<!B63R-
MPLQJ2AFC-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>
MI6.5Z*U .EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!
M9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8
MYL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( !N'+%0'
M04UB@0   +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL
M4$L! A0#%     @ &X<L5%=9[%KN    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ &X<L5)E<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  ;ARQ4,""#,I8$  "V$P  &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ &X<L5.#T.HFJ @  , P
M  T              ( !V0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  ;
MARQ4EXJ[',     3 @  "P              @ &N#P  7W)E;',O+G)E;'-0
M2P$"% ,4    "  ;ARQ4JL0B%C,!   B @  #P              @ &7$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ &X<L5"0>FZ*M    ^ $  !H
M             ( !]Q$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ &X<L5&60>9(9 0  SP,  !,              ( !W!(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  )A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>122</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>ex2-1.htm</File>
    <File>ex99-1.htm</File>
    <File>lfmd-20220111.xsd</File>
    <File>lfmd-20220111_def.xml</File>
    <File>lfmd-20220111_lab.xml</File>
    <File>lfmd-20220111_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "lfmd-20220111_def.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lfmd-20220111_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lfmd-20220111_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lfmd-20220111.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 65,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 122,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "LFMD",
   "nsuri": "http://lifemd.com/20220111",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-01-11to2022-01-11",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://lifemd.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-01-11to2022-01-11",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "LFMD_CommonStockParValue0.01PerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.01 per share"
       }
      }
     },
     "localname": "CommonStockParValue0.01PerShareMember",
     "nsuri": "http://lifemd.com/20220111",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "LFMD_SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share"
       }
      }
     },
     "localname": "SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember",
     "nsuri": "http://lifemd.com/20220111",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://lifemd.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001493152-22-001058-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-001058-xbrl.zip
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M. <S-8IBA7T9=!IYSO2<Z3ES#3CS +,2"I5W2I7U.$&>)?O+DEABDLY4)BL
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M,?+&?=%M/+-VV]1KBKO6^03]DCE\QG])" =$<O0G7:"H6>7,GF[C+)T*\X"
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MO4S3Z%H#_1I5W!(H_E;:KIN1R.?3$<@UQID.:J)7ER;)BA/.7+H;FVZ$]O?
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MAGB;89WO>0FB6[Q_O[,?B#_2-!J5&0(Z??RWV-U]\:IWF-3K.NJ:*"8RNP^
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MK3H9#II#G!&^('9/VEQJ '6'L>0K]F@J<6(2^X.-8FZ(A;5M"T5<Y/!A8ED
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M Q\0%>&J.]M+'+F6/FS6"K%S7#4[?)V5UU6R)@G&J9FP&]-67L56+E2Y#:W
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MR'TGS,"EC(U0+J2SF:D_!22SP=&35]K7ARN16K[KHC2ERY8J38%I/A++U@K
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M415NTZ$A'F7,S%+ ];JH7RU>.4@NO,P6,E='D8N@PY]F0<JV>2YFL%^H8Z)
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MX7RS #)V\?J%,RHNK<5CNUGYI.BT@#[ISCXF%+\EVTG><KZ9*"N,D/6ZS %
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MI[?IE]BS0\6[<Y7U F[X\B])7@FW4/0+R5*:5&F-]+K6WRWH=)>0.0?M;0[
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M/VC\*R^*W(MO'398WIO03FCX%L:/7>EF;:,QZ$F4-5H0H-O=0#@\7(_]_="
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M<*5\0F/;8Q-2YX,)WF[E?%V2-5UK+H)_:P2$;G]-R\0AU6,)BS .2X+G/M1
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M: [/+00Q;D]WXZN^KH)I8BNT!E29QT2KN6%#WKBVI_TBHF4AK530!$&:7].
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M"R7:D+:M"3<>I;5 6(H=M;/^>_23.KQ%#[CBCMX:YW?"RQU$2:$(QUVIEB#
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MG).'CW4KG.!<?8/O5?2!2<SYU/BY)2.BSKYP.(5.<(.4@VK^Y2:A\V\Z(24
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M5^4GDI4OI(;)Y)CQ V W%UHSXVG765)\TCV7H9AA*:P8TMH"OTN Z96?6OH
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MRSN/O.G4A?6D-F9O^^W=F^(##0B'%%3Z![\#67"VN0UFR2FL7YU[=PAZF,7
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MM!5.<*Y^J/5-]#$#$$.2C%^H?B$,Y&E'3QNQI_.![/J&+1TWE%C)'')IR6&
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M5OMYL$UZ=]WG1EG>N3(H,2/R=3AY:XAS5$2D2K!@APY 9E#DQ&3 &#WYI\C
M;7^OW=)?I$H1E*W15!6,>!4Q*_=-89-)GD L8Y2AADOK23YA7F4R492MPT$(
MVR:YQ46:<F1+/\FV9$PB@]:F$?3UF1NSE(TI[9*A7!4AS&16#DT5;N?T+W3I
M UT 7%3) [2!1\5O*I%&28NPF6F<8_S  "7NI$DP/TAW/#!/D$HHG1J6>+?N
MOL7RRZW:MUGV^O'(_XX)LC5%T862F4M_JQJ(BYR7Y,K;K4^]C9F5/)W/3)S
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M5@8$![Z,'\L>H];.P3(A/* :&HV5=C/S=-,6_FTX0%H1ZL6-]*'84Q[#$Z%
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M.*'VG<?>),R\48D"SXK:%\Z?Y-%T[H"O/YE\%E#,$?F)1G24QB;2+XD*OQ#
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MD8%=9S+*4^<Y5T!MPJ71G*&Z,W2P[YS#=^'N6=(1NBKB5E7C2L,23BTK,$B
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MJ<X(M+M8%&PR5#P3-"((X"19#2\M83DK]Y.5U#-!7WZGBIK>W<1CFX@ '?3
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M '712;-:H[\0,E?<W_0QQ3WX%6/O6SC.Q[8LSG0YO'2.'5=;:,.Q2++4F"[
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M8EOJPZ=;/Q!/ZN%EYF#H>2-2W\2*:(7/<>2)Z@XE]>R USGUG/J?L,+5O$D
M[+DJA9,9G\R2<_:$V!7B.O$D[!ZV;,4?I-JQF3=Y#[JXXITHG*N&;[F[P C?
ME,6Q26!6HS^CT<@GBR+#XHF"9IJ)VR/B":V5<AP-J$*4@)WAG?NS0@CBFYHV
ML_2V&1EW0H34U-QN><E8=RO\!2^ONP-C''HYVJWC/.GY,Y^K!W0_Y0BPSU9P
MVL6QCN/9>9U"B,T*'%S+Q!KGED]!]L1JFGNIGS*V.0J5DQ:[11=4W<;[P6Z,
M:UJ^V$;6/8B+LYET]@ORK')O&PJK01M8TSQ8>J45V\#^=F$ENMQ>2+W2/GE
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M#;V.\V8R2'I39(--CG(:3;<_'%SES4^"$C9UA2\5@ R:Z3P<9_26+DQY?0V
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M3 F8"VYQ'PI[/%W2V*4+H]-[M_ECJ_>/)4W<TZVB?P3:#50ZF0#DS$R31 G
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M$F5"_ ?UA"YC<'&"<0!I)W#?/=_G4W.+1WTT0ZP2P@N >H4 0ZHB605ZW!3
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M"R&CF@[=<NX>B?=09N\).1CKZ9]#%>[)"+PXNA&(7+S/@9&D@S@S>_D@T26
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MK3"/S;FAPWE@GM]A)-(%3(I-\G+#HX%B>C!<2-?A(3K8N8&FF@(+BB?'TC=
M+>;':8+ N9!.2<*7/?(@.UZZ@;G!?"/D@W:36!)D/M@>:.$%G%.-XQCT%=X6
M$FP>]][M0V(GQ[@76NY<GHRIB:=T5>$Z" (HR'J"T.E4YD>2?\R1'R&GB@X4
M)<5A-C,M#^.Y(_C4+Q5O^\:R'7@:&0__IN=4QY/1\-2-9GOBM!4_-HDSR9TE
MEC.)9$(VPY\B'H*T#6/;L0R6N9F/G&\BI7'>"C:0:YE@9\,*WZ-PR$F(-!OY
M:#&?#^[3IJ&1Q-/-D4HM<40.R58<L>"N\2CR18< ;I  Q4/SF  5/&_,!]A
M.XO!;% WF@U85IV.D@X'M '%RG E@0D4HYP^O&S&YI!AP5Q,5PS[93/LT(>X
M@S[$H_#2GYB%Q>,RPMI'^;NRI%X.'FOJ>C83K,WK1V>Y7R47D_CS=X52(F&/
MQJJTL577S'@,Z-40 7 D2=%RHJ8Y#O_X*O$ZLZ;YYZ_>MBMW0(@#IYH8%90Y
M$3SG3<&+).8G?U*G%24Z+O*]G%^Z##_U<OW%85W9*/_W25^!>K$W4S_QQ.Y3
M,G#P.E VKA3*&P,/9F+>O41YKM.K4TG;0>1OOTC_"%+$T-&*%)^6%'=V EJ\
MX'Z5CHCL!@08DE[E-9!>N51[*D*)9>4L&NHFGH7E^5&DC3*,BH,J+>I1,+A
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M?K]YZ(_/M<_#\MW?X[\_WO9JY7J_\[=YWKIH?=@Z=(:5TS<!Y?T_4$L#!!0
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MNWA 1NM\Z"J/  &L 83D:C2_G+D>5>[P[C+DP$;+2"U&[" %U-L%IL-VG1M
M[!$^[0X!BG@0JD>YANDR"2C;T,KC$C.ZY9WA\XR&\(RE(\HN6+VJ4,>K-<0C
MR/KX!%"KA;Y1S[0@*A:2RP*0*,$9=6=AR$]6FO]S%25D IX#H]8N82UVZUP9
MA![1!+L#&,J5;XH/2,2@F\0G<*8'5'?J'IQI7W"F7H,S?0DX=T_4(W".#ZCN
ML7MPCON"<^PU.,<O H<WOO,^9\8_WK [^F1ZX!M4.L&F:=4(S5[F'S(-;UW
MB  QOQ$AKE&1DZT;=LOH8Y0$\#0:DCN!!C!M)$?3^H>/V6 70^4DN8AS#5(^
M6>_\LA0R-[U-W:2YJU$:_T"I&^OL9)3:-1:W-,UP_)]HTWJ1;A8[0<1HV A*
M3>D?+B9[7="H&,2#7%UTY]B*'T",R]6T_=9^I3;9*G^:KN[T @23HV:V#W5W
M18E<-+5@E1$,] SUW=8:VF"J;.?*/C^:N6FHT<KR^\TUKK[0(@UA?'M/$_CA
M@J;$5FM#YHH6U_=[T>J *;WEI0Q)G<,[]R(=6FKNRBO[K(WTNIUR8"]V>-'"
MNIO&L%WL=]"BO[$HXT<7N:*V2?[+D.D91$!GJZ5;;1:M;A1Y04";,YV&7(OJ
M8@=HS&D<!5$6):N/_.*41=A4,Y/(%A2PP8*(IL(+'$!;C6PRI1 52@<@W#(B
M8"2\,>2"0Y$1D]TLE\;1OTUL"XQNPP4@L-(+4#KMZ<#P@&%0B4 J!,D8]^A<
MINF6L(, ,H0XP@@T#\#4T/N(%&2R$RP5Z)JO.0FV?+Q\GDP7=U'62(UGEE@;
MGP!SY>BD[?>"#\"4SH/<)]+53J9_6WR/BB@'"%S3.X;%&Q#FS^L%C8%,6$:5
M+1!:+!8L&"1>X #[THFXIBB7(J5UE2FK9MA0)6V_+0B,MHKFK^WTHN%-CAJ=
M0*V]'7;_Y[O@GALCP&('L\SV,& RJ0\%58T7&+08:V;=55)4:%TM=M@/8:ON
M2<'*V:1@U3$I6/DX*5CUG12LG$X*BD.K-"6\C[I9Q-$* TD36]6VP6BQK#-B
MD'J%"^P/[#O*$+2/<9%M4Z9=$^^=8FOIX8)_,-04T%G+M]EFLTRX:1)YP4F;
MLT;*394(KR)&0NV"C6T89214ABZB!"=!A.,R=:/I[GEWB#5B>IHOX>G0^\%1
M/Y,-I%18D6.Q#-RGX71QVUT]Q/$;B>-?$_J4S E.:4)"=;_%].M2N][N4S<=
MMNL/W@!B+Y#JXQ!X_$8$#1]$%"K"\KMESFCZ0N-MDF$FU[ S4P\%Z.S2 ]BL
M4Z.)/*+%[ R@I!0CI7:W*%QEKR@G7NH%FV E(;GE)>*MIK65XD:M1]RT&H36
MC><Y1_;S917E<#EG1A@.Q+MV/N ,Y_[ .D-RVPLXVTSK*S=-6H\P:C4(KM4L
M8T2Z&EQPY31M#9OQZ=>*MCQ]KJGL)Z]I6&SFKRDE'B%B\M62Q8:A0NN,A_D:
MQ_'[;1HE)(4')4UEEP>CQ3H/-8E'/)A\ 3Q(*2JTSG@X7Q.VXL/=+XP^9?=Y
M#EFP?H#:+A^MENN<&*4>\=+F#^"F"$$JIDC[ZPZ@W3X!NLH "=?6(+6,#FA6
MXZ:A\PD:R%R#F)@$XG[,-<W0'46?4X*R>X+.\W<P5S/7JW)<OB4E",2""S5;
M3T+,3!BUB:V_,04TW'AO2D/I!4R=]N!WJ)01J AQ0,X-9YE5K_&D$?%^0' E
M17>(+8KZFB]8ZM)[051/DSI7,JQ^X2T#Y;L>76=5JB;DAZ=]-9'EV;+!H#99
MKBB\X 2T!4V5J^\W<)?/;[N(H^ BIAB^"U/36,[BU[2G)?#;"SRBH.D*2MLG
MA4@JG3'P'B</;+O)@N=;1@-"Q--::=ES==VCZQEMEYN#JE0GJE>H1ZP=XA>@
M<%\$JI3QIC)ZN;[A)QY&%QGF:/ @7^R>WFRS5(RHW!Q\Q[PUR/)/$3TJH/T@
MT1+A$7X];$(_3LA()$/?(!6,*M$.K]O2?79"$KY__D26A(DU#7=DE[WG!WMH
MN?+H$6O[JJYW=?2+O,Y +T \U"UT"9BB:@%H(9XSRXM 7T4A2)9B>D][==,5
M_\0W%YOX7PN<$K[E_U!+ P04    "  <ARQ4)YW5GDT(  !C9   %0   &QF
M;60M,C R,C Q,3%?<')E+GAM;-5=77/B-A1][TS_@TN?"1_IUZ:;=K(D=)AF
M-VE(MQ\O.\(6H(DL44E.X-]7,C8+V)(O[7:NNP]9!XZD>\Z195U;<E[_N$YY
M]$R59E)<=@9G_4Y$12P3)A:7G5^GW:OI:#+I1-H0D1 N!;WL"-GY\8?//XOL
MO]=?=+O1F%&>7$37,NY.Q%Q^'[TC*;V(?J*"*F*D^CYZ3WCF/I%CQJF*1C)=
M<6JH_6+;\$7T]=E@0*)N%U#O>RH2J7Y]F.SJ71JSTA>]WLO+RYF0S^1%JB=]
M%LL45N'4$)/I76W]=;_XMRW^FC/Q=.%^S(BFD=5+Z(NU9I<=UV[1[,OYF52+
MWK#?'_1^?WL[C9<T)5TFG&XQ[92E7"UUY0:O7KWJY=^6T IR/5.\;..\5X:S
MJ]E^RP+XO4@TN]!Y>+<R)B:WO;&9R(MPOW5+6-=]U!T,N^>#L[5..J7XN8)*
M<OI YY'[W[JW:Y6S.4T39U?/?=4;2=L=;9QYH:6B\\L.GZ>)K7LX[ \&><U?
M'H#,9F6[I6:N5W6BWD&K*T4U%28G>FL_."A"U\9V)IJ4%;GV87$99ARTZ"B#
MJ.MZ59;:ENSA%EF$40;"97S0-G?JRR.B94_.-=8T/EO(YUY"F=5Z./CK*W?8
MW1[F*MA?/^2-7<VT420V96V<S"C/V_A@,4>0WK^.;$[T+.\"F>XN"%GEX?4H
M-[K\)(^RVQ\4/>'+XN,/[ERC3J9',G-F5<(M@,>XXYCW;;U2A_$3%9<5V\,#
M3ZO]MT#T5D39^KKQDO%==Y@KF?I$+!J4P:BE2JBRHVJ_WQ+5[1E )_90 Y3?
MPR*K[U$W;,%>^(4-P];8,.)$Z[OYU,CXZ6K-(&Y4B_P?3:FRV)TBN-;L!W8M
M4\*$WY,Z;,O,\'6P(U_JF!2&_%,_JI?JV_';:WN52E,I\H;NB<IG6OVS_N">
MJNG2,GM+T]G'B^N>Y*XPL&R3!;M1X#\2W]^%2M5/(%/I+Y_2C"E5C.I1EF;<
MJO-,;>,K:C+"[VTIJA1-CN/K ZWZ)#4#C3S'-?(3BOAO;?X'L\9RMOIH:ZV?
M-!XB@)[\5Y;X)S"E)96(T:2]LC$D+HXQ)XMZ;8\@0'$'J.K6TL*4]YKJ6+&5
M$ZE!Y0,D]F7B-+%K2"*.%@]TP5P"Y,+9\0@/'YXBV&/\20-*D#:B'5="V.O-
M UU)U>#"(1(H_E>M$+^.)*+FOV1$&:KX!B)[!0Q4_NM6*.^ABCE;441HYL2"
MJ%]% ^7_IA7R^\@BZC]=4L[=W7LB0/V_#@_TX-M6>. GW!(7;I[=),$R@ANQ
M5P3HQ7>M\Z)"&]$.F],Q:9,].U@V&U$! RUXU0H+/%31Q;\1"53Z'12<=+5(
M^2.>B+J/F8X)WT8UMI_5W<+>"[\&#M4?-^MMY(ONP1^4*+ #>V"H_KB)< -7
M!/5'F5(' 04''S\:JC]N"MS$%L& &V&8V;B5).\RSZUH"ZNBH(+CIKT^=FA"
MES<_A'&K94)B'R.A@N-FNR&6:**/;-"*\(E(Z/IGN@FI7H%"9<?-<H,\T72_
M5RPE:C-E<?/84L5"E<?-;<-,T:1_).M)8D-G<[9=EM;L@+<(U C<Q!;$&\V/
MB8BE6LF]N]XCF=FS=3.22? RT% 0Z@UNQGN"!F@.726)U4X7_SDV@Y OM7#P
MT[ 6N!'@VR(/AJ=Y,(1[@)L)-_)MD0?GIWEP#O< -QMNY(OMP<@>WJE'^>)Y
M).\%0_7'S88;N&*KGW.X4_=*/K/M6O\F"RHEH#ZT(4D.L\8VHY@I0,Z#$@D5
MOPT)<SU+;-'OI3:$_\E639/4>CS4@#:DSB'&&+=%MQW!W4?QK<<Z@D#%QLV6
M:WEAZ.LL5Y3X._8A JHN;@I<QPI!W%OI'NXLI0C>4JZBH"+CYK(^=AB#M=MP
MI[TCQ-[7X 6"N$/Q,1\$37]3S-@HW,:"3!3WD#P/ SU0J-:X"6B0)X+N4\E9
MS P3B[<V>L4(KQ>]#@=5'#?=]#-$D/M>46<]M5/\?'6<V[BK[N9SWV@=PD/E
MQ\TVFQGCVS#1.J/J5#-J2D$MP4T\H>PQAB,:9W:$W R&LT>W.=TS&%504.%Q
MDTX?.P2AW\E'1=S[,::;=":Y?Y=/+1 J-VZ*&>"(H/A!+/5:'T&@*N/FEK6\
M$(>.FW6\)&)!_0L]ZI%0M7%SS1!+U/%Z 1JO%R>.U[@YIX\=HM#;]?OV?+N;
M<;8@_GV#P0+@O5.MD#_ &6/K9KZ5R[UZ2:5Y+&-[4.^!!PI5'WFK;(@GANY9
MP@Q-MF&-F2 BMKG<CHKG9D%S*:@;R'MI@>S1GEW\1CG_6<@7,:5$2T&3;5H1
M>GSA+0*UI W/41MXH_GQ7O+,2J;R5;C*<W9XH%#]V_#\U,,3;]'K=JWY[IJU
M?2]?2'Y?":@+;7B0&F:-N/S/4/>F,_9,KXDA190A,WPEH&:TX:%JF#7J9@<U
MLBP6,KRBX @(E;X-"Y)K.:(I/DT)YV\R;</6P2'H" A5O TKCVLYHBE^DU*U
ML./?3TJ^F&6QSS>DO*< U($VK"\.<L9S8OWQU0/;'8]!&VK0X-=<M,$#+UO,
M-[O$L5MWLIT.B(0HCP4A/-2$=FRP]3-&L.'.+*G:GY'E 3D*H?4AS:6@EN F
MS%#V>!?GO3=!!*_-!SBH^&U(C>L8XFV*RV:<Q6,N27#^?P"#BMV&/+B&'YK6
M;XAX4MG*Q)M[)6-*W?,AO3L7 5D8L *H/VW(D$_2!._NQ<<7N^:O^-1WF<G_
M:H*-,7@/(U@.ZE,;DF>( HAS*OUQ-Q]-WFP>W%M:W4*.1[HV;VQC3^$I%J X
MU*QVO-L*K$>-9Z][%8*VR2?[;?&-^^'^(H3]Y&]02P$"% ,4    "  <ARQ4
M:RH_H59! 0!&+PL "0              @ $     97@R+3$N:'1M4$L! A0#
M%     @ '(<L5)@."\"$%0  %'L   H              ( !?4$! &5X.3DM
M,2YH=&U02P$"% ,4    "  <ARQ4&9+PS?,?  "RY@  "P
M@ $I5P$ 9F]R;3@M:RYH=&U02P$"% ,4    "  <ARQ4O13KZ.$#   &#P
M$0              @ %%=P$ ;&9M9"TR,#(R,#$Q,2YX<V102P$"% ,4
M"  <ARQ4]=^3>1 )  #+:0  %0              @ %5>P$ ;&9M9"TR,#(R
M,#$Q,5]D968N>&UL4$L! A0#%     @ '(<L5%3[1BT*#   F9$  !4
M         ( !F(0! &QF;60M,C R,C Q,3%?;&%B+GAM;%!+ 0(4 Q0    (
M !R'+%0GG=6>30@  &-D   5              "  =60 0!L9FUD+3(P,C(P
A,3$Q7W!R92YX;6Q02P4&      < !P"P 0  59D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
